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Introduction 
 
In September 1998, the 48th Regional Committee for Africa met in Harare.  
Through resolution AFRO/RC48/R2, Member States adopted integrated 
disease surveillance as a regional strategy for early detection and 
efficacious response to priority communicable diseases for the African 
region. 
 
Communicable diseases are the most common causes of death, disability 
and illness in the African region.  While these diseases present a large 
threat to the well-being of African communities, there are well-known 
interventions that are available for controlling and preventing them.  
Surveillance data can guide health personnel in the decision making 
needed to implement the proper strategies for disease control and lead to 
activities for preventing future cases. 
 
Surveillance is a watchful, vigilant approach to information gathering that 
serves to improve or maintain the health of the population. A functional 
disease surveillance system is essential for defining problems and taking 
action. Using epidemiological methods in the service of surveillance 
equips district and local health teams to set priorities, plan interventions, 
mobilize and allocate resources and predict or provide early detection of 
outbreaks. 
 
Depending on the goal of the disease prevention programme, the 
surveillance activity objectives guides programme managers towards 
selecting data that would be the most useful to collect and use for making 
evidenced-based decisions for public health actions. 
 
A disease control program may want to know what progress is being made 
with its prevention activities.  The program collects age and vaccination 
statues for cases of vaccine-preventable diseases.  If the program’s goal is 
to prevent outbreaks, the surveillance unit can monitor the epidemiology 
of a particular disease so that the program can more accurately identify 
where the next cases might occur or the populations at highest risk.  In 
addition, improving laboratory support for disease surveillance is essential 
for confirming causes of illness and early detection of outbreaks.   Case-
based investigation and laboratory confirmation provide the most precise 
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information about where action must be taken to achieve an elimination 
target.  Monitoring populations at highest risk for a particular disease can 
help to predict future outbreaks and focus prevention activities in the areas 
where they are most needed. 
 
Too often, however, surveillance data for communicable disease is neither 
reported nor analyzed.  As a result, the opportunity to take action with an 
appropriate public health response and save lives is lost.  Even in cases 
where adequate information is collected, it is often not available for use at 
the local level. 
 
What is integrated disease surveillance? 
 
Experiences with some disease eradication and elimination programs show 
that disease control and prevention objectives are successfully met when 
resources are dedicated to improving the ability of health officials to 
detect the targeted diseases, obtain laboratory confirmation of outbreaks, 
and use action thresholds at the district level. Building on these successes, 
the World Health Organization (WHO) Regional Office for Africa 
(AFRO) proposes a comprehensive strategy for improving communicable 
disease surveillance and response through integrated disease surveillance 
(IDS) linking community, health facility, district and national levels in the 
African region. 
 
The IDS strategy provides for a rational use of resources for disease 
control and prevention.  Currently, many intervention programs have their 
own disease surveillance systems.  Each program has made efforts through 
the years to improve its ability to obtain data for developing timely and 
reliable information that can be used for action. They involve similar 
functions especially at district and health facility levels.  They often use 
the same structures, processes and personnel. 
 
In an integrated system: 
 
· The district level is the focus for integrating surveillance functions.  
This is because the district is the first level in the health system 
with full-time staff dedicated to all aspects of public health such as 
monitoring health events in the community, mobilizing community 
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action, encouraging national assistance and accessing regional 
resources to protect the district’s health. 
 
· All surveillance activities are coordinated and streamlined.  Rather 
than using scarce resources to maintain separate vertical activities, 
resources are combined to collect information from a single focal 
point at each level. 
 
· Several activities are combined into one integrated activity and 
take advantage of similar surveillance functions, skills, resources 
and target populations. For example, surveillance activities for 
acute flaccid paralysis (AFP) can address surveillance needs for 
neonatal tetanus, measles and other diseases. Thus, health staff 
who routinely monitor AFP cases can also review district and 
health facility records for information about other priority diseases. 
 
· Surveillance focal points at the district, regional and national levels 
collaborate with epidemic response committees at each level to 
plan relevant public health response actions and actively seek 
opportunities for combining resources. 
 
Objectives of integrated disease surveillance 
 
The general overall objective of the IDS strategy is to provide a rational 
basis for decision-making and implementing public health interventions 
that are efficacious in responding to priority communicable diseases.  To 
implement IDS, WHO/AFRO has proposed to countries a system of 
simplified tools and response actions.  These tools should contribute to 
efficient and timely decision-making based on the use of timely 
information, selection of appropriate responses and effective use of 
available resources for preventing and controlling communicable diseases. 
 
The goal of IDS is to improve the ability of districts to detect and respond 
to diseases and conditions that cause high levels of death, illness and 
disability in the district’s catchment area.  By strengthening skills and 
resources for integrated disease surveillance and response, improved 
health and well-being for the communities in the district can result.   
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To that end, integrated disease surveillance seeks to: 
 
· Strengthen the capacity of countries to conduct effective 
surveillance activities 
· Integrate multiple surveillance systems so that forms, personnel 
and resources can be used more efficiently and effectively 
· Improve the use of information for decision making 
· Improve the flow of surveillance information between and within 
levels of the health system 
· Improve laboratory capacity in identification of pathogens and 
monitoring of drug sensitivity 
· Increase the involvement of clinicians in the surveillance system. 
· Emphasize community participation in detection and response to 
public health problems 
· Strengthen the involvement of laboratory personnel in 
epidemiologic surveillance. 
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How does information flow in an integrated disease surveillance 
system?  
An ill person presents to medical attention.  Information about the patient is recorded in a 
register.  The register is updated daily to include information for both inpatients and 
outpatients.  At a minimum, the following data is collected: the patient’s ID number, date of 
onset, date of presentation at the facility, date of discharge (inpatient only), village (location), 
age, gender, diagnosis, treatment, and outcome (inpatient only).  
 
If the clinician suspects a disease or condition that is targeted for elimination or eradication, 
or if the disease has high epidemic potential, the disease is reported immediately to the 
designated health staff in the health facility and at the district level. The health facility should 
begin a response to the suspected outbreak.  At the same time, the district takes steps to 
investigate and confirm the outbreak.  The investigation results are used to plan a response 
action with the health facility. 
 
Periodically, once a month, weekly, quarterly or annually, the health facility summarizes the 
number of cases and deaths for each routinely reported IDS condition and reports the totals to 
the district. The health facility performs some analysis of the data such as keeping trend lines 
for selected priority diseases or conditions and observing whether certain thresholds are 
passed to alert staff to take action.  One action that is taken if an outbreak is suspected is to 
obtain laboratory confirmation.  Laboratory specimens are obtained and the following data is 
documented: type of specimen, date obtained, date sent to the lab, condition of specimen when 
received in the lab (good or poor), and lab results. 
 
At the district level, data is compiled monthly for each of the IDS conditions. The district 
prepares analyses of time, place and characteristics of the patients such as age and gender for 
both outpatients and inpatients.  These results are sent to either the regional level or the 
central level. 
 
The district uses the data to plot graphically the routine surveillance trends and epidemic 
curves for IDS conditions. In addition, the district maintains a log of suspected outbreaks 
reported by health facilities. This list documents the nature of the potential outbreak, the 
number of possible cases, the dates of investigations and actions taken by the district.  It also 
includes any findings of investigations led by district, regional or national levels. 
 
The district surveillance focal point provides disease-specific data and information to each 
disease prevention program. 
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How can IDS contribute to epidemic preparedness? 
 
When an outbreak of an infectious disease occurs or is detected, there is 
no time to conduct initial training or assemble supplies. All efforts must be 
focused on meeting the needs of patients and the community. 
 
Being prepared for an emergency situation can ultimately save lives. In 
cases where epidemic preparedness plans have been in place, timely 
detection of outbreaks has been followed by prompt and appropriate 
response actions. 
 
Because epidemiologic surveillance collects data for describing and 
analyzing health events, it provides skills and information for early 
detection of emergency outbreaks leading to enhanced preparedness for 
emergency situations. For example, a district’s epidemic management 
committee can define each level’s role in outbreak response in advance. 
Limited resources are maximized by combining resources for training, 
simulations and setting aside adequate supplies of equipment, vaccines, 
drugs and supplies.  
 
How are surveillance functions described in these guidelines? 
 
These guidelines assume that all levels of the health system are involved 
in conducting surveillance activities for detecting and responding to 
priority diseases and conditions and include the following: 
 
Step 1 - Identify cases.  Using basic, standard case definitions, identify 
priority diseases and conditions. 
 
Step 2 - Report suspected cases or conditions to the next level. If this is 
an epidemic prone disease, or a disease targeted for elimination or 
eradication, investigate and respond immediately. 
 
Step 3 - Analyze and interpret data.  Compile the data, and analyze it 
for trends.  Compare information with previous periods and summarize the 
results. 
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Step 4 - Investigate and confirm suspected cases and outbreaks.  Take 
action to ensure that the case or outbreak is confirmed including 
laboratory confirmation wherever it is feasible.  Gather evidence about 
what may have caused the outbreak and use it to select appropriate control 
and prevention strategies. 
 
Step 5 - Respond.  Mobilize resources and personnel to implement the 
appropriate outbreak or public health response. 
 
Step 6 - Provide feedback.  Encourage future cooperation by 
communicating with levels that reported outbreaks and cases about the 
investigation outcome and success of response efforts. 
 
Step 7 - Evaluate and improve the system.  Assess the effectiveness of 
the surveillance system, in terms of timeliness, quality of information, 
preparedness, thresholds, case management and overall performance.  
Take action to correct problems and make improvements. 
There is a role for each surveillance functions at each level of the health 
system.1  The levels are defined as follows: 
 
Community: Represented by basic village-level services such as 
trained birth attendants, village leaders, school 
teachers, and village health workers or similar care 
providers. 
 
Health facility:   Defined by each country.  For example, for 
surveillance purposes, all institutions with 
outpatient and in-patient facilities are defined as a 
“health facility” 
 
District, region, 
or province:   The intermediate administrative unit serving a 
population of between 100,000 and 300,000 people.  
Countries may have two intermediate levels, for 
example, the district and the region. 
                                                 
1These guidelines focus on improving surveillance for public facilities.   In districts or regions 
where reporting from public facilities is of good quality, integrate private and non-governmental 
organizations into the system. 
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National level: In many countries this is the federal level where 
policies are set and resources are allocated. 
 
Laboratory:   In an integrated system, some laboratory services 
are available at each level guided by a national level 
system of quality assurance and linked to reference 
laboratories for specific diseases.   
 
How can districts strengthen surveillance and response? 
 
Most countries have completed an assessment of their surveillance system 
using an assessment tool developed by WHO/AFRO.  Your country’s 
national assessments may have already resulted in specific plans and 
activities being carried out.  If this has not been done, a district may 
update the district’s profile to decide where priority activities can take 
place to improve surveillance and response capacity.  There is a checklist 
in Annex 1 at the end of this introduction that outlines what needs to be in 
place in order to conduct IDS. 
 
Districts can also use a matrix of surveillance functions and skills to 
describe their role in the surveillance system.  On the following two pages 
there is a matrix that describes a complete system in which all the skills 
and activities are in place.  Each level supports activities at other levels 
and reinforces the opportunity for successful decision-making at 
corresponding levels and functions.  In a developing system, the matrix 
provides a systematic framework for improving and strengthening the 
system.       
 
Practical uses of the matrix include: 
 
· Ensuring that all necessary functions and capacities have been 
identified 
· Establishing accountability to provide a basis for assigning 
functions to appropriate levels and determining what capacities 
should be present 
· Developing activities and training for human resource 
development 
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· Managing and monitoring programs 
· Planning for surveillance and laboratory personnel, supplies and 
materials. 
 
Moreover, the matrix illustrates several key assumptions about 
surveillance systems.   
 
· If one or more of the elements at each level is not present or is 
being performed poorly, the risk of failure increases for achieving 
surveillance and control objectives. 
· An effective system will be supported at each level from the levels 
above and below. 
· A complete system minimizes any delay in taking public health 
actions. 
· The functions of detection, analysis, investigation, response, 
feedback and evaluation are interdependent and should always be 
linked. 
 
The matrix on the next two pages defines the surveillance functions and 
how they are achieved at each level of the health system. 
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What is contained in these guidelines? 
 
This manual contains practical guidelines for use as: 
· A general reference for surveillance activities across all levels 
· A set of definitions for thresholds that trigger some action for 
responding to specific diseases 
· A stand-alone reference for level-specific guidelines 
· A resource for developing training, supervision and evaluation of 
surveillance activities 
· A guide for improving early detection and preparedness  activities 
for improved and timely response. 
 
The manual sets forth basic general guidance on surveillance and 
response. Guidelines can be adapted by each country to suit unique 
situations and public health objectives and specific information for 
diseases targeted by WHO/AFRO. 
 
 
Who are the guidelines for? 
 
The information and recommendations in this manual are intended for use 
by health staff in the surveillance coordination unit at district and health 
facilities.  Information in these guidelines applies also to: 
 
· Surveillance officers 
· Hospital outbreak coordinators 
· National epidemiology unit staff 
· National communicable disease program managers 
· District health management teams 
· Medical and nursing officers, sanitarians, EPI managers 
· Health facility managers 
· Public health officers and administrators 
· Medical and nursing educators 
· Public health educators 
· Laboratory personnel 
· Community 
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Which diseases are to be included? 
 
The WHO-Regional Office suggests 19 communicable diseases and 
conditions for integrated disease surveillance to be implemented in the 
African region.  The diseases are recommended because they fall into one 
or more of the following categories: 
 
· Are top causes of high morbidity and mortality in the African 
Region (for example, malaria, pneumonia, diarrhoeal diseases, 
tuberculosis, and HIV/AIDS); 
· Have epidemic potential (for example, plague, yellow fever and 
cholera); 
· Surveillance required internationally (for example, plague, yellow 
fever and cholera); 
· Have available effective control and prevention interventions for 
addressing the public health problem they pose (for example, 
schistosomiasis, onchocerciasis, trypanosomiasis, and so on); 
· Can easily be identified using simple case definitions; and 
· Have intervention programmes supported by WHO for prevention 
and control, eradication or elimination of the diseases (for 
example, the Expanded Programme on Immunizations (EPI) and 
the Integrated Management of Childhood Illness Strategy (IMCI). 
 
The list of priority diseases could vary from country to country depending 
on the local epidemiological situation.  We encourage countries to keep 
the list to the minimum possible to ensure that it is manageable by the 
system. 
 
Nineteen Recommended Diseases 
Epidemic-Prone Diseases 
Cholera 
Diarrhoea with blood (Shigella) 
Measles 
Meningitis 
Plague 
Viral hemorrhagic fevers 
Yellow Fever 
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Diseases Targeted for Eradication and Elimination 
Acute flaccid paralysis (AFP)/polio 
Dracunculiasis 
Leprosy 
Neonatal tetanus 
Other Diseases of Public Health Importance 
Pneumonia in children less than 5 years of age 
New AIDS cases 
Malaria 
Onchocerciasis 
Sexually transmitted infections (STIs) 
Trypanosomiasis 
Tuberculosis 
 
 
 
How does WHO/AFRO support efforts to strengthen disease 
surveillance? 
 
The World Health Organization’s Regional Office for Africa (AFRO) 
provides IDS support for every level of the health system, including: 
 
· The development of comprehensive technical guidelines for each 
level 
· A framework for adapting guidelines to each level within each 
country 
· Advocacy for resources and resource mobilization, and 
· Monitoring and detection of diseases across regions and the 
continent. 
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ANNEX 1 Using assessment  results to improve surveillance and 
response at the district level 
 
Most countries have assessed their surveillance systems and identified where improvements are 
needed.  This assessment uses a tool developed by WHO/AFRO.  It provides results that can be 
used to solve problems with resources, the quality and timeliness of information, and how the 
information is used.   The assessment tool includes an action planning and prioritization step. 
 
IDS is not proposing a new system, but is providing guidance in how surveillance and response 
activities can be improved.  National assessment results may already have resulted in specific 
plans and activities being carried out.  If this has not been done, or if districts want to update 
their district profiles, a checklist such as the one below can be used to help identify where 
districts can select priority activities to improve their surveillance and response capacity. 
    
1. __________ Define the sources of information about health events in the district, 
including points of contact the community has with health services.  For 
example, list the following sources on a list of district reporting sites such 
as the list in Annex 6 of this section: 
 
9 health facilities and hospitals 
9 community health workers 
9 traditional birth attendants 
9 rural community leaders who have knowledge of health 
events in the community (for example, the village elders, 
traditional healer, school teacher, leaders of faith-based 
communities, etc.) 
9 public health officers 
9 private sector practitioners 
9 public safety officers such as fire, rescue or police 
departments 
9 others (please describe)_____________________________ 
 
2. __________ Identify surveillance focal points for each source.  Identify and specify the 
opportunities for community involvement in surveillance of health events.   
 
3. __________ Describe how communication about surveillance and response takes place 
between the district and the surveillance focal points.  Include methods 
such as monthly meetings, newsletters, telephone calls and so on. Update 
the description periodically. 
 
4. __________ Describe the laboratory referral network for confirming priority diseases 
and conditions in the district.  For example, list the following: 
9 Public, private or NGO district facilities with reliable 
laboratory services for confirming priority diseases. 
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9 Prevention, control or special surveillance activities in the 
district with laboratory access (for example, any HIV 
sentinel surveillance sites in the district). 
 
5. __________ Update the policies of the district epidemic response team so that 
assessing preparedness is a routine agenda item of the team.  Specify and 
disseminate schedules for: 
 
9 Meeting to routinely assess preparedness for response and 
discuss current problems or activities 
9 Outbreak response meetings 
 
6. __________ Describe the communication links between the community and health 
facilities with the epidemic response committee that can be activated 
during an outbreak and for routine activities. 
 
7. __________ Specify the priority diseases and conditions for surveillance within the 
district and those directed by national policy.  List diseases that are: 
 9 Epidemic-prone diseases 
 9 Diseases targeted for eradication and elimination 
 9 Other diseases of public health importance 
 
8. __________ For each priority disease or condition selected, state the available public 
health response activity.   
 
9. __________ For each disease or condition that the district can respond to, specify the 
target, alert threshold or analysis results that would trigger an action. 
 
10. __________ For each priority disease or condition, review the minimum data element 
that health facilities and other sources should report.  State when it should 
be reported, to whom, and how.  For example: 
 
9 State the information that should be reported from in-
patient sources and outpatient sources.  For example, a 
minimum requirement would be to report all cases and 
deaths for the selected diseases and conditions. 
9 State the diseases or conditions that require immediate 
reporting and communicate the list to health facilities in the 
district. 
9 Define the means for reporting data to the district (by 
phone, by form, by voice).  If there is electronic reporting, 
do all facilities have access to computers and modems? 
9 Define how often the required data should reported. 
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11. __________ Define the data management tools available in the district and how they 
should be used in an integrated system 
 
 9 Routine reporting forms 
 9 Case-based surveillance reporting forms 
 9 Line lists for use in outbreaks of more than 5 cases 
 9 Tables for recording summary totals 
 9 Graphs for time analysis of data 
 9 Maps for place analysis of data 
 9 Charts for person analysis of data 
  
 
12. _________ Define the exact data management requirement for each reporting site.  
For example, develop and disseminate a policy and specify the procedures 
so that reporting sites know they must each month: 
 
9 Tally, compile and report summary totals 
9 Analyze monthly summaries in graphs, tables or maps 
9 Provide some interpretation to the district level. 
 
13. __________ Periodically update the availability of relevant supplies at each reporting 
site for conducting surveillance.  (Note: If a reporting site has capacity for 
electronic reporting, is there an electronic format that is compatible with 
the methods used at the district, region and national levels?  If electronic 
reporting is not available, do the focal points who are required to manage 
data have a reliable supply of paper, coloured pencils, graph paper, log 
books?)  
  
14. __________ Decide if current forms address the priorities of integrated disease 
surveillance and response.  For example, do current forms provide the 
information necessary for detecting problems and signaling a response to 
the priority integrated disease surveillance diseases? 
 
15. __________ Decide if additional indicators will be evaluated and plan how to monitor 
and evaluate timeliness and completeness of reporting.   
 
 
16. __________ Define methods for informing and supporting health staff in the 
implementation of integrated disease surveillance.  For example: 
 
9 List the current opportunities for training health staff in 
surveillance, response or data management in the district.   
9 Coordinate training opportunities between disease 
programs that take advantage of overlapping skills between 
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programs such as supervision, report writing, budgeting, 
data analysis, and using data to set priorities. 
9 Define the training needs for each category of health staff 
for either initial training in surveillance and response skills 
or refresher training in how to integrate surveillance 
activities. 
 
17. __________ Review and update feedback procedures and methods between the district, 
health facilities and community as well as between the district and higher 
levels.  For example, specify the feedback methods and update as 
necessary: 
 
9 Bulletins summarizing data reported by health facilities to 
the district 
9 Periodic meetings to discuss public health problems and 
recent activities 
9 Supervisory visits 
 
18. __________ Gather and present relevant data about your district that can be used to 
advocate for additional resources for improving surveillance and response 
activities in your district. (Example: Health staff are able to document an 
increase in malaria cases, they know that an effective response is available 
with insecticide-treated bednets.  The district surveillance officer used data 
to show the expected reduction in malaria cases if some of the 
community’s bednet cost could be supported by local businesses.) 
 
19. __________ State three objectives you would like to achieve for improving 
surveillance in your district over the next year. 
 19 
 
 
 
 
 
 
 
 
 
 
 
Section 1 
Identify cases of priority diseases and conditions 
 
 
 
 
This section describes how to: 
 
· Use standard case definitions for reporting suspected 
priority diseases and conditions 
· Improve district procedures for surveillance and response 
· Use the laboratory network to confirm suspected 
outbreaks. 
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1.0  Identify cases of priority diseases and conditions 
 
Cases and suspected outbreaks of priority diseases and conditions may 
come to the attention of the health system in several ways.  For example: 
 
· A patient falls ill and seeks treatment from a health facility 
 
· A member of the community reports a single suspected case, a 
cluster of deaths or unusual event to the health facility.  For 
example, a pharmacy reports a sharp increase in the number of 
purchases of a particular medication or treatment.   The school 
reports an increased number of absences due to similar signs and 
symptoms. 
 
· During active searches to find additional cases for a particular 
disease, the surveillance officer identifies cases of other priority 
diseases that have not been reported.  For example, during a review 
of the clinic register for cases of acute flaccid paralysis, the officer 
also looks for suspected cases of other vaccine-preventable 
diseases, such as measles, neonatal tetanus, meningitis and cholera. 
 
· Radio, television or newspapers report rare or unexplained health 
events in the area. 
 
· An individual health facility reports a cluster of deaths or an 
unusual increase the number of cases which may not cross the 
health facility’s action threshold.  When the cases are added 
together and analyzed at the district with reports from other health 
facilities, an outbreak is detected. For example, an individual 
health facility reports that there has been an adult with bloody 
diarrhoea who dies, the problem appears to be only in that 
catchment area.  If several health facilities report a similar event, a 
district problem is detected and action can be taken. 
 
· Vital events records show an increase in neonatal deaths. 
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1.1 Use standard case definitions  
 
A case definition is a standard set of criteria used to decide if a person has 
a particular disease, or if the case can be considered for reporting and 
investigation.  Case definitions make use of both clinical and surveillance 
criteria.  For example: 
 
· Clinical case definition: Clinical staff (doctors, nurses, or a 
clinical assistant) see a patient with signs and symptoms.  A 
clinical case definition provides the criteria for identifying 
appropriate and potentially life-saving treatment to offer the 
patient. Resources permitting, the clinician will ask for a 
diagnostic laboratory test to support the diagnosis.  Without the 
laboratory confirmation, the clinician may not be able to determine 
either the cause of or appropriate treatment for the patient’s 
condition.  
 
· Surveillance case definition: A case definition for surveillance is 
used to: 
 
-- Obtain an accurate detection of all cases of a disease or 
condition in a given population 
-- Exclude detection of other similar conditions. 
 
Using the same case definition throughout a country’s public 
health surveillance system ensures efficient tracking of particular 
diseases or conditions.   Data can be compared more accurately 
from one area to another.  When health facilities and districts use 
different case definitions, tracking the trend of a particular 
infectious disease will be impossible.  Health staff who analyze the 
data and take action will not know if the trends are due to the 
disease under surveillance or to some other cause.  
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1.1.1  Review case definitions used by health facilities in the 
district.   
 
Take action to ensure that health facility staff know how to use standard 
case definitions specified by national policy for reporting priority diseases 
and conditions to the district level.   
 
Suggested case definitions for the priority diseases in an integrated disease 
surveillance system are in Annex 1 at the end of this section.   
 
Also refer to information about case definitions in the disease specific 
recommendations in Section 8 of these guidelines. 
 
1.1.2 Distribute simplified case definitions to the community 
 
Involve the community in plans to improve surveillance and response 
procedures in the district.  If the community does not know to notify 
health authorities when priority diseases or unusual health events occur, 
suspected cases will not be seen at the health facility, and cases will not be 
reported.  
 
Community health workers, traditional healers, birth attendants and 
community leaders should know how to recognize and report selected 
priority diseases to the health facility.  They should also refer people with 
the suspected disease or condition to the health facility for treatment.  
Provide information to the community about priority diseases on posters, 
newsletters and announcements during community meetings. 
 
Being prepared to respond effectively to the community reports will 
encourage the community to participate in the system.  
 
A list of simplified case definitions for use in community surveillance are 
in Annex 2 of this section. 
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1.2 Improve district procedures for surveillance and 
response  
 
Use national assessment results to plan improved activities based on the 
prioritized list.  Each year, evaluate the system and modify plans to 
address the next priority on the list. 
 
1.2.1 Update the description of the catchment area  
 
Periodically, update information about the catchment area.  For example, 
make sure you have up-to-date information about: 
 
· The size of important target populations in the district such as 
children less than 5 years of age, women of childbearing age, all 
children and adults from ages 1 through 30, people living in 
refugee settlements, youth out of school, and so on. 
 
· Major public health activities in the area including public, private, 
and NGO immunization activities, clean water projects, family 
planning clinics, feeding centers for undernourished children, and 
so on. 
 
· List five to ten current leading public health problems treated in 
the district or facility. 
 
1.2.2 Update the list of reporting sites in the district  
 
Identify all of the health facilities in the district required to report 
surveillance information to the district level.  Record the health facility 
and names of staff who are responsible for surveillance activities.   Annex 
6 of this section is a worksheet that can be used to list the reporting sites 
and contact focal person at each site. 
 
When reporting from public facilities is of good quality, add private and 
non-governmental sources of information to the routine reporting system. 
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1.3 Define laboratories for confirming suspected 
outbreaks  
 
There are several diseases or conditions with signs and symptoms that are 
the same or similar as other diseases or conditions.  For example, a child 
with fever and rash over the entire body might be diagnosed with measles, 
even though there could be several causes for the child’s clinical 
presentation.  
 
Laboratory testing is a useful tool for public health because it can support 
or confirm the diagnosis.  Even well-trained, experienced health providers 
may be unable at times to make the correct diagnosis.  Having laboratory 
support for the diagnosis increases the likelihood that the diagnosis is 
correct, and that public health action will be efficient and appropriate.  
Laboratory confirmation ensures that surveillance data (for example, the 
number of measles cases diagnosed according to clinical signs and 
symptoms) does not result in unnecessary public health actions (for 
example, conducting a  mass immunization campaign for measles vaccine 
when the cause of the illness is not measles).  
 
Annex 3 at the end of this section contains a rapid reference table for 
requesting, collecting, and shipping specimens for recommended 
laboratory tests to confirm priority diseases.  General information about 
interpreting laboratory tests is in the introduction to Annex 3. 
 
1.3.1 Establish communication with the designated 
laboratories  
 
Establish or strengthen routine communication with identified laboratories 
that will receive specimens from your health facility or district and 
confirm suspected outbreaks.   The purpose of this routine contact is to 
strengthen procedures between the health facilities in the district who will 
be sending specimens and the laboratory that will be receiving them.  
Ensure that the procedures for confirming the disease or condition and 
reporting the results are clear and can be reliably carried out.   
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1.3.2 Identify a district laboratory focal point  
 
A district level focal point should make sure that laboratory confirmation 
procedures are known and followed in the district.  The designated staff 
person should: 
 
· Support the health facility in determining when to take a specimen 
for confirming the suspected case 
· Coordinate with the laboratory, as needed, to identify the correct 
specimen for collection and any special concerns or procedures 
· Collect and package the specimen safely or assist the health facility 
in collecting the specimen. 
· Ensure the safe and reliable transport of the specimen from the 
health facility to the district 
· Receive the laboratory results from the laboratory and report them 
promptly to the health facility and national levels. 
· Take action with the health facility based on the laboratory report. 
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Annexes to Section 1  
 
· ANNEX 2 WHO/AFRO recommended case definitions for reporting suspected 
priority diseases or  conditions from the health facility to the district  
 
· ANNEX 3 Simplified messages for use in community surveillance  
 
· ANNEX 4 Recommended laboratory tests for confirming priority diseases and 
conditions  
 
· ANNEX 5 List of laboratories for confirming priority diseases and conditions  
 
· ANNEX 6 List of district reporting sites  
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ANNEX 2 WHO/AFRO recommended case definitions for reporting 
suspected priority diseases or conditions from the health 
facility to the district 
 
WHO/AFRO recommends that health facilities use the following surveillance case definitions 
for reporting suspected cases of priority diseases and conditions to the district level.  Please refer 
to the disease-specific guidelines in Section 8 for additional information about specific case 
definitions. 
 
 
Epidemic-prone diseases 
Cholera Any person 5 years of age or more who develops severe 
dehydration or dies from acute watery diarrhoea 
 
Diarrhoea with blood 
(Shigella) 
Any person with diarrhoea and visible blood in the stool. 
Measles Any person with fever and maculopapular (non-vesicular) 
generalized rash and cough, coryza or conjunctivitis (red 
eyes) or any person in whom a clinician suspects measles.  
A measles death is a death occurring within 30 days of 
onset of the rash. 
Meningitis Any person with sudden onset of fever (>38.5EC rectal or 
38.0EC axillary) and one of the following signs: neck 
stiffness, altered consciousness or other meningeal signs. 
Plague  Any person with sudden onset of fever, chills, headache, 
severe malaise, prostration, and very painful swelling of 
lymph nodes, or cough with blood-stained sputum, chest 
pain, and difficulty in breathing.  
Viral hemorrhagic fevers Any person with severe illness, fever, and at least one of 
the following signs: bloody stools, vomiting blood, or 
unexplained bleeding from gums, nose, vagina, skin or 
eyes. 
Yellow fever Any person with sudden onset of high fever (>39EC rectal 
or 38EC axillary), followed by jaundice within two weeks of 
onset of first symptoms. 
Diseases targeted for eradication and elimination 
Acute flaccid paralysis (AFP)/polio Any child less than 15 years of age with AFP or a person of 
any age in whom the clinician suspects polio. 
Dracunculiasis Any person with a history of skin lesion and emergence of 
Guinea worm within one year of the skin lesion. 
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Leprosy Any person with clinical signs (as defined by the national 
program) of leprosy with or without bacteriological 
diagnostic confirmation and requiring chemotherapy 
(excluding patients released from treatment). 
Neonatal tetanus Any newborn with a normal ability to suck or cry during the 
first two days of life, and who, between 3 and 28 days of 
age, cannot suck normally and becomes still or has 
convulsions or both. 
Other diseases of public health importance 
Diarrhoea in children 
less than 5 years of 
age  
Diarrhoea with some dehydration: 
Any child less than 5 years of age with diarrhoea and two or more of the 
following: 
– restless or irritable 
– sunken eyes 
– drinks eagerly, thirsty 
– skin pinch goes back slowly 
 
Diarrhoea with severe dehydration 
Any child less than 5 years of age with diarrhoea and two or more of the 
following: 
– lethargic or unconscious 
– sunken eyes 
– not able to drink or drinking poorly 
– skin pinch goes back very slowly 
Pneumonia in 
children less than 5 
years of age 
Pneumonia 
Any child aged 2 months up to 5 years of age with cough or difficult breathing 
and  
– breathing 50 breaths or more per minute in an infant 2 months up to ?1 
year 
– breathing 40 breaths or more per minute for a child aged 1 to 5 years 
 
(Infants less than 2 months with fast breathing 60 breaths or more per minute are referred for 
serious bacterial infection.) 
 
Severe Pneumonia 
Any child age 2 months up to 5 years with cough or difficult breathing, and 
with any general danger sign, or chest indrawing, or stridor in a calm child.  
General danger signs are: unable to drink or breast-feed, vomits everything, 
convulsions, lethargy or unconsciousness. 
New AIDS case s Any person who meets the AIDS case definition adopted by national policy. 
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Malaria  Uncomplicated malaria 
Any person with fever or fever with headache, back pain, chills, sweats, 
myalgia, nausea and vomiting diagnosed clinically as malaria. 
 
Confirmed uncomplicated malaria 
Any person with fever or fever with headache, back pain, chills, sweats, 
myalgia, nausea and vomiting and with laboratory confirmation of diagnosis by 
malaria blood film or other diagnostic test for malaria parasites. 
 
Malaria with severe anaemia 
Any child 2 months up to 5 years with malaria and, if an outpatient, with 
severe palmar pallor, or if an inpatient, with a laboratory test confirming severe 
anaemia. 
 
Severe malaria 
Any person hospitalized with a primary diagnosis of malaria and confirmed by 
a positive blood smear or other diagnostic test for malaria. 
Onchocerciasis In an endemic area, any person with fibrous nodules in subcutaneous tissues. 
Sexually transmitted 
infections (STIs) 
Genital ulcer syndrome (non-vesicular) 
any male with an ulcer on the penis, scrotum, or rectum, with or without 
inguinal adenopathy, or any female with ulcer on labia, vagina, or rectum, with 
or without inguinal adenopathy. 
 
Urethral discharge syndrome 
any male with urethral discharge with or without dysuria 
Trypanosomiasis Early stage trypanosomiasis 
Any person with a painful chancre that originates as a papule and then 
evolves into a nodule at the fly bite site.  There may be fever, intense 
headache, insomnia, painless lymphadenopathy, anaemia, local edema and 
rash. 
 
Late stage trypanosomiasis 
Cachexia, somnolence, and central nervous system signs 
Tuberculosis Smear-positive pulmonary tuberculosis 
Any patient with cough for 3 weeks or more and: 
 
– at least 2 sputum specimens positive for acid-fast bacilli by 
microscopy, or  
-- 1 sputum specimen smear positive for acid-fast bacilli and 
radiographic abnormalities consistent with active pulmonary 
tuberculosis as determined by the treating medical officer, or 
– one sputum specimen smear positive for acid-fast bacilli and one 
sputum specimen culture positive for acid-fast bacilli. 
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ANNEX 3 Simplified messages for use in community surveillance  
 
Inform community health workers, traditional healers, birth attendants, health workers who 
conduct outreach activities in hard-to-reach areas, and community leaders about the priority 
diseases and conditions under surveillance in your area.  Use simplified messages such as the 
following to help the community to recognize when a person with these signs should be referred 
to the health facility. 
 
Simplified community messages 
Acute flaccid paralysis  Any acute paralytic disease 
Acute watery diarrhoea Any person with 3 or more loose stools within the last 
24 hours and a danger sign or dehydration. 
Cholera  Any person 5 years of age or more with lots of watery 
diarrhoea 
Diarrhoea with blood Any person with diarrhoea and visible blood in the 
stool 
Malaria  Any person who has an illness with high fever and a 
danger sign 
 (Danger signs are lethargy, unconsciousness, vomits 
everything, convulsions, and in children less than 5, 
unable to drink or breast-feed) 
Measles Any person with fever and rash 
Meningitis Any person with fever and neck stiffness 
Neonatal tetanus Any newborn who is normal at birth, and then after 2 
days, becomes unable to suck or feed. 
Plague  Any person with painful swelling under the arms or in 
the groin area.  In an area known to have plague, any 
person with cough, chest pain and fever. 
Pneumonia Any child less than 5 years of age with cough and 
fast breathing or difficulty in breathing. 
Tuberculosis Any person with cough for 3 weeks or more 
Viral hemorrhagic fevers  Any person who has an unexplained illness with fever 
and bleeding or who died after an unexplained severe 
illness with fever and bleeding 
Yellow fever Any person with fever and yellowing in the white past 
of the eyes or yellowing of the skin 
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ANNEX 4  Recommended laboratory tests for confirming priority 
diseases and conditions 
 
Confirming diagnoses of infectious diseases is essential.  The laboratory results are used to: 
 
C Accurately diagnose illness in an individual patient, and 
C Verify the cause (or etiology) of a suspected outbreak. 
 
Laboratory specimens should arrive in the laboratory in good condition.  This is to ensure that 
processing provides reliable results.  Specimens should be collected safely, stored in appropriate 
media, and kept within a specific temperature range.  Minimize delays between collection of the 
specimen and processing it at the laboratory. 
 
Many factors can affect the reliability of interpretation of a laboratory test report. For example, 
results are difficult to interpret when: 
 
C A serum specimen has been collected inappropriately and becomes hemolyzed. 
C There has been a delay in transportation or refrigeration resulting in bacterial overgrowth 
in the collected specimen. 
C The storage media is not adequate causing reduced viability of the suspected organism or 
antibody. 
C The specimens are not plated on the appropriate media or reagents are out-of-date. 
 
A positive result for serum IgM or viral isolation taken from any site (blood, serum, urine, 
cerebral spinal fluid (CSF) or tissue) usually confirms a suspected condition.  In situations when 
a negative result is received for testing of serum IgM or viral isolation, repeating the laboratory 
test may be indicated.  Implementing public health measures even before the laboratory 
confirmation is complete may be necessary. 
   
The reference chart on the following pages lists recommended laboratory tests for confirming 
priority diseases and conditions.  The table contains information about: 
 
C the diagnostic test for confirming the disease or condition 
C the specimen to be collected 
C when to collect the specimen 
C how to prepare, store and ship it 
C when to expect the results 
C sources for additional information. 
 
The chart is intended to be used as a rapid reference chart.  Use the information when suspected 
priority diseases or conditions are reported from the health facility or when a suspected outbreak 
is reported.  Refer to the disease specific guidelines in Section 8 for additional information about 
confirming outbreaks of priority diseases and conditions. 
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Specimens for laboratory confirmation for priority diseases at the district level 
Suspected disease or 
condition 
Diagnostic test Specimen When to collect How  to prepare, store and 
ship 
Results 
Acute flaccid paralysis 
   (Suspected polio) 
 
 
 
REFERENCE: 
WHO global action plan for 
laboratory containment of wild 
polio viruses. WHO/V&B/99.32, 
Geneva, 1999  
 
Manual for the virological 
investigation of polio 
WHO/EPI/GEN/97.01 
Geneva, 1997 
Isolation of polio virus from stool 
 
 
 
 
 
 
 
 
 
 
 
 
Stool 
 
 
 
 
 
 
 
 
Note: If no 
specimen is 
collected, re-
evaluate patient 
after 60 days to 
confirm clinical 
diagnosis of polio 
(AFP). 
Collect a sample from every 
suspected AFP case.   
 
Collect the first specimen when 
the case is investigated.   
 
Collect a second specimen on 
the same patient 24 to 48 hours 
later. 
C Place stool in clean, leak-proof 
container and label clearly. 
C Immediately place in 
refrigerator or cold box not 
used for storing vaccines or 
other medicines. 
C Ship specimens so they will 
arrive at designated polio 
laboratory within 72 hours of 
collection 
C When there is a delay, and 
specimen will not be shipped 
within 72 hours, freeze 
specimen at -20°C or colder.  
Then ship frozen specimen with 
dry ice or cold packs also 
frozen at -20°C or colder. 
Preliminary test results are usually 
available 14-28 days after receipt of 
specimen by the laboratory. 
  
If wild polio virus is detected, the 
national programme will plan 
appropriate actions 
Cholera 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCE: 
“Laboratory Methods for the 
Diagnosis of Epidemic 
Dysentery and Cholera”. 
CDC/WHO, 1999 
CDC, Atlanta, GA, USA 
Isolate V. cholerae from stool 
culture and determine O1 
serotype using polyvalent 
antisera for V. cholerae O1. 
 
If desired, confirm identification 
with Inaba and Ogawa antisera.  
 
If specimen is not serotypable, 
consider, V. cholerae O139 (see 
note in Results column). 
Liquid stool or 
rectal swab 
Collect stool sample from the 
first suspected cholera case.  If 
more than one suspected case, 
collect until specimens have 
been collected from 5 to 10 
cases.  Collect stool from 
patients fitting the case 
definition and: 
 
C onset within last 5 days, 
and 
C before antibiotics 
treatment has started 
 
Do not delay treatment of 
dehydrated patients.  
Specimens may be collected 
after rehydration (ORS or IV 
therapy) has begun. 
 
C Place specimen (stool or rectal 
swab) in a clean, leakproof 
container and transport to lab 
within 2 hours. 
C If more than 2- hour delay is 
expected, place stool-soaked 
swab into Cary-Blair transport 
medium. 
 
If Cary-Blair transport medium is 
not available and specimen will not 
reach the lab within 2 hours: 
C Store at  4°C to 8°C 
C Do not allow specimen to dry. 
Add small amount of 0.85% 
NaCl if necessary. 
C To ship, transport in well  
marked, leakproof container 
C Transport container in cold box 
at 4°C to 8°C 
Cholera tests may not be routinely 
performed in all laboratories. 
 
Culture results usually take 2 to 4 
days after specimen arrives at the 
laboratory. 
 
Cary-Blair transport medium is stable 
and usually good for at least one year 
after preparation.  It does not require 
refrigeration if kept sterile and in 
properly sealed container.  If color 
changes (medium turns yellow) or 
shrinks (depressed meniscus), do not 
use the medium. 
 
The O139 serotype has not  been 
reported in Africa and only if a few 
places in southwest Asia. 
 
Serological determination of Ogawa 
or Inaba is not clinically required.  It is 
also not required if polyvalent antisera 
results are clearly positive. 
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Suspected disease or 
condition Diagnostic test Specimen When to collect 
How to prepare, store and 
ship Results 
Diarrhoea with blood 
(Shi gella dysenteriae 
type 1) and other shigellae  
 
Note: SD1 infections are 
epidemic-prone and associated 
with high levels of antibiotic 
resistance. SD1 is the most 
significant of the shigellae due 
to the high levels of mortality in 
the young and elderly and due 
to its association with hemolytic 
uremic syndrome (HUS).  
 
REFERENCE: 
“Laboratory Methods for the 
Diagnosis of Epidemic 
Dysentery and Cholera”. 
CDC/WHO, 1999 
CDC, Atlanta, GA, USA 
Isolate Shigella dysenteriae type 1 
(SD1) in culture to confirm 
shigella outbreak.   
 
If SD1 is confirmed, perform 
antibiotic sensitivity tests with 
appropriate drugs. 
 
 
 
 
Stool or rectal 
swab.     
 
 
Collect sample when an outbreak 
is suspected.  Collect stool from 
5-10 patients who have bloody 
diarrhoea and: 
 
·    Onset within last 4 days, 
and 
·    Before antibiotic treatment 
has started. 
 
Preferably, collect stool in a 
clean, dry container. Do not 
contaminate with urine.  
Sample stool with a swab, 
selecting portions of the 
specimen with blood or mucus.  
 
If stool can not be collected, 
obtain a rectal swab sample 
with a clean, cotton swab. 
·    Place stool swab or rectal swab 
in Cary-Blair transport medium. 
Ship to laboratory refrigerated. 
 
·    If Cary-Blair not available, send 
sample to lab  within 2 hours in 
a clean, dry container with a 
tightly-fitting cap. Specimens 
not preserved in Cary-Blair will 
have significant reduction of 
shigellae after 24 hours. 
  
·    If storage is required, hold 
specimens at 4°C to 8°C, do not 
freeze.  
 
 Culture results are usually 
available 2 to 4 days after receipt by 
the laboratory. 
 
SD1 isolates should be characterized 
by antibiotic susceptibility. 
 
After confirmation of an initial 5-10 
cases in an outbreak, sample only  a 
small number of cases until the 
outbreak ends. 
 
Refer to disease specific guidelines in 
Section 8 for additional information 
about the epidemic potential of 
Shigella dysenteriae 1 
Dracunculiasis Routine laboratory confirmation for surveillance is not required. 
HIV 
 
 
 
 
 
 
 
 
 
 
 
REFERENCE: 
Guidelines for Second 
Generation HIV Surveillance, 
WHO and UNAIDS, 2000 
WHO/CDC/CSR/EDC/2000.5 
ELISA for HIV  
 
or 
 
Refer to national HIV/AIDS 
program guidelines for 
recommended diagnostic test in 
your area.   
Serum Obtain specimens according to national HIV/AIDS program 
strategy for clinical or 
epidemiological sampling. 
Use universal precautions to 
minimize exposure to sharps and 
any body fluid. 
 
For ELISA: 
Collect 10 ml of venous blood. 
C Let clot retract for 30 to 60 
minutes at room temperature or 
centrifuge to separate serum 
from red blood cells. 
C Aseptically pour off serum into 
sterile, screw capped tubes. 
C Store serum at 4°C. 
C Ship serum samples using      
appropriate packaging to            
prevent breakage or leakage. 
HIV testing is highly regulated with 
strict controls on release of 
information.  Results are usually 
available within one week from arrival 
in the laboratory. 
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Suspected disease or 
condition Diagnostic test Specimen When to collect 
How to prepare, store and 
ship Results 
Leprosy Routine laboratory confirmation for surveillance is not required. 
Malaria  
 
 
 
 
 
 
 
 
REFERENCE: 
“Basic Laboratory Methods in 
Medical Parasitology” WHO, 
Geneva, 1991 
C Presence of malarial 
parasites in blood films for 
suspected cases admitted 
to inpatient facility 
 
 
 
 
 
C Hematocrit or hemoglobin 
for suspected malaria in 
children 2 months to 5 
years in age. 
Blood  
 
Usually finger-
stick sample 
 
 
 
 
 
Finger stick or 
other accepted 
method for 
collecting blood 
from young 
children 
For blood smear: prepare 
blood film for all suspected 
cases admitted to inpatient 
facility, or according to national 
malaria case management 
guidelines 
 
 
 
For hematocrit or hemoglobin: 
 
In the inpatient setting, perform 
a  laboratory test confirming 
severe anaemia 
For blood smear: 
Collect blood directly onto correctly 
cleaned and labeled microscope slides 
and prepare thick and thin smears. 
C Allow smears to dry thoroughly. 
C Stain using the appropriate stain and 
technique. 
C Store stained and thoroughly dried 
slides at room temperature out of 
direct sunlight.  
 
For hematocrit or hemoglobin: 
Collect specimen according to 
instructions in national guidelines. 
Thick and thin smear results can be 
available the same day as preparation. 
 
Microscopic examination of malarial 
slides may also reveal the presence of 
other blood-borne parasites. 
Measles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCE: 
WHO Guidelines for Epidemic 
Preparedness and Response to 
Measles Outbreaks 
WHO/CDS/CSR/ISR/99.1 
Presence of IgM antibodies to  
measles virus in serum.   
Serum Collect blood samples on 5 
suspected measles cases 
when the number of cases 
exceeds the measles outbreak 
threshold (usually more than 5 
cases in a district in a month). 
 
In countries with an elimination 
target: 
C Collect specimen from 
every suspected case of 
measles 
 
C Collect serum for antibody 
testing at first opportunity or 
first visit to the health 
facility. 
 
C For children, collect 1 to 5 ml of 
venous blood depending on size of 
child.  Collect into a test tube, 
capillary tube or microtainer. 
C Separate blood cells from serum: 
–    Let clot retract for 30 to 60 
minutes at room temperature.  
Centrifuge at 2000 rpm for 10-20 
minutes and pour off serum into a 
clean glass tube. 
–     If no centrifuge, put sample in 
refrigerator overnight (4 to 6 hours) 
until clot retracts.  Pour off serum the 
next morning. 
–     If no centrifuge and no 
refrigerator, let blood sit at an angle 
for at least 60 minutes (without 
shaking or being driven in a vehicle).  
Pour off serum into a clean tube. 
C Store serum at  4°C. 
C Ship serum samples using 
appropriate pac kaging to prevent 
breaking or leaks during shipment. 
The specimen should arrive at the 
laboratory within 3 days of being 
collected. 
 
Results are usually available after 7 
days. 
 
If as few as 2 our of 5 suspected 
measles cases are laboratory confirmed, 
the outbreak is confirmed. 
 
Avoid shaking of specimen before serum 
has been collected. 
 
To prevent bacterial overgrowth, ensure 
that the serum is poured into a clean 
glass test tube.  The test tube does not 
need to be sterile,  just clean. 
 
Transport the serum in an EPI hand 
vaccine carrier at 4EC to 8EC to prevent 
bacterial overgrowth (up to 7 days).  If 
not refrigerated, serum stored in a clean 
tube will be good for at least 3 days. 
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Suspected disease or 
condition Diagnostic test Specimen When to collect 
How to prepare, store and 
ship Results 
Meningitis 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCE: 
“Laboratory Methods for the 
Diagnosis of Meningitis 
Caused by Neisseria 
meningitis, Streptococcus 
pneumoniae and Haemophilus 
influenzae”. 
WHO document 
WHO/CDS/EDC/99.7 
WHO, Geneva 
Microscopic examination of 
CSF for Gram negative 
diplococci  
 
Culture and isolation of N. 
meningitis from CSF  
Cerebral spinal 
fluid (CSF) 
 
 
 
Note: CSF is 
the specimen 
of choice for 
culture and 
microscopic 
exam.  If CSF 
not available, 
collect blood 
(10 ml adults, 
1-5 ml for 
children) for 
culture. 
Collect specimens from 5 to 
10 cases once the alert or 
action threshold (see 
“Meningitis” in Section 8) has 
been reached. 
C Prepare the patient and aseptically 
collect CSF into sterile test tubes 
with tops. 
 
C Immediately place 1 ml of CSF into a 
pre-warmed bottle of trans-isolate 
medium.  
 
C Incubate at body temperature (36EC 
to 37EC). 
 
C Never refrigerate specimens that will 
be cultured. 
 
C Keep CSF for microscopic exam and 
chemistry in the original syringe 
(replace cap).  Refrigerate the 
capped syringe and send it to the  
laboratory as soon as possible. 
Isolation of Nausari meningitis, a 
fastidious organism, is expensive, and 
difficult.  It requires excellent 
techniques for specimen collection and 
handling and expensive media and 
antisera. 
 
Initial specimens in an outbreak or for 
singly occurring isolates of N. 
meningitis should be serotyped and an 
antibiogram performed to ensure 
appropriate treatment. 
 
Trans Isolate medium (TI) is stable.  If 
properly stored at refrigerator 
temperature (4EC) it can be kept for up 
to two years after preparation.  In the 
refrigerator, the liquid phase turns 
gelatinous but reliquifies at room 
temperature.  Unused TI bottles should 
be kept tightly sealed.  If there is any 
color change (yellowing or clouding of 
the liquid medium) or obvious drying or 
shrinkage of the agar slant, the 
medium should not be used. 
Neonatal tetanus Laboratory confirmation is not required. 
Onchocerciasis Routine laboratory confirmation for surveillance is not required. 
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Suspected disease or 
condition Diagnostic test Specimen When to collect 
How to prepare, store and 
ship Results 
Plague  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCE: 
“Plague Manual: Epidemiology, 
Distribution, Surveillance and 
Control”. WHO/CDS/EDC/99.2 
WHO, Geneva, 1999 
 
“Laboratory Manual of Plague 
Diagnostic tests”. CDC/WHO 
publication, 2000, Atlanta, GA  
Isolation of Yersinia pest s 
from bubo aspirate or from 
culture of blood, CSF or 
sputum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identification of antibodies to 
the Y. pestis F1 antigen from 
serum. 
Aspirate of 
buboes, blood, 
CSF, sputum, 
tracheal washes 
or autopsy 
materials for 
culture 
 
 
 
 
 
 
 
 
 
 
Blood for 
serological tests 
C Collect specimen from the 
first suspected plague 
case.  If more than one 
suspected case, collect 
until specimens have 
been collected on 5 to 10 
suspected cases before 
the administration of 
antibiotics.  
 
C With buboes, a small 
amount of sterile saline 
(1-2 ml) may be injected 
into the bubo to obtain an 
adequate specimen  
 
 
C If antibiotics have been 
started, plague can be 
confirmed by 
seroconversion (4-fold or 
greater rise in titer) to the 
F1 antigen by passive 
hemaglutination using 
pared sera.  Serum 
should be drawn within 5 
days of onset then again 
after 2-3 weeks.  
C Specimens should be collected 
using aseptic tec hniques.  
Materials for culture should be 
sent to the laboratory in Cary Blair 
transport media or frozen 
(preferably with dry ice (frozen 
CO2). Unpreserved specimens 
should reach the laboratory the 
same day. 
C Liquid specimens (aspirates) 
should be absorbed with a sterile 
cotton swab and placed into Cary-
Blair transport medium. 
Refrigerate. 
C If transport will require 24 or more 
hours and Cary Blair transport is 
not available, freeze the specimen 
and transport it frozen with cool 
packs. 
Cultures should only be sent to a 
laboratory with known plague 
diagnostic capabilities or to a WHO 
Collaborating Center for Plague. 
 
Plague culture results will take a 
minimum of 3 to 5 working days from 
reception in the laboratory. 
 
Antibiotic treatment should be 
initiated before culture results are 
obtained.  
 
Plague patients seroconvert to the F1 
Y.pestis antigen 7-10 days after 
onset. 
Sexually transmitted 
infections (STIs) Routine laboratory confirmation for surveillance is not required. 
Trypanosomiasis Routine laboratory confirmation for surveillance is not required. 
Tuberculosis  
(Smear positive pulmonary 
tuberculosis) 
REFERENCE: 
Laboratory Services in 
Tuberculosis Control, Parts I, II 
and III.  WHO publications 
WHO/TB/98.258 
Presence of acid fast bacillus 
(AFB) in Ziehl Neelsen (ZN) 
stained smears 
Deep-chest 
sputum 
Collect sputum (not saliva) for 
direct smear microscopy and 
examine at least two stained 
specimens taken on different 
days. 
Smear should be examined at health 
facility where the specimen is taken. 
TB microscopy is read daily. 
Quantification of observed 
mycobacteria are reported using 
various reporting methods.  Refer to 
the criteria used by the examining 
laboratory. 
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Suspected disease or 
condition Diagnostic test Specimen When to collect 
How to prepare, store and 
ship Results 
Viral hemorrhagic fevers 
 
 
 
 
 
 
 
REFERENCES: 
Infection Control for Viral 
Hemorrhagic Fevers in the 
African Health Care Setting 
WHO/EMC/ESR/98.2 
 
Viral Infections of Humans; 
Epidemiology and Control. 
1989. Evans, A.S. (ed). 
Plenum Medical Book 
Company, New York 
Presence of IgM antibodies 
against  Ebola, Marburg, 
CCHF, Lassa or Dengue 
fever 
 
 
or 
 
 
 
Presence of Ebola in post-
mortum skin necropsy 
For ELISA: 
 Whole blood, 
serum or plasma 
 
For PCR: 
Whole blood or 
blood clot,  
serum/plasma or 
tissue 
 
For 
immunohistoche
mistry: Skin or 
tissue specimens 
from fatal cases. 
Collect specimen from the first 
suspected case.  
 
If more than one suspected 
case, collect until specimens 
have been collected from 5 
to10 suspected cases. 
HANDLE AND TRANSPORT 
SPECIMENS FROM SUSPECTED VHF 
PATIENTS WITH EXTREME CAUTION.  
WEAR PROTECTIVE CLOTHING AND 
USE BARRIER PRECAUTIONS. 
 
For ELISA or PCR: 
C Refrigerate serum or clot 
C Freeze (-20C or colder) tissue 
specimens for virus isolation 
 
For Immunohistochemistry: 
C Fix skin snip specimen in formalin.  
Specimen can be stored up to 6 
weeks.  The specimen is not 
infectious once it is in formalin. 
C Store at room temperature  
C Formalin-fixed specimens may be 
shipped at room temperature.   
Diagnostic services for VHF are not 
routinely available.  Advance 
arrangements are usually required for 
VHF diagnostic services.  Contact the 
appropriate National authority or 
WHO.   
 
 
 
Yellow fever 
 
 
 
 
 
 
 
REFERENCES: 
 
District guidelines for Yellow 
Fever Surveillance, 
WHO/GPVI/EPI/98.09 
 
Yellow Fever. 1998. 
WHO/EPI/Gen/98.11 
ELISA for the presence of 
yellow fever IgM antibodies 
Serum Collect specimen from the first 
suspected case of yellow 
fever.  If more than 1 
suspected case, collect until 
specimens have been 
collected from 5 to 10 
suspected cases. 
C Collect 10 ml of venous blood from 
adults, 1-5 ml from children. In a 
standard glass test tube, capillary 
tube or microtainer. 
C Separate blood cells from serum: 
– Let clot retract for 30 to 60 
minutes at room temperature.  
Centrifuge at 2000 rpm for 10-
20 minutes and pour off serum 
into a clean glass tube. 
– If no centrifuge, put sample in 
refrigerator overnight (4 to 6 
hours) until clot retracts.  Pour 
off serum the next morning. 
– If no centrifuge and no 
refrigerator, let blood sit at an 
angle for at least 60 minutes 
(without shaking or being 
driven in a vehicle.  Pour off 
serum into a clean tube. 
C Store serum at  4°C. 
C Ship serum samples using 
appropriate packaging to prevent 
breaking or leaks during shipment.  
The specimen should arrive at the 
laboratory within 3 days of being 
collected. 
 
Avoid shaking of specimen before 
serum has been collected.   
 
To prevent bacterial overgrowth, 
ensure that the serum is poured into a 
clean glass test tube.  The test tube 
does not need to be sterile – just 
clean. 
 
Transport the serum in an EPI hand 
vaccine carrier at 4EC-8EC to prevent 
bacterial overgrowth (up to 7 days).  If 
not refrigerated, serum stored in a 
clean tube will be good for at least 3 
days.   
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ANNEX 5 List of laboratories for confirming priority diseases and 
conditions 
 
Periodically update the list of laboratories or those specified by the national level for confirming 
priority diseases in your district.  Also record whom to contact for assistance. 
 
Name of disease Available laboratory tests 
Name, address, and phone number for 
laboratory  
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ANNEX 6 List of district reporting sites 
 
Record information for contacting the health staff who provide information to the district related 
to surveillance and outbreak detection.  For example, include community health workers, trained 
birth attendants, village leaders and public safety officials. 
 
Name of health facility 
or point of patient 
contact with health 
service 
Address or location 
of facility or 
point of contact 
Designated focal 
person for 
surveillance and 
response  
Telephone or 
facsimile number (or 
other 
contact information 
such as e-mail) 
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Section 2 
Report priority diseases and conditions 
 
 
 
 
This section describes how to: 
 
· Decide how often to report priority diseases and 
conditions 
· Record information in clinic registers or patient 
charts 
· Use standard methods for reporting diseases 
· Improve routine reporting practices 
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2.0 Report priority diseases and conditions 
 
Ensuring reliable reporting of surveillance data throughout the system is 
important so that program managers, surveillance officers and other health 
care staff can use the information to: 
 
· Identify problems and plan appropriate responses 
· Take action in a timely way 
· Monitor disease trends in the area 
 
2.1 Know how often to report priority diseases and 
conditions 
 
National policy determines whether the data from the districts and health 
facilities are reported immediately, weekly, monthly, or quarterly.  The 
recommendations about when to report will depend on specific disease 
control activities in your country or district.   
 
These guidelines recommend two kinds of reporting: 
 
· Immediate reporting: Report information about an individual case 
when an epidemic-prone disease is suspected and requires 
immediate notification.  Also report case-based information for 
diseases targeted for elimination or eradication or when an action 
threshold is crossed. 
 
Note: Some epidemic-prone diseases may have specific reporting 
requirements depending on national policy.  For example, leprosy 
is reported quarterly.  Meningitis cases and deaths should be 
reported weekly.  
 
· Routine summary reporting: Routinely report the total number of 
cases and deaths seen in a given period (for example, monthly or 
weekly).  These totals are analyzed and the results used to monitor 
progress toward disease reduction targets, measure achievements 
of disease prevention activities in the district, and identify hidden 
outbreaks or problems so that early action can be taken. 
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The following list suggests when to report a suspected outbreak and 
monthly summary reporting: 
 
Name of disease  When to report a suspected outbreak 
For these diseases, a single suspected case is a 
suspected outbreak: 
 
Acute flaccid paralysis (AFP) 
Cholera 
Dracunculiasis 
Measles (elimination) 
Neonatal tetanus 
Plague 
Viral hemorrhagic fever 
Yellow fever 
C Report case-based information immediately to 
the district as soon as an outbreak is 
suspected 
 
-- Make the initial report by fastest 
means possible (telephone, 
facsimile, E-mail, radiophone) 
 
-- Follow up with a written report of 
the case-based information 
recorded on a form 
 
C Report summary information monthly.  Enter 
“zero” when no cases were suspected or 
confirmed during the reporting period.  
For these diseases, report a suspected outbreak 
when the threshold is crossed: 
 
Measles (non-elimination) 
Meningitis 
C Report suspected measles outbreak when 5 
or more cases are suspected in one month. 
 
C Report suspected meningitis outbreak when 
the alert threshold is crossed.  (See Section 8 
for specific guidance on alert and action 
thresholds for meningitis.) 
For these diseases, report monthly summaries of 
cases and deaths to the next level 
 
Diarrhoea with severe dehydration in 
children < 5 years of age 
Diarrhoea with some dehydration in 
children < 5 years of age 
Bloody Diarrhoea 
Leprosy (report quarterly) 
Malaria  
New AIDS cases 
Pneumonia in children <5 years of age 
Severe pneumonia in children <5 years  
Sexually transmitted infections (STIs) 
TB (report quarterly) 
C Health facilities report summary totals to the 
district.  District reports summary totals to the 
provincial, regional or central level. 
 
C Observe alert and action thresholds for 
specific diseases during analysis of monthly 
summary reports. 
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2.2  Record information in clinic registers or patient charts 
 
Each district or health facility has its own procedures for recording the 
patient’s diagnosis.   
 
For immediately notifiable diseases, contact the district immediately and 
provide information about the patient.  As a follow-up, complete a case-
based reporting form and send it to the district.   
 
To collect daily summaries, a clinician, nurse, or clinical assistant records 
the diagnosis in the ward register.  Other staff such as a nurse or records 
clerk visits the ward daily to tally the cases and deaths for each diagnosis.  
Each month, the daily totals are summarized and reported to the district 
level as required.  Another method is when the clinician records the 
patient’s diagnosis in a patient record.  Other health staff review the charts 
and tally cases and deaths which are then used to compile weekly or 
monthly summaries. 
 
To ensure that cases of priority diseases and conditions are recorded 
correctly: 
 
· Take steps to ensure that all health staff know the standard case 
definitions recommended by national policy.  Establish or modify 
existing procedures so that all health staff will be able to apply the 
standard case definitions in detecting or suspecting cases or 
outbreaks.   
 
· Highlight with staff those diseases or conditions that require 
immediate reporting for case-based surveillance.  For example, all 
the health staff should be aware of the epidemic-prone disease for 
which one case is a suspected outbreak requiring immediate action.  
  
· Depending on the recommendations for a specific priority disease 
or condition, as soon as an epidemic-prone disease is suspected, 
ask the patient about additional cases in the home, work place or 
community. 
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· Identify the focal person at the health facility who will be 
responsible for tracking priority diseases and reporting them as 
required.  If the disease is one that requires immediate reporting, 
specify how the information should be reported to the district level 
through the fastest means possible.  For the district, specify how 
the district should notify the regional or national levels.  Use 
facsimile, telephone, electronic mail, telegrams, personal 
messages, or other rapid communication methods. 
 
Identify sources in the community who will be able to report suspected 
cases of priority diseases to the health facility.  Examples of community 
sources include: 
 
-- Pharmacists 
-- School teachers 
-- Private clinics 
-- Village leaders 
-- Religious leaders 
-- Traditional healers  
-- Trained birth attendants or other community health workers.   
 
Provide the community sources with information about the priority 
diseases you are interested in monitoring through surveillance.  
Give enough information about the disease so that the community 
source can refer cases to the health facility, or notify the health 
facility when unusual or unexplained health events occur in the 
community.   
 
Please refer to the list of simplified messages for community surveillance 
in the Annex to Section 1. 
 
2.3 Use standard methods for reporting priority 
diseases  
 
In an integrated system, streamlining reporting allows for data to be 
reported efficiently by using a minimum number of forms and reporting 
contacts.  Rather than requiring health facilities to provide reports using 
several forms for different disease control and prevention programs, data 
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about the priority diseases can be reported on a single form.   Case-based 
information can be reported first verbally.  Then written information is 
provided on a case reporting form.  Summary data is reported on monthly 
summary reporting forms. 
 
2.3.1 Report immediately reportable diseases or unusual 
events promptly  
 
When an immediately reportable disease or outbreak of any priority 
disease is suspected, report the patient’s locating information, 
immunization history, date of onset of symptoms, and other relevant risk 
factors to the next level.  The verbal or written notification should reach 
the district within 24 hours from when the case was first seen by the health 
facility.   
 
Also report immediately any unusual health event reported by the 
community such as a large number of deaths with fever that did not 
respond to usual treatment for causes of fever in the area.  Report 
information about the health event verbally by telephone or radiophone.  
Or, use an electronic method such as E-mail or facsimile.   Prompt 
reporting is required for certain diseases because action can be taken to 
control the wider transmission of the disease and prevent additional cases 
from occurring. 
 
2.3.2 Report case-based information on a form  
 
After the initial verbal report is made, complete a case-based surveillance 
form.  If a verbal report cannot be made, the case reporting form may be 
the first contact that the district receives about the case.  An example of 
the form and instructions for completing it are in Annex 8 at the end of 
this section.  Adapt the generic case reporting form provided at the end of 
this section, or compare these criteria to the form you already use to 
ensure that there are places for recording important information about the 
case including: 
 
· The patient’s name.  If neonatal tetanus is reported, also record the 
name of the mother 
· Patient’s date of birth, if known, or the age of the patient 
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· Patient’s locating information (address, village, neighborhood) 
· How to contact the patient or the parents of the patient if more 
information is needed 
· Patient’s gender 
· The date the patient was seen at the health facility and the date the 
case was reported to the district 
· Date of onset of the disease (refer to disease specific guidelines for 
signs and symptoms that define onset of the disease) 
· If you are reporting a suspected case of a vaccine preventable 
disease, describe the patient’s immunization history (and also for 
the mother if neonatal tetanus is suspected) 
· Patient’s status at the time of the report (if an inpatient, report final 
outcome as living or deceased) 
· Provide the date of the report. 
 
The health staff person who completes the form should record his or her 
name and the date the form was sent to the district.  Make two additional 
copies of the form by photocopy, carbon copy or by hand.   Submit the 
original to the district.  Keep one copy at the health facility.  Use the 
second copy as a laboratory transmittal slip if a laboratory specimen is 
taken.  Send the copy of the case-based form with the specimen to the 
laboratory. 
 
Refer to Annex 4 or the disease specific guidelines in Section 8  for 
information about which laboratory tests to request. 
 
2.3.3 Report summary data routinely  
 
Each month, the health facility calculates the total number of cases and 
deaths due to priority diseases and conditions seen in the health facility.  
Separate totals are calculated for outpatient cases and inpatient cases.  The 
summary totals are recorded on a form and sent to the district level. 
 
The district aggregates the totals from all the health facilities who reported 
and reports district summary totals to the provincial, regional or central 
level. 
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2.4 Improve routine reporting practices   
 
In some health facilities, more than one person may be responsible for 
recording information about patients seen in the facility.  For example, the 
clinician records the patient’s name and diagnosis in a clinic register.  
Later in the day, a nurse tallies the number of cases and deaths seen in an 
outpatient service.  The ward nurse tallies the number of hospitalized 
cases.  Each month, a records clerk or statistician calculates summaries for 
all the diseases and records them in a standard form. 
 
2.4.1 Review the flow of information in the health facility 
 
Make sure that: 
 
· Clinicians record information in the clinic register using the 
recommended case definition so that health staff who tally the 
cases at the end of the day can reliably record the required 
diagnoses on the tally sheet. 
 
· Clinicians, ward nurses or other responsible staff should complete 
the case form while the patient is still present. 
 
· Records clerks or statisticians have summary forms that contain 
spaces for recording cases and deaths due to the priority diseases 
according to the standard case definitions. 
 
· Records clerks know how to complete the summary forms. 
 
· Health staff review the monthly totals and provide comments on 
the forms about results seen in monthly analysis.  (See Section 
3.0). 
 
· Health staff record the totals on a recommended monthly summary 
reporting form. 
 
Note: In the sample monthly summary reporting forms at the end of this 
section, there is space for recording observations about the data that health 
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professionals at the health facility and district observe either during 
routine analysis or when they complete the form each month.   
 
2.4.2 Submit zero-reporting when no cases of immediately 
reportable diseases are diagnosed 
 
If no cases of an immediately reportable disease have been diagnosed 
during the month, record a zero (0) on the reporting form for that disease.  
If the space is left blank, the staff who receive the report will not know 
why there is a blank space. 
 
Submit a zero for each immediately reportable disease even if no cases 
were detected during the month.  This will tell the staff at the next level 
that a complete report has been submitted by the health facility or district. 
 
2.4.3 Use line lists and summary reporting during outbreaks 
 
When a limited number of cases of a single disease occur during a 
specified period of time, report the information about each case on an 
individual case reporting form.   
 
If more than 5 to 10 cases occur in a specified time, use a line list instead 
of individual case reporting forms to record and report the cases weekly. 
 
When a large number of cases occur in a single suspected outbreak, report 
summary totals of cases and deaths each week. 
 ________________ 
How to conduct routine analysis of surveillance data is described in 
Section 3.0. 
 
Indicators for monitoring timeliness of immediately reportable diseases 
are in Section 7.0. 
 
Monitoring timeliness of reporting suspected outbreaks is in Section 7.0. 
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Annexes to Section 2 
 
· ANNEX 7 Maintaining clinic registers for recording priority diseases and conditions 
 
· ANNEX 8 Case-based surveillance reporting form (sample) 
 
· ANNEX 9 Line list for reporting case-based information when several cases occur 
during a short period: health facility to districts 
 
· ANNEX 10 Monthly summary reporting form for in-patient cases and deaths: health 
facility to district 
 
· ANNEX 11 Monthly summary reporting form for district out-patient and in-patient 
cases and deaths: district to next level 
 
· ANNEX 12 Leprosy quarterly report form 
 
· ANNEX 13 Tuberculosis quarterly report form 
 
· ANNEX 14 Managing public health surveillance data 
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ANNEX 7 Maintaining clinic registers for recording priority diseases 
and conditions  
 
Each health facility should maintain registers for recording cases of priority diseases and 
conditions seen in the health facility.  At a minimum, the clinic register should have spaces for 
recording the following information: 
 
C The patient ’s name and age 
 
C The patient’s diagnosis.  This is mainly important for reporting summary information.  
Use IMCI diagnosis for diarrhoea with dehydration and for pneumonia in children less 
than 5 years of age. 
C The patient’s status if an inpatient 
C The date the patient was seen. 
 
Some registers include spaces also for recording: 
 
C The patient’s gender 
C Treatments 
C Laboratory results, if case was confirmed with laboratory specimen 
C Other notes relevant to patient’s disease, treatment or outcome. 
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ANNEX 8 Case-based surveillance reporting form 
 
WHO/AFRO recommends a generic case-based reporting form that can be used to report written 
information about individual cases of priority diseases recommended for case-based surveillance.  
These include: 
 
· Epidemic-prone diseases (cholera, diarrhoea with blood*, measles, meningitis, plague, 
viral hemorrhagic fevers and yellow fever) 
 
*       Not every case of bloody diarrhoea is reported.  Report diarrhoea with blood when an outbreak is 
suspected either because there has been an adult death in a patient who had diarrhoea with blood, 
or when a threshold has been reached that prompts reporting.  Please see disease specific 
guidelines in Section 8 for guidance on when to report a suspected outbreak of Shigella. 
 
· Diseases targeted for eradication or elimination (polio (AFP), Dracunculiasis, and 
neonatal tetanus.)  Leprosy is reported quarterly. 
 
· Other diseases recommended by national policy for case-based surveillance. 
 
If the health facility suspects a disease or condition in one of the above categories, health facility 
staff should contact the district immediately by telephone, facsimile, e-mail or other prompt 
communication.  Send the form as a follow-up to the verbal report. 
 
The sample form on the next page has two sections.  The top half is where information is 
recorded about the individual case.  It provides information that can be used to plan a more 
detailed case investigation.  The bottom half of the form is a laboratory transmittal slip.  It 
contains spaces where laboratory results and information about the timeliness of the laboratory 
testing should be recorded.  After the health facility or district staff complete the top part of the 
form, a copy of it can be made and included with the specimen, if a specimen has been collected, 
when it is sent to the laboratory. 
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_________________________                                                                 _________________________ 
                     Reporting Health Facility                                                                                                                                         Reporting District  
 
Generic Reporting Form – from Health Facility/Health Worker to District Health Team 
 
£    £        £            £         £        £        £         £        £               £ 
AFP    Cholera   Diarrhea with     Dracunculiasis   Neonatal      Measles    Meningitis        Plague           Viral                      Yellow          ____________ 
                          Blood/Shigella                               Tetanus                                                              Hemorrhagic Fever          Fever                   Other 
 
                                                                                                                                                                                                       
                                                                                                                                                                                                    _____/______/______ 
                                                                                                                                                               Received form at national level  
 
Name(s) of                                                   Date of                                           Age:   _____     ______        _____ 
Patient: __________________________   Birth: _____/______/______       (If DOB     years   months     days 
                                                                                                                                                           unknown)                  (If <12 months)     (NNT only) 
                                                                                                                                                                      
 
Patient’s Residence: Village/Neighborhood __________________________                        Sex:               M=Male   F=Female 
                                                                                                            District of                                                                                
Town/City: ______________________________    residence: _________________            U=Urban   R=Rural    
                                                                                                                                                          Urban/Rural  
Locating Information:____________________________________________________________ 
If applicable, Name of mother and father  
if neonate or child 
 
                                                                                                                                      For cases of Measles, NT (TT in mother), Yellow Fever, and Meningitis: 
Date Seen at Health Facility:    ______/_______/______           Number of vaccine doses received                                           9=unknown 
Date Health Facility                                                                     For Measles, TT, YF- documented by card.  For Meningitis, by history. 
Notified District:                        ______/_______/______ 
 
Dates of Onset:                            ______/_______/______            Date of last vaccination:       ______/_______/______          
                                                                               (Measles, Neonatal Tetanus (TT in mother), Yellow Fever, and Meningitis only) 
 
Blank variable #1____________________________________________                    In/Out patient :            1=In-patient              Outcome         1=Alive 
                                                                                                                                                                                                2=Out-patient                                                     2=Dead                                                             
Blank variable #2____________________________________________                                                                                                                                                     9=unknown  
                                                                                Final Classification:                1=Confirmed 
                                                                                                                                                                                                                      2=Probable/Compatible 
                                                                                                                                                                                                                      3=Discarded 
                                                                                                                                                                                                                      4=Suspected 
                                            
Person Completing   Name: ___________________________ 
Form                          Signature: ______________________                  Date Sent Form to District:_____/______/_____ 
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If Lab Specimen Collected 
 
For Health Facility: If lab specimen is collected, complete the following information. And send a copy of this form to the lab 
with the specimen. 
 
Date of specimen collection: ______/_______/______                      Specimen source:  Stool     Blood      CSF    ___________ 
Date Specimen sent to lab:    ______/_______/______                                                                                         Other 
 
For the Lab: Complete this section and return the form to district team and clinician 
 
Date lab specimen:                 ______/_______/______                      Specimen Condition:  Adequate   Not adequate 
 
 
 
 
                                                                                                            Other lab results: ______________________________                                                                                                
                                                                                                           ____________________________ 
Date lab sent results to district:  ______/_______/______               ____________________________                     
 
Name of lab sending results:_______________________               Other pending tests: ____________________________ 
 
 
                                                                                                                 Date lab results sent to  
Date district received lab results:  ______/_______/______           clinician by district: ______/_______/______ 
 
NOTE: District is responsible for ensuring lab results get to clinicians. Failure to do so will undermine cooperation with clinicians on reporting of 
cases in the future  
Disease/ 
Condition             
Type of test           Results (P=pending)       Disease /  
Condition 
Type of 
test            
Results  
Cholera Culture  +    -    P Yellow Fever       IgM +    -    P  
    Direct Exam +    -    P     ____________ Measles IgM +    -    P  
Meningitis                                Method used for Direct                                              Exam 
Rubella IgM +    -    P Virus Detection 
N. meningitidis  Culture +    -    P RVF IgM +    -    P +    -    P 
S. pneumonia  Culture +    -    P Ebola IgM +    -    P +    -    P 
H. influenza  Culture +    -    P CCHF IgM +    -    P +    -    P 
N. meningitidis  Latex +    -    P Lassa IgM +    -    P +    -    P 
S. pneumonia  Latex +    -    P Marburg IgM +    -    P +    -    P 
H. influenza  Latex +    -    P 
Shigella Dysenteriae  Culture SD type 1   Other shig    No shig 
Plague Culture +    -    P 
 IFA>1: 64  +    -    P 
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Instructions for completing the Generic Case Reporting Form 
 
For the health facility: 
 
1. Complete the name of the health facility submitting the case-based reporting form. 
 
2. Record the name of the district that is receiving the report. 
 
3. Tick the box at the top of the form to indicate which disease is being reported.  If the 
disease or condition is not stated, or its cause is unknown, write the name of the disease 
or condition (or “unknown”) in the blank marked “Other”.    
 
For the district: 
 
4. If unique identification numbers are used to record cases reported to the district, record 
the identification number (ID number) in the blank for “ID number”. 
 
5. When the report is received at the district, record the date it was received.  If a verbal 
report was made, report the date of the verbal report. 
 
For the health facility: 
 
6. Record the name of the patient.  For a neonatal tetanus case, record the name of the 
mother. 
 
7. Record the patient’s age, if it is known, or the patient’s date of birth. 
 
8. Record information about the patient’s residence.  Include the name of the village or 
neighborhood that the patient lives in.  Include the name of the district that the patient 
lives in also. 
 
9. Record information about how to contact the patient or the patient’s parents for use at a 
later time when additional information about the patient’s illness may be needed. 
 
10. Record “M” for Male, and “F” for Female. 
 
11. Record the date the patient was seen at the health facility and the date the health facility 
reported the disease or condition to the district.  (The form should be a follow-up to 
prompt verbal reporting.) 
 
12. Record the date of onset of the disease, if known.  
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13. For vaccine preventable diseases, such as AFP, neonatal tetanus, measles, meningitis and 
yellow fever, obtain an immunization history for the patient.  Record the date of the last 
immunization dose for the reported illness.  Decide if the dose was more than 15 days 
ago.  If the immunization was received within the last 15 days, there may not have been 
an immunization response.  Do not count doses that were received within the last 15 
days. 
 
· For meningitis, record if there is a history of vaccination during a mass campaign. 
· For neonatal tetanus, record the number of lifetime doses of tetanus toxoid the 
mother received up to 15 days before the delivery. 
 
14. Report whether the patient was an outpatient or inpatient at the time the case was 
reported. 
 
15. Record whether the patient was living or deceased at the time the report was made.  If the 
patient’s illness is reported, and the patient later dies, inform the district.  The district can 
change the status on the form. 
 
16. When the investigation of the case is complete, record “confirmed” or “discarded” in the 
item “Final Classification”.  When the case is first suspected, record “suspected” as the 
Final Classification. 
 
17. The health facility staff member who completes the form should sign his or her name and 
also the date the form was sent to the district. 
 
If there is no laboratory specimen collected, the form is complete. 
 
If a laboratory specimen is taken, send a copy of the form to the laboratory with each 
specimen. 
 
18. Record the date the specimen was collected in the box labeled “If lab specimen 
collected”.  Also record the date the specimen was sent to the laboratory. 
 
19. Circle what type of specimen was collected (blood, CSF, stool). 
 
When the specimen arrives at the laboratory: 
 
20. Record the date the laboratory received the specimen.  Also record the condition of the 
specimen.  See Annex 3 in Section 1 for information about ensuring the quality of 
specimens.  If the specimen arrives in poor condition, inform the health facility promptly 
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to let them know a useful laboratory result is not going to be possible.  They may decide 
to send another specimen.  Give guidance in ensuring the specimen arrives in adequate 
condition. 
 
21. Record the results of the laboratory testing according to the prompts on the bottom part of 
the form. 
 
22. Record the date the results were given (verbally or in writing) to the health facility and/or 
the district.  If it is national policy that results are given to the district, the district will 
inform the health facility.   
 
At the district: 
 
23. Send a complete case reporting form to the national level for data entry and analysis.  
Also send the laboratory results. 
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ANNEX 9  Generic Line List – for Reporting from Health Facility to District and for Use During Outbreaks 
 
Health Facility:  _____________________________________                                                                                 Date received at District:  ________________________ 
District:   ______________________________________________                                                                          Disease/Condition: _________________________________ 
 
 ID Number  
 
(Assigned at the 
district level only) 
001,002, etc. 
 
(O)ut / 
(I)n 
Patient 
 
 
 
Name 
 
 
Village or Town and Neighborhood 
 
 
 
Sex 
 
 
 
Age ** 
 
 
Date seen at 
health facility 
 
 
Date of 
onset of 
disease 
(1)         
(2)         
(3)         
(4)         
(5)         
(6)         
(7)         
 
 
- If district sends specimen to the lab, use ID number as well (PPP-DDD-YY-oox format) to identity lab specimen 
- If health facility sends lab specimen to lab without passing through the district, then the name (only) will be the lab specimen identifier  
 
NOTE: -If more than 100 cases occur in a week (e.g. for measles, cholera, etc.) at a health facility, line listing of cases is not required, record jus the total number of cases 
- If previously reported cases die, update the status by completing a new row with  “died” in the status column and “update record” in the Comments column.  
**Age in years if more than 12 months, otherwise write age in months (e.g. 9m) 
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Generic Line List (Continued) 
 
 
 Lab Tests 
 
 
Number of 
doses of vaccine 
(Exclude doses 
given within 14d 
of onset) 
 
 
Blank variable 
 
 
Blank variable 
Specimen taken 
(Yes/No) 
If yes, date collected 
 
Lab results 
 
Outcome 
(A)live 
(D)ead 
 
 
Comments 
(1)        
(2)        
(3)        
(4)        
(5)        
(6)        
(7)        
 
ANNEX 10 Monthly surveillance report form for out-patient cases and in-
patient cases and deaths (health facility to district level) 
 
Health Facility ___________________________  District ________________________ Province ________________________ 
 
Year _______  Month ________   Record below the total number of cases and total number of deaths for each disease/condition.  
   Report these totals to the next level. Complete the column for the current month for all disease/conditions. 
  Out-Patient In-Patient 
  Cases Cases Deaths 
Uncomplicated     Malaria <5 years 
Severe    
Uncomplicated     Malaria >5 years 
Severe    
 
In-Patient Malaria with severe anemia (<5 years)     
 
Uncomplicated Malaria  < 5 years, lab-confirmed    
 
Uncomplicated Malaria 5+ years lab-confirmed    
 
Pneumonia (<5 years)     
       
Severe Pneumonia  (< 5 years)     
 Diarrhoea with some dehydration (<5 years)     
 
Diarrhoea with severe dehydration (<5 years)    
 
New AIDS cases    
 
Male Urethral Discharge    
 
Male Non-vesicular Genital Ulcer    
 
Female Non-vesicular Genital Ulcer    
 
Diarrhoea with blood    
Number of sites that reported on time    __________    
                               
Number of Out -patient sites that are supposed to report    ________ Number of sites the reported late            __________ 
 
Zero reporting for immediately-reported, case-based disease/conditions: 
Total cases previously reported this month on case forms or line lists  
AFP  Measles   Plague  
Cholera  Meningitis  Yellow Fever  
Dracunculiasis  Neonatal Tetanus  Viral Hemorrhagic Fever  
NOTE: Official counts of immediately notified cases come only from case forms or line lists. The counts from the zero-reporting boxes are not 
official counts. 
 
Analysis, interpretations, comments, and recommendations on both out-patient and in-patient data 
 
Other information: 
 
Look at the trends in the District Analysis Book. Comments on observed trends? Abnormal increase in cases, deaths, or case fatality 
ratios? Lack of decrease of previous increasing trends? Improving trends? 
 
Conclusions, actions taken, and recommendations: 
 
 
Sent                Date: _________________________        Received           Date: _________________________      
Report       Person: ______________________      Report                Person: ______________________    
 
- Some dehydration, severe dehydration, pneumonia, and severe pneumonia are defined according to WHO Integrated Management of Childhood Infections (IMCI) 
definitions. TB and Leprosy data reported quarterly on separate forms.   
ANNEX 11 Monthly surveillance summary report form for out-patient 
cases and in-patient cases and deaths (district to next level) 
 
Year _______        Month ________   District _______________  Province ______________ 
Record below the total number of cases and total number of deaths for each disease/condition. Report 
these totals to the next level. Complete the column for the current month for all disease/conditions 
  Out-Patient In-Patient 
  Cases Cases Deaths 
Uncomplicated     Malaria <5 years 
Severe    
Uncomplicated     Malaria >5 years 
Severe    
 
In-Patient Malaria with severe anemia (<5 years)     
 
Uncomplicated Malaria  < 5 years, lab-confirmed    
 
Uncomplicated Malaria 5+ years lab-confirmed    
 
Pneumonia (<5 years)     
       
Severe Pneumonia  (< 5 years)     
 Diarrhoea with some dehydration (<5 years)     
 
Diarrhoea with severe dehydration (<5 years)    
 
New AIDS cases    
 
Male Urethral Discharge    
 
Male Non-vesicular Genital Ulcer    
 
Female Non-vesicular Genital Ulcer    
 
Diarrhoea with blood    
Number of sites that reported on time    __________    
                               
Number of Out -patient sites that are supposed to report    ________ Number of sites the reported late            __________ 
 
Zero reporting for immediately-reported, case-based disease/conditions: 
Total cases previously reported this month on case forms or line lists 
 
AFP  Measles   Plague  
Cholera  Meningitis  Yellow Fever  
Dracunculiasis  Neonatal Tetanus  Viral Hemorrhagic Fever  
 
NOTE: Official counts of immediately notified cases come only from case forms or line lists. The counts from the zero-reporting boxes are not 
official counts. 
 
Analysis, interpretations, comments, and recommendations on both out-patient and in-patient data 
 
Other information: 
 
 
Look at the trends in the District Analysis Book. Comments on observed trends? Abnormal increase in cases, deaths, or case fatality 
ratios? Lack of decrease of previous increasing trends? Improving trends? 
 
 
Conclusions, actions taken, and recommendations: 
 
 
 
Sent                Date: _________________________        Received           Date: _________________________      
Report       Person: ______________________      Report                Person: ______________________    
 
- Some dehydration, severe dehydration, pneumonia, and severe pneumonia are defined according to WHO Integrated Management of Childhood Infections (IMCI) 
definitions. TB and Leprosy data reported quarterly on separate forms.  Update District Analysis Book if receive late reports from health facilities. If late reports are 
received from health facilities from previous months, send a separate sheet to the next level updating numbers. 
ANNEX 12  Tuberculosis quarterly report form 
Year ___________ Quarter _______________ 
  
Health Facility _________________________ District ____________________ Province_________________  
 
Case Notifications Number 
Pulmonary- Smear + New case  
Pulmonary- Smear + Relapse  
Pulmonary- Smear Negative  
Pulmonary- Smear not done/unknown  
Extra-pulmonary  
Total  
 
Category of Re-treatment cases Number 
Relapses   
Failures  
Re-treatment after interruption  
Total  
 
 
Cohort Analysis done on patients registered in same quarter in the previous year 
Smear conversion  New pulm 
smear+ 
(at 2 months) 
Re-rx smear+  
(at 3 months) 
New sputum + 
converted by 2-3 
months 
  
New sputum + 
evaluated with 
sputum by end of 3rd 
month 
  
 
 
 
 
 
 
 
 
 
 
Analysis, interpretations, comments, and recommendations  
 
Other information: 
 
 
Comments on observed trends? Abnormal increase in cases ? lack of decrease of previous increasing trends? 
Improving trends? 
 
 
Conclusions, actions taken, and recommendations: 
 
 
 
Sent             Date: _________________________                    Received            Date: _________________________      
Report             Report 
      Person: ______________________                                Person: ______________________    
 
Age of new pulmonary smear+ cases 
 M F Total 
0-14    
15-24    
25-34    
35-44    
45-54    
55-64    
65+    
Total    
Treatment results New pulm 
smear+ 
 
Re-rx 
smear+ 
Total registered   
Total evaluated   
Smear negative a tend of 
treatment (cured) 
  
Completed treatment, but smear 
not done at end of treatment 
  
Died   
Failure   
Interrupted treatment   
Transferred out   
ANNEX 13  Leprosy quarterly report form 
 
Year ___________ Quarter _______________ 
  
Health Facility _________________________ District ____________________
 Province_________________  
 
 
Clinical form of leprosy Category Indicators 
Multibacillary Paucibacillary Total 
Total cases under 
treatment during 
the quarter 
Total cases being treated (or about to 
immediately start treatment) during 
the quarter 
   
Total new cases never treated 
(=detection) 
   
              0-14 years    
              15+ years    
             New cases with < 2nd degree                           
             disability 
   
In-coming cases 
seen during the 
quarter 
Relapse, defaulter, or transferred    
Died    
Treatment finished    
Transferred    
Lost to follow-up (at least 1 year 
without treatment 
   
Cases that left 
program during 
this quarter 
Total    
Cases in program 
at the last day of 
the quarter 
Total (=cases at the beginning plus 
new cases during the quarter minus 
cases that left the progra m) 
   
 
 
 
Analysis, interpretations, comments, and recommendations  
 
Other information: 
 
 
 
 
Comments on observed trends? Abnormal increase in cases? lack of decrease of previous increasing trends? 
Improving trends? 
 
 
 
Conclusions, actions taken, and recommendations: 
 
 
 
 
 
Sent             Date: _________________________                    Received            Date: _________________________      
Report             Report 
      Person: ______________________                                Person: ______________________    
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ANNEX 14  Managing public health surveillance data  
 
Effective public health activities, including public health surveillance, depend on a trusting 
relationship between the public health workers and the public they are trying to assist. 
 
The following are obligations of public health workers including epidemiologists: 
 
C Protect the confidentiality and privacy of the community 
  
Privacy is the right of patients to choose what information they will release about 
themselves and to whom.  
 
Confidentiality is the obligation of public health workers to keep information about 
individuals restricted only to those persons who absolutely need it for the health of the 
community.   Patients have the right to know why they are providing information, to refuse 
to provide information, and to expect that information will be handled as confidential. 
 
Information, even when it does not include names, can still be used to identify persons and 
lead to discrimination or other consequences aga inst individuals and, therefore, must be 
protected.  In many countries and districts, even a few pieces of information that may seem 
to be unimportant can be used unintentionally to identify the patient. Additionally, 
consideration will be given to how to protect patients from identification while still 
allowing the public health system to trace contacts or outbreaks when required. A good 
information system will have thought carefully about what information is essential for 
public health action. 
  
C Informed Consent 
  
Make sure that information is used only for the purposes for which it was intended.  
Information for surveillance is not expected by the community to be used for research 
purposes.  There may be national or institutional laws that specify what the uses should be 
and when additional consent from the patient is needed.  The public health worker respects 
these laws. 
  
C Maintaining professionalism and the public trust 
 
To perform public health functions, including surveillance, it is essential that there is public 
support. Trust is an expression of confidence that public health workers will be fair, 
reliable, ethical, and competent. 
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Section 3 
Analyze data 
 
 
 
 
This section describes how to: 
 
· Receive, handle and store data reported from other 
levels 
· Analyze data by time, place and person 
· Draw conclusions based on the analysis results 
· Compare analysis results with thresholds for 
public health action. 
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3.0 Analyze data 
 
Analyzing trends of disease cases and deaths over time has many benefits.  
The analysis provides key information for: 
 
· Identifying trends and taking prompt public health action 
· Identifying causes of problems and their most appropriate solutions 
· Evaluating the quality of public health programs in the district over 
the medium- and long-term. 
 
Analysis of surveillance data emphasizes two important outcomes: 
 
· During an acute outbreak of a disease or condition, the information 
that results from data analysis leads to the identification of the 
most appropriate and timely control actions.  The actions are taken 
immediately to limit the outbreak and prevent further cases from 
occurring.   
 
· Disease rates change over time.  Some of these changes occur 
regularly and can be predicted such as an increase of malaria cases 
during the rainy season.  Analysis and use of the trends in 
summary data over time provides information for improving 
district public health activities that target diseases such as malaria, 
tuberculosis, HIV/AIDS and vaccine preventable diseases.  These 
are diseases that can account for up to 80% of the deaths due to the 
priority diseases and conditions.  Many of the deaths are in 
children less than 5 years of age. 
 
This section focuses on the analysis of data at the district level. 
However, the steps can be applied to data at the health facility level. 
 
Ideally, do some data analysis at each level where data are 
collected.  
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3.1 Receive data from health facilities  
 
The district team receives two types of surveillance data from reporting  
sites, such as health facilities, in the district:  
 
· Case-based or other information from suspected cases of 
immediately reportable diseases 
· Monthly summary totals of cases and deaths for the priority 
diseases. 
 
WHO/AFRO recommends that: 
 
· Reports of suspected cases for immediately reportable diseases be 
received by the district within 48 hours of the case being seen at 
the health facility. 
· Monthly reports of summary data should be received on time. 
 
Note: When an outbreak is suspected, cases and deaths should be 
reported and graphed weekly.  In meningitis-belt countries, weekly 
reporting of immediately reportable meningitis cases is 
recommended.  
 
When written reports are received, review case-based reporting forms to 
see if any essential information is missing. 
 
If reports are not being received at all, or if they are consistently late, 
contact or visit the health facility to find out what has caused the problem.  
Work with the staff at the reporting health facility to help find a solution 
that could be implemented for improving reporting. 
 
Note: Make sure that health staff who record, report or store data 
understand the need for privacy and confidentiality.  Please see Annex 14 
for guidance in managing public health surveillance data. 
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3.2 Prepare to analyze data by time, place, and 
person  
 
In order to detect outbreaks, follow their course, and monitor public 
health activities,  health staff need to know: 
 
· How many cases occurred 
· Where the cases occurred 
· When the cases occurred 
· The population most affected  
· Risk factors that contributed to transmission of the disease 
 
This information comes from patient registers and lists.  But it is easier to 
identify problems and detect outbreaks if the data from the patient record 
or clinic register are summarized and displayed in a table, graph or map.  
When data are displayed, the information can be understood quickly, and 
it is easier to see patterns and trends. 
 
One method for ensuring that at least routine summary data for priority 
diseases is analyzed every month is to maintain an “analysis book” at the 
health facility and district levels.  Recommended graphs, tables and maps 
for analyzing data about the selected priority diseases can be kept together 
in a notebook or placed on the wall.  Each month the graphs and tables are 
updated and conclusions drawn about what is shown. 
 
The analysis book can be easily observed during a supervisory visit or 
when the health facility public health team or district response team want 
to have information about how to respond to health events in the area.  
How to set up and maintain an analysis book is in Annex 16 at the end of 
this section. 
 
The chart on the following page lists recommended methods and tools for 
analyzing surveillance data so that health staff will have the information 
they need to take a public health action.  
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Objectives, tools and methods of descriptive analysis for communicable diseases 
Type of analysis Objective  Tools Method 
Time 
 
for immediately 
reportable diseases and 
monthly summary totals 
of cases and deaths for 
priority diseases  
Detect abrupt or long-
term changes in 
disease occurrence, 
how many occurred, 
and the period of time 
from exposure to onset 
of symptoms. 
Record summary totals 
in a table or on a line  
graph or histogram. 
Compare the number of 
case reports received 
for the current period 
with the number 
received in a previous 
period (months, 
seasons or years) 
Place  
 
usually for immediately 
reportable diseases only 
Determine where 
cases are occurring 
(for example, to identify 
high risk area or 
locations of populations 
at risk for the disease) 
Plot cases on a spot 
map of the district or 
area affected during an 
outbreak. 
Plot cases on a map 
and look for clusters or 
relationship of the 
location of the cases to 
the health event being 
investigated.  
Person 
 
usually for immediately 
reportable diseases only 
Describe reasons for 
changes in disease 
occurrence, how it 
occurred, who is at 
greatest risk for the 
disease, and potential 
risk factors  
Extract specific data 
about the population 
affected on a table. 
Depending on the 
disease, characterize 
cases according to the 
data reported for case-
based surveillance such 
as age, gender, place of 
work, immunization 
status, school 
attendance, and other 
known risk factors for 
the diseases. 
 
3.3 Analyze data by time 
 
Analyzing data to detect changes in the numbers of cases and deaths over 
time is the purpose of “time” analysis.  Observing disease trends over time 
helps to show when regular changes occur and can be predicted.  Other 
disease rates make unpredictable changes.  By examining events that 
occur before a disease rate increases or decreases, it may be possible to 
identify causes and appropriate public health actions for controlling or 
preventing further occurrence of the disease.   
 
Data about time is usually shown on a graph.  The number or rate of cases 
or deaths is placed on the vertical or y-axis.  The time period being 
evaluated is place along the horizontal or x-axis.  Events that occurred that 
might affect the particular disease being analyzed can also be noted on the 
graph.  For example, the graph may indicate the date that refresher training 
was conducted for health workers in IMCI case management for childhood 
diseases.   
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Graphs can show how many cases and deaths have occurred in a given 
time.  It is easier to see changes in the number of cases and deaths by 
using a graph, especially for large numbers of cases or showing cases over 
a period of time.   
 
Graphs are made with bars (a bar graph) or lines (a line graph) to measure 
the number of cases over time.   
 
This is an example of a bar graph.    
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This is an example of a line graph. 
 
A histogram is like a line graph except that it uses squares to represent 
cases rather than a line to connect plotted points. Use histograms to 
analyze outbreak data and to show an epidemic curve (an “Epi” curve).  
For acute outbreak diseases, time may be shown in 1-day, 2-day, 3-day or 
1-week or longer intervals.  In a histogram, the cases are stacked on the 
graph in adjoining columns so that the number of cases and deaths can be 
observed during the period under observation.  
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To make a graph: 
 
1. Decide what information you want to show on the graph.   
 
2. Write a title that describes what the graph will contain (for 
example, Monthly totals for inpatient cases and deaths due to 
malaria with severe anaemia 
 
3. Decide on the range of numbers to show on the vertical axis. 
 
· Start with 0 as the lowest number 
· Write numbers, going up until you reach a number higher 
than the number of cases 
· Chose an interval if the numbers you will show on the 
vertical axis are large. 
 
4. Label the vertical axis, explaining what the numbers represent.  
 
5. Label the horizontal axis and mark the time units on it.  The 
horizontal axis is divided into equal units of time.  Usually you 
will begin with the beginning of an outbreak, or the beginning of a 
calendar period, such as a month or year. 
 
6. Make each bar on the graph the same width. 
 
7. Mark the number of cases on the graph or histogram.  For each unit 
of time on the horizontal axis, find the number of cases on the 
vertical axis.  Fill in one square for each case, or for some number 
of cases in the column for the day on which the patient was seen.  
Show deaths by using a different pattern of lines, or a different 
color.  If you are making a line graph, instead of making a bar or 
filling in squares, draw a cross or make a point where the 
horizontal and vertical lines cross.  Connect the points on the graph 
to show the trend going up or down over time. 
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3.4 Analyze data by place  
 
Analyzing data according to place gives information about where a disease 
is occurring.  Establishing and regularly updating a spot map of cases for 
selected diseases can give ideas as to where, how, and why the disease is 
spreading.   An analysis of place provides information that is used to: 
  
· Identify the physical features of the land  
· Understand the population distribution and density of the area 
· Describe the variety of populations in an area.  (farming area, high 
density urban area, refugee settlement, and so on.) 
· Describe environmental factors (major water sources in a 
community, such as rivers, lakes, pumps, and so on.) 
· Identify clinics, meeting houses, schools, community buildings, 
and large shelters that can be used during emergency situations 
· Show distances between health units and villages (by travel time or 
distance in kilometers) 
· Plan routes for supervisory or case investigation activities 
· Spot locations of disease cases and identify populations at highest 
risk for transmission of specific diseases. 
 
Create a map to use as part of routine surveillance of disease.  
 
· Obtain a local map from the local government office or land 
department.  Trace the main features needed for health work onto 
transparent paper and then to a large card that can be hung on a 
wall for easy use.  If no official map is available, sketch the whole 
district area.   
 
· Prepare a code of signs to use on the map, to represent each of the 
following features that will be shown on the map: 
 
– Location of health facilities in the district and the areas 
each serves 
– Geographic areas such as forests, savannah areas, villages, 
roads, and cities 
– Socio-economic areas of relevance to priority diseases 
– Significant occupation sites such as mines or construction 
sites 
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– Location of suspected and confirmed cases of priority 
diseases 
–  Location of previous confirmed outbreaks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5 Analyze data by person 
 
Analysis by person is recommended for describing the population at risk 
for epidemic-prone diseases and diseases targeted for eradication or 
elimination.  These are diseases that are reported with case-based 
surveillance so data about personal characteristics is likely to be available.  
Analysis by person is not routinely recommended for summary data. 
 
A simple count of cases does not provide all of the information needed to 
understand the impact of a disease on the community, health facility or 
district.  Simple percentages and rates are useful for comparing 
information reported to the district. 
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The first step in analyzing person data is to identify the numerator and 
denominator for calculating percentages and rates. 
 
· The numerator is the number of specific events being measured 
(such as the actual number of cases or deaths of a given disease, 
for example the number of cases of Guinea worm that occurred 
during the year in children less than 5 years of age.)  
 
· The denominator is the number of all events being measured (such 
as the size of the population in which the cases or deaths of a given 
disease occurred, or the population at risk.) 
 
Simple percentages can be calculated to compare information from  
populations of different sizes.  For example: 
 
Health facility 
     Number of measles cases this year in 
children less than 5 years of age 
A 42 
B 30 
 
By looking only at the number of reported cases, it appears that a higher 
occurrence of Guinea worm cases occurred in health facility A. 
 
But when the number of reported cases at each health facility is compared 
to the total number of school-aged children living in each catchment area, 
then the situation becomes clearer. 
 
 Health facility 
 Number of school-aged children  
living in the catchment area 
A 1,150 
B 600 
 
By calculating the percentage of the number of cases of Guinea worm 
during the last 12 months in school aged children, the district officer can 
compare the impact of the illness on each facility.  The numerator is the 
number of cases that occurred over one year.  The denominator is the 
number of school aged children at risk  in each catchment area.   In this 
example, the incidence rate is higher in health facility B than in health 
facility A. 
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 Health facility 
Percentage of cases of Guinea worm in  
school-aged children during last 12 months  
A 0.4% 
B 0.5% 
 
3.5.1 Make a table for person analysis 
 
For each priority disease or condition under surveillance, use a table to 
analyze characteristics of the patients who are becoming ill.  A table is a 
set of data set in columns and rows.  The purpose of a table is to present 
the data in a simple way.  For surveillance and monitoring, use a table to 
show the number of cases and deaths from a given disease that occurred in 
a given time.   
 
To make a table: 
 
1. Decide what information you want to show on the table.  For 
example, consider analysis of measles cases and deaths by age 
group 
 
2. Decide how many columns and rows you will need.   Add an extra 
row at the bottom and an extra column at the right to show totals as 
needed.  In the example, you will need a row for each age group, 
and a column for each variable such as age group or cases and 
deaths. 
 
3. Label all the rows and columns, including measurements of time.  
In the example below, the analysis is done yearly.  Analysis of 
person is also recommended for analysis of outbreak data. 
 
4. Record the total number of cases and deaths as indicated in each 
row.  Check to be sure the correct numbers are in the correct row 
or column. 
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Age group 
Number of  
reported cases Number of deaths 
0 - 4 years 40 4 
5-14 years 9 1 
15 years and older 1 0 
Age unknown 28 0 
Total 78 5 
 
3.5.2 Calculate the percentage of cases occurring within a 
given age group 
 
When the summary totals for each age group are entered, one analysis that 
can be done is to find out what percent of the cases occurred in any given 
age group.  Use the information on the table to: 
 
1. Identify the total number of cases reported within each age group 
from the summary data for which time or person characteristics are 
known.  (For example, there are 40 cases in children 0 up through 
4 years of age.) 
 
2. Calculate the total number of cases for the time or characteristic 
being measured.  (In this example, there are 50 cases whose age is 
known.) 
 
3. Divide the total number of cases within each age group by the total 
number of reported cases.  (For example, for children age 0 up 
through 4 years, divide 40 by 50.  The answer is 0.8.)  
 
4. Multiply the answer times 100 to calculate the percent.  (Multiply 
0.8 X 100.  The answer is 80%.) 
       Age group 
   Number of 
reported cases 
 % of reported cases 
 in each age group 
 0-4 years   40   80% 
  5-14 years   9  18% 
 15 years and older  1    2% 
 Age unknown   28   0% 
 Total  78   5 
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3.5.3 Calculate a case fatality rate 
 
A case fatality rate helps to: 
 
· Indicate whether a case is identified promptly 
· Indicate any problems with case-management once the disease has 
been diagnosed 
· Identify a more virulent, new or drug-resistant pathogen. 
· Indicate poor quality of care or no medical care.  
· Compare the quality of case management between different 
catchment areas, cities, and districts. 
     
Public health programs can impact the case fatality ratio by ensuring that 
cases are promptly detected and good quality case management takes 
place.  Some disease control recommendations for specific diseases 
include reducing the case fatality rate as a target for measuring whether 
the outbreak response has been effective. 
 
To calculate a case fatality rate: 
 
1. Calculate the total number of deaths.  (In the example of the 
measles data, there are 5 deaths.) 
 
2. Divide the total number of deaths into the total number of reported 
cases.  (For example, the total number of reported cases is 78.  The 
number of deaths is 5.  So divide 5 by 78.  5 ÷ 78 is 0.06.) 
 
3. Multiply the answer times 100.  (0.06 X 100 equals 6%.) 
 
Age group 
  Number of 
reported 
cases 
Number of 
deaths 
Case fatality 
rate 
 0-4 years  40 4 10% 
5-14 years  9 1 11% 
15 years and older  1  0  0 
 Age unknown 28 0 0% 
Total  78  5 6% 
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3.6 Draw conclusions from the analysis 
 
Depending on how often data is reported to the next level (for example, 
monthly): 
 
3.6.1 Review the updated charts, tables, graphs and maps  
 
Review the analysis tools to make sure that: 
 
· The total number of cases and deaths under surveillance is up-to-
date. 
· The case fatality rates are calculated and up-to-date 
· The geographical distribution of the cases and deaths are described 
and include case fatality rates as appropriate. 
 
3.6.2 Compare the current situation with previous months, 
seasons and years  
 
1. Observe the trends on the line graphs and look to see whether the 
number of cases and deaths for the given disease is stable, 
decreasing or increasing. 
 
2. If case fatality rates have been calculated, is the rate the same, 
higher, or lower as it was in the previous months? 
 
3.6.3 Determine if thresholds for action have been reached 
 
Thresholds are markers that indicate when something should happen or 
change.  They help surveillance and program managers answer the 
question, “When will you take action, and what will that action be?” 
 
Thresholds are based on information from two different sources: 
 
· A situation analysis describing who is at risk for the disease, what 
are the are the are the risks, when is action needed to prevent an 
wider outbreak, and where do the diseases usually occur? 
 
· International recommendations from technical and disease control 
program experts. 
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Districts may decide to observe thresholds for the most critical diseases in 
their area.  It is not useful to have a threshold or trigger occurring for 
multiple diseases constantly.  Health staff will lose their willingness to 
truly watch for trends and respond to problems if they become 
overextended. 
 
These guidelines recommend two types of thresholds: an alert threshold 
and an action threshold.  Not every disease has both types of thresholds, 
although each disease certainly has a point where a problem needs to be 
reported and some action taken.  The thresholds as described in these 
guidelines represent the continuum of recommended practices and are 
used to describe where action is recommended.  Detailed thresholds for 
specific diseases are in Section 8 of these guidelines.  Definitions of the 
thresholds are included in this section. 
 
An alert threshold suggests to health staff that further investigation is 
needed.  Depending on the disease, an alert threshold is reached when 
there is one suspected case (as for an epidemic-prone disease or for a 
disease targeted for elimination or eradication) or when there is an 
unexplained increase seen over a period of time in monthly summary 
reporting.  Health staff respond to an alert threshold by: 
 
· Reporting the suspected problem to the next level 
· Reviewing data from the past 
· Requesting laboratory confirmation to see if the problem is one 
that fits a case definition 
· Being more alert to new data and the resulting trends in the disease 
or condition  
· Investigate the case or condition 
· Alert the appropriate disease-specific program manager and district 
epidemic response team to a potential problem. 
 
An action threshold triggers a definite response.  It marks the specific data 
or investigation finding that signals an action beyond confirming or 
clarifying the problem.  Possible actions include communicating 
laboratory confirmation to affected health centers, implementing an 
emergency response such as an immunization activity, community 
awareness campaign, or improved infection control practices in the health 
care setting. 
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Suggested thresholds that alert health staff to a possible outbreak are in the 
Annex to Section 4.  Also refer to the disease-specific guidelines in 
Section 8. 
 
3.6.4 Summarize the analysis results 
 
Consider the analysis results with the following factors in mind: 
 
· Trends for inpatient cases describe increases and decreases for the 
most severe cases.  Deaths are most likely to be detected for cases 
that are hospitalized.  The reporting of the case according to the 
definition is likely to be more accurate than those reported for 
outpatient cases. 
 
· Increases and decreases may be due to factors other than a true 
increase or decrease in the number of cases and deaths being 
observed.  The program objectives for the disease reduction 
activities in your area should be to decrease the number of cases 
and deaths over time.   
 
· If this decrease is not occurring, and the number of cases  is 
remaining the same or increasing, consider whether any of the 
following factors are affecting reporting: 
 
–  Has there been a change in the number of health facilities 
reporting information? 
–  Has there been any change in the case definition that is 
being used to report the disease or condition?   
–  Is the increase or decrease a seasonal variation? 
–  Has there been a change in screening or treatment 
programs?  In community outreach or health education 
activities that would result in more people seeking care? 
–  Has there been a recent immigration or emigration to the 
area or increase in refugee populations? 
–  Has there been any change in the quality of services being 
offered at the facility?  For example, lines are shorter, 
health staff are more helpful, drugs are available, clinic fees 
are charged. 
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3.6.5 Compare this month’s achievement towards disease 
reduction targets 
 
Many public health programs have set disease reduction targets.  There 
may be targets for individual health facilities, for communities and for the 
district as a whole.  Collaborate with the managers of the public health 
activity programs to discuss progress towards the targets based on the 
analysis results.  
 
If analysis results indicate that the program strategy is not leading to a 
change or an increase in the number of cases being detected and treated, 
then discuss ways to improve the situation.  For example, any increases or 
lack of decline in the number of cases should prompt further inquiry and 
action to improve the quality of the public health program.  Consider 
improvements such as: 
 
· Improve drug availability for pneumonia case management in 
children under 5 years of age 
· Improve drug availability at least for pregnant women and children 
during the malaria season 
· Work with community health staff to improve community 
awareness about when to bring children to the health facility for 
treatment for diarrhoea with dehydration, pneumonia, and malaria. 
· Expand HIV/AIDS prevention education to reach youth not in 
school. 
· Improve immunization coverage in areas of highest risk for a given 
vaccine-preventable disease (measles, meningitis, neonatal and 
maternal tetanus, yellow fever) 
 
3.7 Summarize and use the analysis results to 
improve public health action  
 
Make statements that describe the conclusions you have drawn from the 
analysis results.  Use them to take action to: 
 
· Conduct an investigation to find out where there is an increase in 
the number of cases.  
· Collaborate with specific disease reduction programs to intensify 
surveillance if an alert threshold has been crossed, 
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· Advocate with political leaders and the community for more 
resources, if a lack of resources is identified as a cause for the 
increased number of cases. 
 
How to investigate public health problems is in Section 4.0. 
 
Providing feedback to other levels of the health system and the community 
is in Section 6.0. 
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Annexes to Section 3  
 
· ANNEX 15 Sample grid for time analysis  
 
· ANNEX 16 Sample tables for person analysis 
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Annex 15    Sample Grid for Time Analysis 
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Annex 16 Sample tables for person analysis 
 
These are examples of person analyses that may be done for outbreak data or at the end of the 
year to analyze summary data for case-based surveillance reports. 
 
Age distribution 
 
Age Group Number of reported 
cases 
% of reported cases 
0 up through 4 years   
5 years up through 14 
years 
  
15 years and above   
Sub-total   
Number with missing 
data 
  
Total   
 
Location: Urban versus rural 
 
Location Number of reported 
cases living in this area 
% of reported cases 
Urban   
Rural   
Sub-total   
Number with missing 
data 
  
Total   
 
 93 
 
Gender distribution 
 
Gender Number of reported 
cases 
% of reported cases 
Female   
Male   
Sub-total   
Number with missing 
data 
  
Total   
 
Comparing Inpatient and Outpatient Status 
 
Source of report Number of reported 
cases 
% of reported cases 
In-patient   
Out-patient   
Sub-total   
Number with missing data   
Total   
 
Comparing immunization status and outcome 
 
Number of doses Number survived Number deceased 
Zero doses   
1 dose   
2+ doses   
Sub total   
Number (%) with missing data   
Total   
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Section 4 
Investigate reported outbreaks 
and other public health problems 
 
 
This section describes how to: 
 
· Decide to investigate a reported outbreak or other 
public health event 
· Plan and carry out a case investigation 
· Analyze the investigation results to determine 
what caused the problem. 
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4.0 Investigate suspected outbreaks and other public 
health problems   
 
An investigation is a method for identifying and evaluating people who 
have been exposed to an infectious disease or affected by an unusual 
health event.  The investigation provides relevant information to use in 
taking immediate action and improving longer term disease prevention 
activities.  The steps for conducting an investigation of a suspected 
outbreak due to an infectious disease can also be used to investigate other 
public health problems in the district.  The purpose of an investigation is 
to: 
 
· Verify the outbreak or the public health problem. 
· Identify and treat additional cases that have not been reported or 
recognized. 
· Collect information and laboratory specimens for confirming the 
diagnosis. 
· Identify the source of infection or cause of the outbreak. 
· Describe how the disease is transmitted and the populations at risk. 
· Select appropriate response activities to control the outbreak. 
· Strengthen prevention of activities to prevent future recurrence of 
the outbreak. 
 
In most countries, districts have the overall responsibility for investigating 
outbreaks.  In other countries, health facilities (at least large health 
facilities with adequate numbers of staff and a public health officer or 
team) will undertake some or all aspects of investigating outbreaks for 
some diseases or conditions. These guidelines assume that the district 
level has responsibility for leading the investigation. 
 
4.1 Decide to investigate a reported outbreak  
 
For some communicable diseases, a single suspected case is the trigger for 
taking action, reporting the case to a higher level, and conducting an 
investigation.  These are dangerous diseases with the potential for 
explosive outbreaks or with high case fatality rates if cases are not treated 
promptly.  
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For other diseases, the trigger is when a certain threshold is reached.  
Health staff should promptly investigate the problem and respond to the 
immediate cases.  Preparations for taking a wider public health response 
should be made.  Alert and action thresholds are described in Section 
3.6.3. 
 
Some health events require investigations to be started as soon as possible.  
Districts should aim to investigate suspected outbreaks within 48 hours of 
notification. 
 
Conduct an investigation when: 
 
· The district receives a report of a suspected outbreak of an 
immediately notifiable disease  
· An unusual increase is seen in the number of deaths during routine 
analysis of data 
· Alert or action thresholds have been reached for specific priority 
diseases.  
· Communities report rumors of deaths or about a large number of 
cases that are not being seen in the health facility 
· A cluster of deaths occurs for which the cause is not explained or 
is unusual (for example, an adult death due to bloody diarrhoea). 
 
NOTE:  The threshold for some diseases will not change between districts 
or health facilities because they are thresholds for immediately notifiable 
diseases and are set by national policy.  
 
 To establish health facility thresholds for notifying the district about other 
diseases such as shigella, malaria, measles in non-elimination countries, 
diarrhoea with some or severe dehydration in children less than 5 years, 
and meningitis, meet with the health facility staff to discuss the following 
steps: 
 
1. If data from previous years is available, review trends in cases and 
deaths due to these diseases over the last 5 years.  Determine a 
baseline number to describe the current extent of the disease in the 
catchment area. 
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2. As appropriate, take into account factors for diseases such as 
malaria or cholera with seasonal increases.  
 
3. State the threshold clearly as a number of cases per month or week, 
so that health staff responsible for surveillance activities can 
readily recognize when the threshold is reached. 
 
4. Periodically, revise the epidemic threshold and adjust it 
accordingly depending on past and current trends for the disease.  
If the extent of the disease’s burden is changing (for example, 
cases are increasing), then adjust the threshold. 
 
Examples of thresholds or triggers for taking action to implement 
interventions or investigations of a case or outbreak are in Section 8 of 
these guidelines. 
 
These thresholds are recommended by WHO/AFRO and can be adapted to 
meet your national policies, priorities, and capacity to respond. 
 
4.2 Record reported outbreaks and rumors 
 
Prepare a method for tracking the reporting of and response to outbreaks 
and rumors reported to the district.   A sample form for tracking reports of 
outbreaks is in Annex 18 of this section.  If the district is using a district 
analysis workbook, include this form in the workbook. 
  
The purpose for tracking reported outbreaks is to ensure that the report of 
each suspected outbreak or rumor is followed by some action and 
resolution.  Keeping this record will help to gather information for 
evaluating the timeliness and completeness of the outbreak investigation 
and response process.   
4.3 Verify the reported outbreak  
 
Promptly verify reported outbreaks from health facilities or community 
rumors.  This is important for making sure that timely decisions are made 
to prevent expending resources on investigating events that are not true 
outbreaks of priority diseases.   
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Consider the following factors: 
 
· Source of information (For example, is the source of the rumor 
reliable?  Is the report from a health facility?) 
· Severity of illness 
· Number of reported cases and deaths 
· Transmission mode and risk for wider transmission 
· Political or geographic considerations 
· Public relations 
· Available resources. 
 
The outbreak situation, when compared to the above factors, may cause 
the district to treat the investigation with more urgency.  For example, 
reports of a suspected viral hemorrhagic fever case are treated with more 
urgency than a report of a neonatal tetanus case because the risk for wider 
transmission of the VHF is greater.  Regardless of the factors, suspected 
outbreaks (including immediately notifiable cases) from health facilities 
need to be reported within 48 hours. 
 
4.4 Prepare to conduct an investigation  
 
Coordinate the investigation objectives with the person in the district 
responsible for control of that disease or condition.  Make sure that the 
objectives of the investigation will provide the essential information for 
implementing the most appropriate and relevant response.   Plan to use 
appropriate methods that are relevant to the disease or condition being 
investigated. If epidemic response and preparedness activities have taken 
place in the district or health facility, staff who might be able to take part 
in the investigation should already be identified and trained. 
 
4.4.1 Specify work health staff is expected to do  
 
Inform health staff about the tasks they will be expected to do and the 
functions they will support.  Contribute to the positive motivation for 
doing the investigation.  For example, make sure that the investigation 
team understands the link between the investigation and the selection of 
response activities for preventing additional cases and saving lives. 
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4.4.2 Define supervision and communication lines 
 
Make a communication plan.  Prepare a diagram showing who will report 
to whom and how information will move both within the investigation 
team and between the district and other levels, including the most local 
level.  For example, define who will communicate with the Ministry of 
Health, the media and the community.  State the methods for 
communicating and how often it should be done during an outbreak to 
keep officials informed.  Methods may include daily updates by 
radiophone, facsimile, electronic mail or conference calls. 
 
Show on the diagram the lines of authority and the roles of each staff 
person on the team.   Define the role of non-health staff and how they 
should be supervised. 
 
4.4.3 Decide where the investigation will take place 
 
1. Review information already known about the suspected illness, 
including its transmission method and risk factors.  Use this 
information to define the geographic boundaries and target 
population for conducting the investigation.  Begin the 
investigation in the most affected place. 
 
2. Contact nearby health facilities to see if they have seen similar 
cases or an increase cases with the same diagnosis. 
 
3. Involve the community and local health facility staff in planning 
and conducting the investigation.  Information about local customs, 
culture, and routines could affect the success of the outbreak 
investigation. 
 
4.4.4 Obtain the required authorizations  
 
Observe the appropriate authorizations, clearances, ethical norms, and 
permissions that are required to do the investigation. 
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4.4.5 Finalize forms and methods for collecting information 
and specimens  
 
Review with the investigation team how to collect the required 
information and record it.  For example, at a minimum, staff should know 
how to gather and record information on a line list. 
 
Select the variables to identify, record and analyze for the disease being 
investigated.  Depending on staff responsibilities, review how to identify 
and record information for preparing the following: 
 
· Line list for summarizing time, place and person analysis 
· Epidemiologic curve 
· Spot map 
· Analysis tables for risk factors, age group, gender, immunization 
status and so on. 
 
Refer to the steps in Section 3.0. 
 
4.4.6 Arrange transportation  
 
Make travel arrangements for getting to and from the site of the 
investigation and for traveling during the investigation.  Make sure 
transportation for moving specimens to the appropriate laboratories have 
been arranged. 
 
4.4.7 Gather supplies for collecting lab specimens  
 
In some districts, there is a rapid response kit that contains supplies and 
equipment for carrying out the investigation. 
 
If a kit is not available in your district, look at the disease specific program 
guidelines and talk to laboratory specialists to find out the requirements 
for laboratory supplies for proper collection, storage, and transport of 
relevant specimens.     
 
Refer to the laboratory chart in Section 1.0 and to the disease specific 
guidelines in Section 8. 
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4.5 Confirm the diagnosis 
  
4.5.1  Review the clinical history  
 
Examine the patient or patients to confirm that their signs and symptoms 
meet the case definition.  Ask the patient or a family member who can 
speak for the patient: 
  
· Where do you live? 
· When did the symptoms begin? 
· Who else is sick in your home (or workplace, village, 
neighborhood) 
· Where have you trave led recently? 
· Where did you live within the 2 weeks prior to the onset of 
symptoms (residence at time of infection)? 
· Were you visited by anyone within the last 2 weeks? 
 
4.5.2 Collect laboratory specimens and obtain laboratory 
results  
 
If the disease is confirmable by laboratory testing, refer to the laboratory 
chart in Section 1.0 to determine the diagnostic test and the specimen that 
is required.  The chart also describes how to collect, store and ship the 
specimen, and how many specimens to collect to confirm an outbreak for 
a particular disease. 
 
Review laboratory results with the investigation team, clinicians, and 
laboratory persons at the health facility.  Are the laboratory results 
consistent with the clinical findings?  Seek additional assistance from 
national level program managers or technical experts if you have any 
questions about the laboratory results. 
 
  4.6 Isolate cases as needed and treat them   
 
Strengthen case management at the health facility (or where the patients 
are being seen).  Provide the health facility with advice, support, and 
supplies as indicated by the case management guidelines.  For example: 
 
· Monitor the patients’ signs and symptoms 
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· Treat the patient with available recommended drugs and therapies 
· Support the health facility in enhancing infection control as needed 
depending on the specific disease.  Use standard precaution with 
all patients in the health facility, especially during an outbreak of a 
disease transmitted by contact with contaminated supplies and 
body fluids. 
 
4.7 Search for additional cases  
 
Once the initial cases have been confirmed and treatment has begun,  
actively search for additional cases. 
 
4.7.1 Search for cases in the health facility records  
 
In the health facilities where cases have been reported, search for 
additional cases in the registers.  Look for other patients who may have 
presented with the same or similar signs and symptoms as the disease or 
condition being investigated.  Request health workers and hospital staff to 
search for similar cases in the registers of neighboring health facilities. 
 
See Annex 18 at the end of this section for instructions on conducting a 
register review.  Make sure to follow up any cases that have been allowed 
to go home. 
 
4.7.2 Search for cases in the community  
 
Identify areas of likely risk where the patients have lived, worked, or 
traveled.  Also talk to other informants in the community such as 
pharmacists or school teachers.   
 
The areas for the search may be influenced by the disease, its mode of 
transmission, and factors of risk related to time, place and person analysis.  
Visit those places and talk to people who had or were likely to have had 
contact with the patient.  Ask if they or anyone they know has had an 
illness or condition like the one being investigated. Find out if anyone else 
in the area around the case has been ill with signs or symptoms that meet 
the case definition.  Collect information that will help to describe the 
magnitude and geographic extent of the outbreak. 
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Refer newly identified cases to the health facility for treatment. 
 
4.8  Record information about  the additional cases  
 
For each new case either in the health facility register or in searches of the 
community that fits the surveillance case definition, record the collected 
information on either a case-based reporting form, line list or other 
recommended form. 
 
4.8.1 Record information on a case reporting form  
 
Record information on a case reporting form for at least the first five 
patients.  Also record information on a case form for all those from which 
laboratory specimens will be taken.  For each case, record at least:  
   
· The patient’s name, address, and village or neighborhood and 
locating information.  If a specific address is not available, record 
information that can be used to contact patients if additional 
information is needed or to notify the patient about laboratory and 
investigation results. 
· The patient’s age and gender.  This information is used to describe 
the characteristics of the population affected by the disease.  
· The date of onset of symptoms and date the patient was first seen 
at the health facility 
· Relevant risk factor information such as immunization status if the 
disease being investigated is a vaccine-preventable disease. 
· The name and designation of the person reporting the information 
 
NOTE: To streamline data collection methods, WHO/AFRO recommends 
using the case reporting form as a laboratory transmittal slip. (See the 
sample form in Annex 8). 
 
Some diseases have their own more detailed case investigation form.  A  
copy of the more detailed forms for neonatal tetanus and AFP case 
investigation forms are in Annexes 20 and 21 of this section. 
 
According to national guidelines, the more detailed neonatal tetanus and 
AFP case forms can be completed by the health facility or by a member of 
the district team when the district is notified about the case. 
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4.8.2 Record information about additional cases on a line list  
 
When more than five to ten cases have been identified, and the required 
number of laboratory specimens have been collected, record any 
additional cases on a line list.  Use the line list as a laboratory transmittal 
form if 10 or more cases need laboratory specimens collected on the same 
day and specimens will be shipped off to the lab in a batch. 
 
4.9  Analyze data about the outbreak  
 
The methods for analyzing outbreak data are similar to how the analysis of 
summary data is described in Section 3.  Data about the outbreak is 
analyzed and reanalyzed many times during the course of an outbreak. 
 
During the initial analysis, summarize the outbreak and look for clues 
about where the outbreak is occurring, where it is moving, the source of 
the outbreak (from a single source, for example, a well or a funeral), and 
the persons at risk of becoming ill (for example, young children, refugees, 
persons living in rural areas, and so on).  Present the data in the following 
way: 
· Draw a histogram representing the course of the disease (an “epi” 
curve). 
· Plot the cases on a spot map. 
· Make tables of the most relevant characteristics for cases (for 
example, comparing age group with  vaccination status). 
 
During an outbreak, these data will need to be updated frequently (often 
daily) to see if the information being received changes the ideas regarding 
the causes of the outbreak. 
 
4.9.1 Analyze data by time 
 
Prepare a histogram using data from the case reporting forms and line 
lists.  Plot each case on the histogram according to the date of onset.  Use 
symbols to represent each case.  
 
As the histogram develops, it will demonstrate an epidemic curve.  Define 
the geographic area the curve will represent.  For example, decide if the 
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curve should describe the entire district or the health facility catchment 
area where the case occurred. 
 
The results of the time analysis allows program managers and surveillance 
officers to look back at the outbreak and answer questions such as when 
were patients exposed to the illness and the length of the incubation 
period.   
Highlight significant events on the histogram with arrows.  For example, 
review the log of reported outbreaks and rumors to highlight the dates 
when: 
 
· Onset of the first (or index) case 
· The health facility notified the district 
· The first case was seen at the health facility 
· The district began the case investigation 
· A concrete response began 
· The district notified the national level 
 
Note:  The purpose for highlighting these events with arrows is to evaluate 
whether detection, investigation and response to the outbreak was timely.  
For example, monitoring the interval between the onset of the first known 
case and when the first case was seen in the health facility is an indicator 
of the community’s awareness of the disease’s signs and symptoms and 
the need to refer cases to the health facility.  These intervals are discussed 
further in Section 7.0 Evaluate and Make Improvements to the System. 
 
Section 3.0 describes in more detail how to prepare and plot cases on a 
histogram. 
 
Section 7.0 describes how to use information on the histogram to monitor 
and evaluate timeliness of the case detection, investigation and response 
actions. 
 
4.9.2 Analyze data by place  
 
Use the place of residence on the case reporting forms or line lists to plot 
and describe: 
 
· Clusters of cases are occurring in a particular area 
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· Travel patterns that relate to the method of transmission for this 
disease 
· Common sources of infection for these cases. 
 
Please see Section 3 for detailed steps describing how to prepare a map for 
marking the location of suspected and confirmed cases. 
  
Mark on a map of the area where the suspected and confirmed cases 
occurred the following: 
 
· Roads, water sources, location of specific communities and other 
factors related to the transmission risk for the disease under 
investigation.  For example, a map for neonatal tetanus includes 
locations of traditional birth attendants and health facilities where 
mothers deliver infants. 
 
· Location of the patients’ residences or most relevant geographic 
characteristic for this disease or condition (for example, by village, 
neighborhood, work camp, or refugee settlement.  Another 
example is when mapping patients during a meningitis outbreak, 
locate the school where the patients attend.) 
 
· Other locations that are appropriate to the disease being 
investigated.  Please see the disease specific guidelines for specific 
recommendations for analyzing data by place. 
 
4.9.3 Analyze data by person 
 
Review the case forms and line lists and compare the variables for each 
person suspected or confirmed to have this disease or condition.   For 
example, depending on the factors that must be considered in planning a 
specific response, compare the total number and proportion of suspected 
and confirmed cases according to: 
 
· Age or date of birth 
· Gender 
· Urban and rural residences 
· Immunization status 
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· Inpatient and outpatient status 
· Risk factors 
· Outcome of the episode, for example, whether the patient survived, 
died or the status is not known. 
· Laboratory results 
· Final classification of the case 
· Other variables relevant to this disease (death by age group, for 
example). 
 
Use disease-specific information to decide which variables to compare.  
For example, if information has been collected about a malaria outbreak, 
specify the age groupings that are targeted by the National Malaria 
Program.  Compare the age groupings of cases detected in young children 
(age 2 months up to 5 years) cases in older children ( age 5 to 15 years) 
and cases in adults (age 15 and over). 
 
Please see the disease specific guidelines for recommendations about the 
essential variables to compare for each disease.  Please refer to Section 3.0 
for detailed steps about preparing tables for analyzing data by person. 
 
4.10 Interpret analysis results  
 
Review the analysis results and make conclusions about the outbreak.  For 
example: 
 
· What was the causal agent of the outbreak? 
· What was the source of infection? 
· What was the transmission pattern? 
· What control measures were implemented and to what effect? 
 
4.10.1 Interpret the time analysis results  
 
Look at the histogram and observe the shape of the epidemic curve. Draw 
conclusions about when exposure to the agent that caused the illness 
occurred, the source of infection and related incubation period. 
 
· If the shape of the curve suddenly increases to develop a steep up-
slope, and then descends just as rapidly, exposure to the causal 
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agent was probably over a brief period of time.  There may be a 
common source of infection. 
· If exposure to the common source was over a long period of time, 
the shape of the epidemic curve is more likely to be a plateau 
rather than a sharp peak. 
· If the illness resulted from person-to-person transmission, the 
curve will present as a series of progressively taller peaks 
separated by periods of incubation. 
 
4.10.2 Interpret the place analysis results  
 
Use the map to: 
 
· Describe the geographic extent of the problem. 
· Identify and describe any clusters or patterns of transmission or 
exposure.  Depending on the organism that has contributed to this 
outbreak, specify the proximity of the cases to likely sources of 
infection. 
 
4.10.3 Interpret the person analysis results  
 
Information developed from the person analysis is essential for planning 
the outbreak response because it describes more precisely the population 
at risk for transmission of this disease or condition.  For example, if 
yellow fever cases occurred in patients less than 15 years of age, then the 
immunization response action would need to target children less than 15 
years of age. 
 
4.10.4  Calculate case fatality rates  
 
Refer to the steps in Section 3 that describe how to calculate case fatality 
rates. 
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Annexes to Section  4 
 
· ANNEX 17 Log of suspected outbreaks and rumors 
 
· ANNEX 18 How to conduct a register review 
 
· ANNEX 19 Checklist of laboratory supplies for use in an outbreak investigation 
 
· ANNEX 20 Neonatal tetanus case investigation form 
 
· ANNEX 21 AFP case investigation form 
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ANNEX 17    District log of Suspected Outbreaks and Rumors 
 
Record verbal or written information from health facilities or communities about suspected outbreaks, rumors, or reports of unexplained events.  
Record the steps taken and any response activities carried out. 
 
 
 
 
 
 
 
Condition or Disease 
 
 
 
 
(1) 
Number of cases 
initially reported 
 
 
 
(2) 
Location 
 (Health Center, village, 
etc) 
 
 
(3) 
Date district 
was notified 
 
 
 
(4) 
Date suspected 
outbreak was 
investigated by 
the district 
 
(5) 
Result of District investigation 
 
(Confirmed, 
Ruled Out, or 
Unknown) 
(6) 
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District log of Suspected Outbreaks and Rumors (CONTINUED) 
 
 
 
Date Outbreak Began  
Date onset index 
case/date crossed 
threshold or first cluster) 
 
(7) 
Date a case was 
first seen at a 
health facility 
 
 
(8) 
Date Concrete 
intervention began 
 
 
 
(9) 
Type of Concrete 
Intervention that was begun 
 
 
 
(10) 
Date District 
Notified National 
Level of the 
Outbreak 
 
(11) 
Date District 
received national 
response 
 
 
(12) 
Comments 
 
 
 
 
(13) 
       
       
       
       
       
       
 115 
 
ANNEX 18  How to conduct a register review 
 
The purpose of a register review is to collect information on cases admitted to the health facility 
during a specific period.  Explain that the information will be used to determine what caused the 
outbreak or increase in number of cases. 
 
1. Select the facilities for review.  Depending on the local conditions and the priority 
disease or condition being investigated, select: 
 
C Any inpatient facility with more than 10 hospital beds.  Give priority to government 
health facilities.   
 
C Large reference or teaching hospitals with pediatric wards because they receive 
referrals from other health facilities.   
 
C Small hospitals or health facilities that serve remote areas and high risk populations. 
For example, nomadic groups, refugees, or areas without regularly scheduled health 
services. 
  
2. Meet with the health facility staff and explain the purpose of the review. 
 
Explain to the health facility's senior staff the purpose of the review.  The information will assist 
the district and health facility in determining the most appropriate action for limiting the 
outbreak and preventing future cases from occurring.  Emphasize that the activity is an 
information-gathering exercise, and is not a review of health worker performance. 
 
3. Arrange to conduct the review. 
 
Arrange a time to conduct the review when staff who will assist with the review are present and 
available to help or to answer questions. 
 
4. Identify sources of information. 
 
During the visit, depending on the priority disease or condition being investigated, check 
inpatient registers for the pediatric and infectious disease wards.   The inpatient register for the 
pediatric ward is a good source because it lists all children admitted to the ward.  Annual 
summary reports are not always accurate, and outpatient registers often include only a 
provisional diagnosis.  
 
Review the system and procedures health workers use to record information in the registers 
about diagnoses.  Make sure that the information needed for investigating any suspect case is 
available.  At a minimum, the register should include: 
 
-- the patient’s name and where it was born 
-- the signs and symptoms 
-- date of onset of symptoms and outcome (for example, date of death, if relevant) 
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-- immunization status, if appropriate to this disease 
 
If the health facility does not keep at least the minimum information, talk with senior staff about 
how to strengthen the record keeping so that the minimum information is collected. 
 
5. Do the record review at the scheduled day and time. 
 
Go to the selected wards as scheduled.  During the visit, look in the health facility registers for 
cases and deaths that may be suspected cases of NT.  These should be cases or deaths that  meet 
the standard case definition for suspected cases.  Find out whether the suspected case was 
investigated and reported according to national guidelines.   
 
6. Line list the suspected cases that are found.  
 
Record information about the suspect cases.  This information will be used during case 
investigation activities. 
 
7. Provide feedback to the health facility staff. 
 
Meet with the health facility supervisor and discuss the findings of the activity.  Use the 
opportunity to review any features of case management for the illness that may help health 
workers in the facility.  Reinforce the importance of immediate reporting and case investigation 
as tools for prevention of priority diseases and conditions.   
 
8. Report any suspected cases to the next level. 
 
Report the suspected cases according to local procedures.  Investigate the case further to 
determine the factors that placed the patient at risk for the disease or condition.  Develop an 
appropriate case response. 
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ANNEX 19 Checklist of laboratory supplies for use in an outbreak 
investigation 
 
• For using standard safety precautions when collecting and handling all specimens: 
 
_____ Pieces of bar soap and bleach for setting up handwashing stations 
_____ Supply of gloves 
_____ Safety boxes for collecting and disposing of contaminated supplies and  
             equipment 
 
 
• For collecting laboratory specimens: 
 
Blood     Cerebral spinal fluid (CSF) 
_____ Sterile needles, different sizes _____ Local anaesthetic 
_____ Sterile syringes   _____ Needle and syringe for anaesthetic 
_____ Vacutainers   _____ Antiseptic skin disinfectant 
_____ Test tube for serum   _____ Screw-top tubes and tube rack 
_____ Antiseptic skin disinfectant  _____ Microscopic slides in a box 
_____ Tourniquest   _____ Trans-Isolate media 
_____ Transport tubes with screw-on tops 
_____ Transport media - Cary-Blair, Trans-Isolate 
 
 
Blood films (malaria)   Stool 
_____ Sterile or disposable lancet  _____ Rectal swabs 
_____ Glass slides and cover slips  _____ Cary-Blair transport media 
_____ Slide box 
 
 
• If health facility has a centrifuge: 
 
_____ Sterile pipette and bulb 
______ Sterile glass or plastic tube, or 
bottle with a screw-on top  
 
 
• For packaging and shipping samples: 
 
____ Cold box with frozen ice packs or vacuum flask 
_____ Cotton wool for cushioning sample to avoid breakage 
_____ Shipping labels for addressing shipment to lab 
_____ Labels for marking “store in a refrigerator” on outside 
         of the shipment box 
_____ Case forms and line lists to act as specimen transmittal form 
_____ Marking pen to mark tubes with name of patient and ID  
          number (if assigned by the district)    
ANNEX 20  CASE INVESTIGATION FORM – NEONATAL TETANUS 
Official Use  Epid Number : ______-______-______-______             Received 
Only   (completed by district team)    Province         District       Year Onset    Case Number      at National _____/_____/_____ 
IDENTIFICATION 
District: ____________________________    Province: _____________________________ 
Nearest Health                            Village/       Town/ 
Facility to Village: ___________________ Neighborhood: ____________________     City: ___________________ 
 
Address: ________________________________________________________________________________________________ 
_________________________________________________________________________________________________ 
 
Name(s) of patient: _______________________________  Mother: __________________________ 
Sex:  £   1 = Male, 2 = Female     Father: ________________________    
NOTIFICATION/INVESTIGATION  
Notified     Date     Date Case 
by: _________________________  Notified:  _______/_______/______Investigated: ______/______/______ 
MOTHER'S VACCINATION HISTORY                 Please use the following key, 1=Y, 2=N, 9=U, where applicable. 
 
1st  _____/_____/_____  4th  _____/_____/_____ 
2nd _____/_____/_____ 5th _____/_____/_____ 
3rd  _____/_____/_____If >5, last dose______/______/_____     
**1= up-to-date, 2= not up -to-date, 9= unknown 
 
 
BIRTH OF INFANT 
Date of birth: ______/______/______                     Please use the following key, 1=Y, 2=N, 9=U, where applicable. 
 
Questions  Questions  
Mother received antenatal care?  Location of birth: ***   
How many prenatal visits?     If birth in institution, name of institution:  
Attended by a trained TBA/midwife?  Cut cord with a sterile blade?  
If attended by a trained TBA/midwife, give name  Cord treated with anything?  
Attended by doctor/nurse?  Describe treatment of cord: Where?  
*** 1=Hospital, 2=Health center, 3=Home, trained attendant, 4=Home, untrained attendant, 5=Home, no attendant, 9=Unknown 
 
 
INITIAL CLINICAL HISTORY                   Please use the following key, 1=Y, 2=N, 9=U, where applicable. 
                             
Was baby normal at birth?  
Normal cry and suck during first 2 days?    
Stopped sucking after 2 days?  
Arched back?  
Stiffness?  
Onset of symptoms: ____/_____/______ 
 
 
TREATMENT      
Date of admission ______/_______/______            
             
Medical record number: __________            
Facility Address: 
 
COMMENTS:  
 
RESPONSE                 Please use the following key, 1=Y, 2=N, 9=U, where applicable. 
 
Date of response: ______/______/_____  
Details of response: __________________________ 
___________________________ 
 
 
FINAL CLASSIFICATION OF THE CASE:      Neonatal Tetanus: £   1=Yes, 2=No, 9=Unknown 
INVESTIGATOR 
Name: ______________________________________       Title: _________________________________________ 
Unit: ____________________ Address: ___________________________________ Phone: _________________________
Question Answer 
Mother vaccinated with TT?  
Have card?                                             
Number of doses:   
Vaccination status of mother prior to delivery? **  
Spasms or Convulsions?                   
Complications?  
Did the baby die?  
Age at death:                            Days 
Age of onset in days:                            Days   ( 99=Unknown) 
Questions Answer    1=Y, 2=N, 9=U  
Seen in OPD?   
Admitted?  
Questions Answer   
Mother given protective dose of TT within 3 months of report?  
Supplemental immunization within same locality as the case?  
ANNEX 21  INVESTIGATION CASE FORM – ACUTE FLACCID PARALYSIS 
Official Use  Epid Number:     _______-_______-_______-______             
Only                    (completed by district team)       Province            District                Year Onset     Case Number            Received :  _______/_______/_______ 
IDENTIFICATION 
District: ____________________________ Province: _____________________________ 
Nearest Health                            Village/       Town/ 
Facility to Village: ___________________ Neighborhood: _________________________    City: ____________________________ 
 
Address: _________________________________________________________________________________________________________ 
______________________________________________________________________________________ 
 
Name(s) of patient: _______________________________  Mother/Father: ____________________________________ 
Sex:  £    1 = Male, 2 = Female      Date of birth: ______/______/______  or     Age: years ______ months ______ 
                          (If DOB is unknown)    
NOTIFICATION/INVESTIGATION  
Notified by: _______________________ Date Notified: ______/_______/______ Date Investigated: ______/______/______     
HOSPITALIZATION         
Admitted to hospital? £  1= Y, 2= N     Date of admission ______/_______/______ Medical record number: __________      
Facility Address:  
 
CLINICAL HISTORY                   Please use the following key, 1=Yes, 2=No, 9=Unknown. 
                              
    Site of paralysis 
 
 
                       Onset of paralysis: ____/_____/______ 
 
 
 
AFTER INVESTIGATION, WAS IT TRUE AFP?  £  1= Y, 2= N   If “No,” then the rest of the form does not need to be  
completed. Mark “6” for Final Classification. 
 
VACCINATION HISTORY          Birth    _____/_____/_____                         3rd  _____/_____/_____ 
Total Doses of  Polio: £ 99=Inconnu           1st  _____/_____/_____              4th _____/_____/_____ 
      2nd  _____/_____/_____      If >4, last dose _____/______/_____      
 
 
SPECIMEN COLLECTER DE SELLES                 Date Sent to 
Date 1st Stool: _____/______/______ Date 2nd Stool: _____/______/_____    National lab: ____/_____/_____ 
 
STOOL SPECIMEN RESULTS:     Condition of Stool: £ 1=Adequate, 2= Not Adequate 
_____/_____/_____                       ______/_____/_____      _____/_____/_____  
               Date received by national Lab                   Date results sent by lab to district                 Date results receive by district  
______/_____/_____               _____/______/______               ______/______/______      
Date isolate sent by national Lab to regional lab   Date differentiation result sent by regional lab  Date differentiation result received by district  
                             
Primary Isolation Results: 
 
 
 
 
FOLLOW UP EXAMINATION  
Date of follow up examination: ______/______/_____  Residual Paralysis?                       Findings at Follow-up: £   
      1= Residual paralysis       3= Lost to follow-up 
      2= No residual paralysis  4= Death before follow-up 
 
 
 
FINAL CLASSIFICATION OF THE CASE:      £      1=Confirmed, 2=Compatible, 3= Discarded 6=Pas PFA 
INVESTIGATOR 
Name: ______________________________________       Title: _________________________________________ 
Unit: ____________________ Address: ___________________________________ Phone: ________________________ 
Question Answer 
Fever at Onset of paralysis  
Paralysis progresses <= 3 days   
Flaccid & sudden paralysis   
Asymmetrical  
LA   RA 
LL   RL 
P1 P2 P3 NP-Ent W1 W2 W3 V1 V2 V3 NP-Ent 
           
LA   RA 
LL   RL 
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Section 5 
Respond to outbreaks and other 
public heath problems 
 
 
 
 
This section describes how to: 
 
· Work with the district epidemic team to improve 
preparedness for responding to epidemics and other 
public health problems 
· Select appropriate public health responses based on 
investigation and analysis results and disease-specific 
recommendations for: 
 
-- Strengthening case management of priority diseases 
and conditions 
-- Updating health staff’s skills 
-- Conducting an emergency immunization campaign 
-- Enhancing surveillance during an outbreak response 
activity 
-- Informing and educating the community 
-- Improving access to clean water 
-- Ensuring safe disposal of human waste 
-- Improving food handling practices 
-- Reducing exposure to mosquitoes 
-- Controlling animal vectors 
· Prepare in advance to obtain the necessary resources for 
responding to epidemics and other public health 
problems 
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5.0 Respond to outbreaks and other public health 
problems 
 
This section describes steps for responding to: 
   
· A confirmed outbreak of a priority disease (for example, a 
confirmed outbreak of cholera) and  
 
· Trends seen in routine analysis (for example, a persistent increase 
in the number of deaths in children under 5 due to severe 
pneumonia.) that indicate no change or an increase in the number 
of cases or deaths targeted by a disease prevention program. 
 
When an outbreak of a priority disease occurs, the response is immediate.  
All efforts and resources are aimed at controlling the outbreak.  If 
preparations have been done in advance of the outbreak, the health system 
will be able to function effectively.  Measures to treat and control the 
disease and prevent unnecessary deaths or disabilities can be taken in a 
timely way.    
 
When a problem is identified through analysis of routine data, select an 
appropriate response and take action.  For example, improve the 
assessment and treatment of pneumonia cases in children less than 5 years 
of age.  
 
For either case, coordinate information and planning of responses with the 
appropriate district staff.  For responding to epidemic-prone diseases, the 
response is planned by an epidemic response committee.  For situations 
where disease reduction targets are not being achieved as planned, the 
district surveillance staff works with the district staff responsible for 
prevention and control of the specific disease to take action.  
 
District staff who respond to outbreaks or public health problems should 
routinely: 
 
1. Review surveillance data for trends that cause a concern for public 
health. 
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2. Make sure that the medical supervisors in all the health facilities in 
the district know and use protocols for recommended case 
management of priority diseases and conditions. 
 
3. Review and update supplies and resources for epidemic response 
of priority diseases, including: 
 
· Presence of trained staff     
· Treatment equipment and supplies  
· Resources for transportation and communication. 
· Supplies for collecting and shipping specimens for 
confirmation 
· Supplies for giving vaccinations 
· Procedures for procuring stocks of vaccine in an emergency 
and conducting a prompt vaccine response to an 
emergency. 
 
4. Check emergency stock of supplies periodically (every 4 months, 
for example), to make sure they are dry, clean and ready for use. 
 
5. Make sure steps for obtaining laboratory confirmation are known 
by the appropriate staff. 
 
5.1  Regularly meet with the epidemic response 
committee  
 
Periodically meet with the epidemic response team whether or not there is 
an outbreak. During an epidemic, meet as soon as the epidemic is 
recognized.  Then meet as often as needed to plan, implement, monitor 
and report on the epidemic response.  
 
5.1.1 Specify who should be on the epidemic response team  
 
If a national epidemic response committee exists in your country, pattern 
the local committee after the national epidemic response committee.  
Emphasize a multisectoral approach.  Include the following: 
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From the public sector: 
· the district medical officer 
· district or provincial manager for the Expanded Programme on 
Immunization (EPI) 
· disease control officers for specific priority diseases or conditions 
· district sanitarian or public health officer 
· clinicians 
· laboratorian from the district or reference laboratory 
· district supervisor of community health workers 
· vector control officer 
· politicians, administrators, an other officials and community 
representatives 
· police or other public safety officers 
 
From non-governmental organizations with health care activities in the 
area: 
 
· community health programmes 
· manager of outreach program to special populations 
· Red Cross or Red Crescent 
 
From the private sector: 
 
· principal clinical or nursing officer from private hospital , clinic or 
laboratory 
· pharmacist 
 
5.1.2 Prepare to respond to an epidemic  
  
You may have already prepared for epidemic response in your district.  If 
not, assess the supplies, equipment and resources currently available.  
Take action to set aside a set of supplies that can be used in an emergency 
response activity.  Each level should be prepared for some response 
action.  It will be necessary to have the necessary resources available. 
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5.2 Select a response for the outbreak or public 
health problem  
  
When an outbreak is confirmed, or a need for public health action is 
identified, review the investigation results and data analysis conclusions.  
Refer to the disease specific guidelines and select response activities that 
involve: 
 
· Proven measures to prevent unnecessary deaths or disabilities due 
to the specific cause of the problem. 
 
· A mix of activities for immediately controlling the problem in the 
short-term, and reducing the risk of ongoing transmission in the 
long-term through prevention activities. 
 
· Participation from the community, health care facilities and the 
district personnel. 
 
Refer to Section 8 for disease specific epidemic response activities. 
 
5.3 Plan outbreak response activities  
  
Responding to problems identified during analysis of summary data 
reported monthly is in Section 7.0.   
 
Consider the following factors when planning the response activity: 
 
1. If emergency response funds will be needed, set up procedures for 
obtaining them.  For example, ask the regional or national level 
how to request funds and provide the required information as 
needed.  
 
2. If laboratory specimens will be collected from a remote location, 
set up a procedure for shipping specimens.  Make sure the shipping 
procedure allows for the specimens to: 
 
· Be kept at the recommended temperature 
  127 
 
· Arrive at the laboratory as quickly as possible. 
 
3. Identify areas or populations at high risk for the disease or 
condition.  Review the analysis data to refine the description of the 
outbreak characteristics.  Review at least the: 
 
· Incidence rate for the outbreak disease 
· Extent of risk factors for the outbreak disease.  For 
example, look at the case investigation results for 
information about the extent of unsafe delivery practices in 
a neonatal tetanus outbreak, unsafe food practices for 
diarrhea, and the number of people who have  forest-related 
occupations during a yellow fever outbreak. 
· Rate of immunization coverage for the outbreak disease.   
 
4. Alert nearby districts or catchment areas about the outbreak.  If 
they are having a similar outbreak, coordinate response efforts.  
For example, combine efforts to: 
 
· Obtain supplies and resources 
· Develop health education messages and materials 
· Conduct emergency immunization activities 
· Ship specimens to reference laboratory for confirmation 
 
5. Review the lists of supplies and resources made by the epidemic 
response team.  Obtain the emergency supplies and set them aside 
at the district and local levels for emergency use 
 
6. If supplies are not available locally: 
 
· Contact the regional office to find out where they might be 
obtained quickly 
· Borrow from other services, activities, or non-
governmental organizations in your area 
· Identify practical low-cost substitutes 
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7. Assign clear responsibilities to individuals or units for specific 
response activities. 
   
8. Provide training and supplies so that health staff will be able to: 
   
· Keep detailed records on the response activities.  For 
example, keep a tally sheet of individuals immunized; a list 
of the community education messages, communication 
channels, and dates of community education activities; a 
list of individuals receiving bed nets. 
 
· Throughout the response activity, review data on cases, 
laboratory confirmation, and treatment. 
 
· Identify problems in implementing the activities and 
modify activities, as necessary. 
 
5.4 Implement response activities  
  
Refer to disease-specific guidelines for recommended responses.  The 
response activities include the following:  
 
· Strengthen case management 
· Update health staff’s skills 
· Conduct emergency immunization campaigns 
· Enhance surveillance during the response activity 
· Inform and educate the community 
· Improve access to clean water  
· Improve safe disposal of human waste 
· Improve food handling practices 
· Reduce exposure to mosquitoes 
· Control vectors 
· Disseminate the technical recommendations appropriate for the 
outbreak. 
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5.4.1 Strengthen case management  
 
Take steps to support improved clinical practices.  Review the 
recommendations in Annex 22 for treating cases during an outbreak.  
Prepare health staff to take these and other responses. 
    
· Review with each health facility whether the clinical staff know 
and use recommended protocols for case management of outbreak 
diseases. 
 
· Make sure that clinicians get laboratory confirmation of the 
outbreak disease, if the disease is laboratory confirmable. 
 
· In a large epidemic, ask the medical officer at each health facility 
to identify an area that can be used for a large number of patients. 
 
· Make the necessary drugs and treatment supplies available.   
 
5.4.2 Update health staff skills  
  
1. Give clear and concise directions  to health staff taking part in the 
response. 
 
2. Select training topics.   Emphasize case management for the 
specific disease according to disease specific recommendations.  
Select other training topics depending on the risk of transmission 
for the specific disease, for example: 
 
· Intensifying standard precautions (use of clean water, hand 
washing and safe sharps disposal) 
· Barrier nursing and use of protective clothing 
· Isolation precautions 
· Treatment protocols such as delivering oral rehydration 
salts (ORS) and using intravenous fluids 
· Disinfecting surfaces, clothing and equipment 
· Disposing of bodies safely  
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3. Implement training.   In an urgent situation, there often is not 
time for formal training.  Provide on-the-job or one-on-one training 
as needed.   For example, ask a skilled clinician to do one-on-one 
demonstrations on the wards.  Make sure there is an opportunity 
for the training physician or nursing staff to observe the trainees 
using the updated or new skill. 
 
5.4.3 Conduct an emergency immunization activity 
 
Collaborate with the district or national EPI and disease control 
programme manager to conduct an emergency immunization activity, if 
indicated.  Begin planning the emergency immunization activity as soon 
as possible.  Speed is essential in an emergency immunization because 
time is needed to obtain and distribute vaccine.  Establish a plan for 
acquiring an emergency stock of vaccine before an epidemic occurs. 
    
1. Determine the target population for the activity based on the case 
and outbreak investigation results 
 
2. Refer to the EPI programme guidelines for specific 
recommendations about delivery of the indicated vaccine. 
 
A worksheet called “Planning an emergency immunization activity” is in 
Annex 24 at the end of this section. 
 
A worksheet called “Estimating vaccine supplies for immunization 
activities in Annex 25 at the end of this section. 
 
5.4.4 Enhance surveillance during the response activities 
 
During a response to an outbreak, encourage health staff at all health 
facilities to be vigilant in surveillance of the disease or condition.  Make 
sure that health staff: 
 
· Search for additional persons who have the specific disease and 
refer them to the health facility or treatment centers for treatment 
(cholera, for example), or quarantine the household (plague, for 
example) and manage the patient. 
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· Update line lists and monitor the effectiveness of the outbreak or 
response activity. 
 
5.4.5 Inform and educate the community  
 
Keep the public informed to calm fear and to encourage cooperation with 
the outbreak response.  Develop community education messages to 
provide the community with information about recognizing the illness, 
how to prevent transmission and when to seek treatment.  Begin 
communication activities with the community as soon as an epidemic or 
public health problem is identified. 
 
1. Decide what to communicate by referring to disease specific 
recommendations in Section 8.  Make sure to include: 
 
· Signs and symptoms of the disease 
· How to treat the disease at home, if home treatment is 
recommended. 
· Prevention behaviors that are feasible and that have a high 
likelihood of preventing disease transmission 
· When to come to the health facility for evaluation and 
treatment 
· Immunization recommendations, if any. 
 
2. Decide how to state the message.  Make sure that the messages:  
 
· Use local terminology  
· Are culturally sensitive 
· Are clear and concise 
· Work with local traditions 
· Address beliefs about the disease. 
 
Sample community education messages are in Annex 25 at the end of this 
section. 
  
3. Select appropriate communication methods that are present in your 
district.  For example: 
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· Radio 
· Television 
· Newspapers 
· Meetings with health personnel, community, religious and 
political leaders 
· Posters 
· Fliers 
· Presentations at markets, health centers, schools, women’s 
& other community groups, service organizations, religious 
centers. 
  
4. Give health education messages to community groups and service 
organizations and ask that they disseminate them during their 
meetings. 
 
5. Give health education messages to trusted and respected 
community leaders and ask them to spread them to the community. 
 
6. Select and use a community liaison officer or health staff to serve 
as spokesperson to the media.  As soon as the outbreak has been 
recognized: 
 
· Tell the media the name of the spokesperson, and that all 
information about the outbreak will be provided by the 
spokesperson 
· Release information to the media only through the 
spokesperson to make sure that the community receives 
clear and consistent information.   
 
7. On a regular basis, meet with the community spokesperson to give: 
 
· Frequent, up-to-date information on the outbreak and 
response 
· Clear and simple health messages that the media should use 
without editing 
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· Clear instructions to communicate to the media only the 
information and health education messages from by the 
Epidemic Response Committee. 
 
5.4.6 Improve access to safe water 
 
Make sure the community has an adequate supply of safe water for 
drinking and other uses.   The daily water needs per person during non-
outbreak situations are shown below.   Water needs are much higher 
during an outbreak situation, especially outbreaks of diarrhoeal diseases. 
 
Daily water needs per person* 
 Non-outbreak 
situation 
During outbreak of 
diarrhoeal disease 
Home use 20 liters per day 50 liters 
Health care setting 
40 to 60 liters per day 50 liters in wards 
100 liters in surgery 
10 liters in kitchen 
**Refugee Health: an Approach to Emergency Situations, Medecins sans Frontieres, 1997 MacMillan 
 
Safe sources of drinking water include:  
 
· Piped chlorinated water 
 
· Exposed water sources (a river, pond, or open well), if protected 
from contamination by people or animals.  For example, make sure 
that the water source is at least 30 meters away, upstream from 
areas where people or animals defecate. 
 
· Protected water sources (for example, closed wells with a cover). 
  
· Boiled water from any reliable source. 
 
If no local water sources are available, during an emergency, water supply 
may need to be brought in by truck.  However, transporting water is 
expensive and difficult to sustain.   
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To make sure that families have safe drinking water at home provide: 
 
· Community education on how to keep home drinking water safe. 
 
· Containers that prevent contamination of water.  For example, 
provide containers with narrow mouths so that people cannot 
contaminate the water by putting their hands into the container. 
 
· Location site for defecation at least 30 meters or more from 
sources of water. 
  
5.4.7 Ensure safe disposal of human waste 
 
To make sure that human feces are disposed of safely:  
  
· Assign teams to inspect local areas for human waste disposal.  Safe 
practices include disposing of feces in a latrine or burying them in 
the ground more than 10 meters from a water supply.   
 
· If unsafe practices are found, provide information to the 
community.  Construct latrines appropriate for local conditions 
with the cooperation of the community. 
 
· Conduct community education on sanitation practices.   
 
5.4.8  Improve food handling practices 
 
Make sure that people in the home, in restaurants, at food vending 
settings, and in factories handle food safely.  Refer to the nationally 
established standards and controls for the handling and processing of food.  
To ensure food hygiene:  
  
· Conduct community education on food hygiene practices for the 
general public and those in the food industry. 
 
· Visit restaurants, food vendors, food packaging factories, and so on 
to inspect food-handling practices.  Look for safe practices such as 
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proper hand washing, cleanliness and adherence to national 
standards. 
 
· Close restaurants, vending areas or factories if inspection results 
show unsafe food handling practices. 
 
· Strengthen national controls as necessary. 
 
5.4.9  Reduce exposures to mosquitoes 
  
Encourage prevention of mosquito-borne diseases by helping people in 
your district reduce their exposure to mosquitoes during the day and at 
night.  Work with the malaria control programme in your district to: 
 
· Implement a bednet programme. 
· Conduct community education on the proper use of bednets and 
how to avoid dawn-to-dusk mosquito bites. 
 
5.4.10 Control vectors 
 
Encourage prevention of diseases carried by rodents animals by helping 
people in your districts reduce their exposure to these animals.  For 
example, rodents can carry Lassa fever and they may be infested with 
fleas that carry plague.  Work with the vector control officer in your 
district to encourage the community to:  
 
· Avoid contact with the blood and saliva of dead rodents 
· Keep food and water in the home covered to prevent making food 
available to rodents 
· Keep your home and cooking area clean and uncluttered to remove 
places where rodents could nest in your home 
 
5.5 Report on the outbreak  
 
A detailed report on the outbreak can be helpful in planning for the next 
outbreak.  As soon as the epidemic has been controlled, write a report and 
include:   
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· Details on the response activities.  Include dates, places, and 
individuals involved in each activity. Also include the “epi” curve, 
spot map, table of person analyses, and the line list of cases. 
 
· Any changes that were made to the initial response activities 
 
· Recommended changes to improve epidemic response in the 
future.  For example, you might recommend changes in the 
immunization strategy and programme to make the immunization 
activity more effective.  You might recommend changes in the 
shipping procedure for laboratory specimens to allow specimens to 
reach the reference laboratory in good condition or more quickly. 
 
· Disseminate a report on the outbreak. 
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Annexes to Section 5 
 
· ANNEX 22  Treat cases during an outbreak 
 
· ANNEX 23  Prepare disinfectant solutions by using other chlorine products 
 
· ANNEX 24  Planning an emergency immunization campaign 
 
· ANNEX 25  Estimating vaccine supplies for immunization activities 
 
· ANNEX 26  Recommended immunization practices 
 
· ANNEX 27  Sample messages for community education 
 
· Handwashing 
· Safe handling of food 
· Safe disposal of human waste 
· Clean drinking water and storage 
· Safe burial of bodies 
· Reducing exposure to mosquitoes 
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Annex 22 Treat cases during an outbreak 
 
Use appropriate drugs and treatments for managing cases during an outbreak.  These are 
treatment recommendations for use in an outbreak situation for cholera, dysentery, measles and 
bacterial meningitis. 
1. Treat cholera in an outbreak situation 
Source: WHO guidelines for management of the patient with cholera, 
WHO/CDD/SER/91.15 
1. Assess the patient’s level of dehydration.   See assessment guide below. 
2. Give fluids according to the appropriate treatment plan.  (See next page.) 
3. Collect a stool specimen from the first 5 suspected cholera patients that are seen 
in the health facility. 
4. Give an oral antibiotic to patients with severe dehydration. 
Assess the patient for signs of dehydration 
• Look at patient’s general condition: Is the patient: lethargic or unconscious? 
restless and irritable? 
• Look for sunken eyes. 
• Offer the patient fluid.  Is the patient:  not able to drink, or drinking poorly? 
drinking eagerly, thirsty? 
• Pinch the skin of the abdomen.  Does it go back: very slowly (longer than 2 seconds?) 
slowly? 
Decide if the patient has severe, some or no signs of dehydration and give extra fluid according 
to the treatment plan  
If two of the following signs are present: 
• lethargic or unconscious   ¸ 
• sunken eyes     
• not able to drink or drinking poorly 
• skin pinch goes back very slowly 
SEVERE DEHYDRATION* 
 
Give fluid for severe dehydration  
(Plan C) 
*In adults and children older than 5 years, other signs for severe dehydration are “absent radial pulse” and “low blood pressure”.   
If two of the following signs are present: 
• restless, irritable   ¸ 
• sunken eyes     
• drinks eagerly, thirsty 
• skin pinch goes back slowly 
SOME DEHYDRATION 
 
Give fluid according to for some dehydration 
(Plan B) 
If there are not enough signs to classify  
as some or severe dehydration   
 ¸ 
NO DEHYDRATION 
 
Give fluid and food to treat 
diarrhoea at home. 
(Plan A) 
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<    Give antibiotics recommended for treatment of  
severely dehydrated cholera patients 
Antibiotic Children Adults 
Doxycycline 
 
one single dose – 300 mg1 
Tetracycline 
 
4 times per day for 3 days 12.5 mg per kg 500 mg 
Trimethoprim-sulfamethoxazole 
(TMP-SMX) 
 
2 times a day for 3 days 
TMP 5 mg per kg  
and  
SMX 25 mg per kg2 
TMP 160 mg  
and  
SMX 800 mg 
Furazolidone 
4 times per day for 3 days 1.25 mg per kg 100 mg3 
Erythromycin4 
 
adults: 4 times per day for 3 days 
 
children: 3 times per day for 3 days 10 mg per kg 250 mg 
 
· If the patient vomits while taking fluid, wait 10 minutes.  Then allow the patient to 
resume feeding, but more slowly. 
· Continue monitoring the patient and replacing fluid until the diarrhoea stops. 
· When the patient is ready to leave the facility, counsel the patient on treating diarrhoea at 
home. 
· Refer to IMCI guidelines for treating children under 5 years of age and to national 
guidelines for further information on treating acute watery diarrhoea and confirmed 
cholera. 
 
                                                 
1 Doxycycline is WHO’s antibiotic of choice for adults (except pregnant women) because only one dose is required. 
2 TMP-SMX is WHO’s antibiotic of choice for children. Tetracycline is equally effective.  However, in some 
countries, it is not available for pediatric use. 
3Furazolidone is WHO’s antibiotic of choice for pregnant women. 
4Erythromycin or chloramphenicol may be used when the other recommended antibiotics are not available, or where V. cholerae 
is resistant to them. 
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Plan A: Treat diarrhoea at home 
 
If patients showed no signs of dehydration when they were first assessed, they may be treated at 
home.  Give a 2-day supply of ORS and explain how to take the ORS solution according to the 
following schedule: 
 
AGE 
Amount of solution  
after each loose stool 
Provide enough ORS  
packets for preparing: 
Up to 2 years 50 to 100 ml after each loose stool 500 ml per day 
2 years up to 10 years 100 to 200 ml after each loose stool 1000 ml per day 
10 years or more As much as the patient wants 2000 ml per day 
 
< Plan B: Treat some dehydration with ORS 
 
In the clinic, give the recommended amount of ORS over a 4-hour period.  Determine the 
amount according to the patient’s weight. Use the patient’s age only when the weight is not 
known. 
 
< Determine the amount of ORS to give during the first 4 hours 
AGE 
or 
WEIGHT 
Up to 4 
months 
4 months 
up to  
12 months 
12 months 
up to 
 2 years 
2 years up 
to 5 years 
5 years up 
to 14 years 
15 years and 
more  
Weight  
in kg 
< 6 kg 6 - < 10 kg 10 - < 12 kg 12 - < 19 kg 19 - 30 kg 30 kg and 
more  
Give this 
amount of 
ORS  
200 - 400 ml 400 - 700 ml 700- 900 ml 900 -400 ml 1400-2200 ml 2200-4000 ml 
 
· If the patient wants more ORS than shown, give more. 
· For infants under 6 months who are not breast- fed, also give 100-200 ml of clean water 
during this period. 
· Give frequent small sips from a cup. 
· If the patient vomits, wait 10 minutes.  Then continue giving fluids, but more slowly. 
· For infants who are breast- feeding, continue breast-feeding whenever the infant wants. 
· Assess patients every 1-2 hours to make sure they are taking ORS adequately and to 
monitor fluid loss.  Completely reassess the patient’s dehydration status after 4 hours, and 
follow the appropriate treatment plan for the patient’s dehydration classification. 
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Plan C: Treat severe dehydration quickly 
 
1. Start intravenous fluids immediately.  If the patient is a child and can drink, give 
ORS by mouth while the drip is set up.  Give 100 ml per kg of Ringer’s Lactate 
Solution divided as follows: 
For giving IV fluids: 
For adults  
(and patients 1 year and older), 
give 100 ml  
per kg IV within 3 hours  
as follows: 
First, give 30 ml/kg as rapidly as 
possible within 30 minutes 
Then, give 70 ml per kg during  
the next 2 ½ hours 
For patients less than 1 year, 
give 100 ml per kg IV in 6 hours 
as follows: 
First, give 30 ml per kg 
 in the first hour* 
Then, give 70 ml per kg  
in the next 5 hours 
* Repeat once if radial pulse is still very weak or not detectable after the first 30 ml per kg is given. 
 
2. Reassess the patient after the first 30 ml per kg, and then every 1 to 2 hours.  If 
hydration status is not improving, give the IV drip more rapidly.   
3. Also give ORS (about 5 ml per kg per hour) as soon as the patient can drink.  This 
is usually after 3 to 4 hours for infants and after 1 to 2 hours for patients older 
than one year. 
4. Reassess the patient after 6 hours (for infants) or 3 hours (for one year and older).  
Classify dehydration.  Then choose the appropriate plan (Plan A, Plan B, Plan C) 
to continue treatment. 
5. Give antibiotics recommended for treatment of severely dehydrated cholera 
patients.  See the schedule on the next page. 
6. Give patients information about home care before they leave the health facility. 
 
-- If the patient vomits while taking ORS, wait 10 minutes and then 
continue giving fluids more slowly. 
-- Continue breast- feeding of infants and young children. 
-- Return for treatment if the patient develops any of the following: 
 
§ increased number of watery stools 
§ eating or drinking poorly 
§ marked thirst 
§ repeated vomiting 
§ fever 
§ blood in the stool. 
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2. Give an appropriate oral antibiotic for outbreaks of bloody diarrhoea 
due to Shigella dysentariae type 1. 
Source: WHO Guidelines for the control of epidemics due to S. dysentariae type 1.  WHO Geneva.  1995 
 
 NALIDIXICACID 
< Give four times 
daily for 5 days 
CIPROFLOXACIN 
< Give two times 
daily for 5 days 
COTRIMOXAZOLE 
(trimethoprim + sulphamethoxazole) 
?Give two times daily for 5 days 
WEIGHT 
TABLET 
250 mg 
TABLET 
250 mg 
ADULT 
TABLET 
80 mg 
trimethoprim 
+ 400 mg 
sulphametho
xazole 
PEDIATRIC 
TABLET 
20 mg 
trimethoprim 
+ 100 mg 
sulphametho
xazole 
SYRUP      
40 mg 
trimethoprim 
+ 200 mg 
sulphametho
xazole per 5 
ml 
Children’s 
dose      
3 - 5 kg 1/4 1/4 1/4 2 5.0 ml 
6 - 9 kg 1/2 1/2 1/2   
10 - 14 kg 1 1 1 3 7.5 
15 - 19 kg 1 1 1 3 7.5 ml 
20-29 kg 2 2 1 6 15 ml 
Adult dose 
TABLET 
250 mg 
TABLET 
250 mg 
TABLET 
160 mg TMP 
+  
800 mg SMX   
 4 tablets 4 tablets 2 tablets   
 
3. Give vitamin A to children with measles 
Source: WHO guidelines for epidemic preparedness and response to measles outbreaks, 
WHO/CDS/CSR/ISR/99.1 
 
· Give the first dose in the health facility or clinic. 
· Give the mother one dose to give at home the next day. 
 
Vitamin A Capsules 
AGE 200 000 IU 100 000 IU 50 000 IU 
Up to 6 months  ½ capsule 1 capsule 
6 months up to 12 months ½ capsule 1 capsule 2 capsule 
12 months up to 5 years 1 capsule 2 capsules  4 capsules  
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4. Give appropriate antibiotic for bacterial meningitis cases during an 
outbreak 
Source: Control of epidemic-prone meningococcal disease, WHO practical guidelines, 
2nd edition 1998, WHO/EMC/BAC/98.3 
 
1. Admit patient to a health facility for diagnosis and treatment. 
 
2. Start an antibiotic immediately.  Intra-muscular injectable oily chloramphenicol is 
best choice during an epidemic. It is very effective and a single dose is usually 
effective.  If injectable treatment is not possible, give oral amoxicillin or 
cotrimoxazole or treat with an antimicrobial recommended by national treatment 
guidelines for meningitis.     
 
 3. Patient isolation is not necessary.  Provide good supportive care and simplify case 
management. 
 
< Give a single dose of oily chloramphenicol 
INTRAMUSCULAR OILY CHLORAMPHENICOL 
? 100 mg per kg in a single dose  
If the patient has not improved,  
give a second dose 24 to 48 hours later. 
AGE 
 Dose in grams Dose in milliliters 
Adult: 
age 15 years and older 
3.0 g 12 ml 
Child: 
10 to 14 years 
2.5 g 10 ml 
6 to 9 years 2.0 g 8 ml 
3 to 5 years 1.5 g 6 ml 
1 to 2 years 1.0 g 4 ml 
2 to 11 months  0.5 g 2 ml 
1 to 8 weeks  0.25 g 1 ml 
 
See next table for other recommended antibiotics. 
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< Other recommended antibiotics to treat meningitis 
Agent Route Dose for adults Dose for children 
Duration of 
treatment 
Penicillin G IV 3-4 MU daily  every 4-6 hours  400 000 Units per kg 4 days  
Ampicillin or 
Amoxicillin IV 2-3 g daily every 6 hours 250 mg per kg 4 days  
Amoxicillin Oral 2-3 g every 6 hours 250 mg per kg 4 days  
Chloramphenicol IV 1 g every 8-12 hours  100 mg per kg 4 days  
Chloramphenicol 
(oily) IM single dose 3 g 
single dose - 
100 mg per kg 1-2 days  
Cefotaxime IV 2 g every 6 hours 250 mg per kg 4 days  
Ceftriaxone IV 1-2 g over 12-24 hours  50-80 mg per kg 4 days  
Ceftriaxone IM 1-2 g single dose 50-80 mg per kg 1-2 days  
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ANNEX 23  Preparing disinfectant solutions by using other 
chlorine products 
 
During a response to an outbreak of any disease transmitted through direct contact with 
infectious body fluids (blood, urine, stool, semen, and sputum for example), an inexpensive 
system can be set up using ordinary household bleach.   
 
The following table describes how to make 1:10 and 1:100 chlorine solutions from household 
bleach and other chlorine products. 
 
Use this chlorine product To make a 1:10 solution for 
disinfecting: 
 
-- Excreta 
-- Cadavers 
-- Spills of infectious body 
fluids 
To make a 1:100 solution for 
disinfecting: 
-- Gloved hands 
-- Bare hands and skin 
-- Floors 
-- Clothing 
-- Equipment 
-- Bedding 
Household bleach 
5% active chlorine 
1 liter bleach per 10 liters of 
water 
100 ml per 10 liters of water,  
or 
 
1 liter of 1:10 bleach solution per 
9 liters of water 
Calcium hypochlorite powder or 
granules 70% (HTH) 
7 grams or ½ tablespoon per  
l liter of water 
7 grams or ½ tablespoon per  
10 liters of water 
Household bleach 
30% active chlorine 
16 grams or 1 tablespoon per  
l liter of water 
16 grams or 1 tablespoon per  
10 liters of water 
 
To disinfect clothing: 
 
C Promptly and thoroughly disinfect patient’s personal articles and immediate 
environment using one of the following disinfectants: 
-- Chlorinated lime powder 
-- 1% chlorine solution 
-- 1% to 2% phenol solution 
  
 C Promptly and thoroughly disinfect patient’s clothing: 
-- Wash clothes with soap and water 
-- Boil or soak in disinfectant solution 
-- Sun dry 
-- Wash utensils with boiling water or disinfectant solution 
-- Do not wash contaminated articles in rivers or ponds that might be sources of 
drinking water, or near wells. 
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ANNEX  24 Planning an emergency immunization activity 
 
1. Specify the target population for the immunization activity. 
 
2. Estimate the necessary amounts of vaccine, diluent, and immunization supplies 
such as sterile syringes and sterile needles, and safety boxes, (See the worksheet 
in Annex 3.) 
 
3. Choose the immunization sites and inform the community. 
    
· Coordinate with the EPI or disease control programme in your district to 
identify sites for conducting the immunization activity.   
 
· Identify the facilities that can participate in the activity 
 
· Identify a mobile vaccination team, if needed.   
 
· Determine if there are any hard-to-reach areas, e.g. a transient workers’ 
camp.  Identify a mobile vaccination team to reach these areas. 
 
· Contact the facilities and schedule the immunization sites.  
 
· Contact the national level for vaccine.  If a national reserve stock is not 
available, the national EPI programme manager will request an emergency 
supply from WHO. 
 
· Make sure there is enough capacity to store extra amounts of the vaccine 
during storage and transportation to the immunization site. 
 
4. Select vaccinator teams.  For every 100 to 150 people expected at the 
immunization site, the followed staff is required: 
   
· 1 to 2 vaccinators to give immunizations 
· 1 recorder to record on immunization cards 
· volunteers to verify age and vaccination status. 
   
5. Work with you EPI representative to conduct refresher training for vaccinators on 
recommended immunization practices.   See Annex 26 for recommended 
immunization practices. 
 
6. Mobilize the community.  Inform the public about the emergency immunization 
activity.  
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7. Arrange transportation to the immunization site. 
 
 C Plan their transportation to and from the site 
 C Schedule vehicles and plan for fuel and other costs.   
C Estimate per diem costs and make necessary arrangements for lodging if 
the site is away from the health worker’s usual station. 
 
8. Monitor the number of immunizations given. 
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ANNEX 25 Estimating vaccine supplies for immunization activities  
 
Outbreak: _____________________   Date confirmed: ______________ 
 
Target population:  ___ children age 0 up to 5 years 
___ children age 9 months up to 14 years 
___ children and adults age 0 up to 30 years 
___ women of childbearing age - 15 years up to 45 years 
___ all adults and children in the general population 
 
1. Calculate the size of the target population. If the activity only targets a proportion of The 
general population, estimate the size of the target population.  Multiply the general 
population times the percentage of children or adults in the target population.  If you do 
not know the exact age distribution rates in your area, use recommended estimates such 
as the following: 
 
-- children age 0 up to 5 years   20% 
-- children age 9 months up to 14 years  45% 
-- children and adults age 1 up to 30 years 70% 
-- women of childbearing age 15-45 years 20% 
 
2. Find out how many doses each person should receive.  Record the number below as 
“number of doses recommended”. 
 
3. Allow for wastage.  Use a wastage factor of 20%.  Multiply the size of the target 
population (see step 1) times the number of doses times 1.20. 
 
____________________ x  __________  x  1.20  =   ________________ 
Size of target population  Number of   wastage  Number of doses 
recommended doses   to order including wastage 
 
4. Allow for a reserve stock.  Use a reserve factor of 25%.  Multiply the estimated number 
of doses including wastage times 1.25 to obtain the total estimated number of doses. 
____________________ x  1.20   =  __________________ 
Number of doses   Reserve factor   Total number of estimated doses 
including wastage 
 
5. To obtain the total number of vials of vaccine to order, divide the total number of 
estimated doses by the number of doses that are contained in the vial.   (This is usually 
printed on the label.) 
 
__________ ÷ __________ = _______________ 
Total number of  Doses per vial  Total number of vials 
estimated doses     required 
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6. If the vaccine requires a diluent, multiply the number of milliliters of diluent per vial 
times the total number of vials required. 
 
__________ x __________ = _______________ 
Diluent required  Total number of vial Total diluent to order 
per vial    
 
 
7. Estimate the number of sterile needles and syringes that will be needed to carry out the 
activity.   If single-use needle and syringes are used, order the same amount as for the 
estimated number of doses in Step 4. 
 
8. Estimate the number of dilution syringes necessary for preparing the vaccine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source:  Field Guide for Supplementary Activities Aimed At Achieving Polio Eradication, World Health 
Organization, Geneva 1997 
 
District guidelines for yellow fever surveillance, Division of Emerging and other communicable disease 
surveillance and control, World Health Organization, Geneva 1998  
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ANNEX 26 Recommended immunization practices  
 
Work with your EPI representative to give refresher training to the vaccinator teams that will 
conduct the emergency immunization activity.  At a minimum, make sure vaccinator teams know 
how to: 
  
1. Reconstitute the vaccine correctly: 
-- Determine the appropriate quantity of diluent to reconstitute the freeze-dried 
vaccine.   
-- Use a sterile syringe and sterile needle. 
-- Draw up and expel the diluent several times in the vial that contains the vaccine. 
  
2. Wrap the vial in silver foil or cover it with a dark cloth.  This will protect the vial from 
sunlight. 
  
3. In a field situation, protect the vaccine and diluent from contamination.  Cover the open 
top of the vial with foil to keep out dirt and flies.    
  
4. Place the vaccine immediately into a cup of ice, or stand it on an ice pack.  Keep the ice 
and vaccines in the shade. 
  
5. Do not discard the reconstituted vaccine at the end of the session.  Follow national policy 
for reusing opened vials. 
  
6. Record the dose on an immunization card for each person immunized, if it is national 
policy to require vaccinated persons to have a card. 
  
7. Collect data for monitoring the activity.  For example, record the number of doses given 
on a tally sheet so that coverage from the campaign can be calculated.  
  
8. Remind health workers about the risk of getting blood-borne diseases from an accidental 
needle stick.  Review safe practices for handling and disposing of sharp instruments and 
needles. 
 
9. Arrange for safe disposal of used injection materials at the end of the activity.  They can 
be burned or buried in a pit. 
 
10. Give instructions for use of injection techniques.  Review with health staff the need to 
plan vaccination campaigns. 
 
11. Follow national policy for use of opened vials. 
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ANNEX 27 Sample messages for community education 
 
Improve  handwashing: 
 
Hand washing with soap may be the most effective way to prevent transmission of some  
organisms causing infectious diseases.  For that reason, promote handwashing in every family.  
Hand-washing is particularly important after defecation, after cleaning a child who has 
defecated, after disposing of a child’s stool, before preparing or handling food and before eating. 
 
Hand washing is practiced more frequently where water is plentiful and within easy reach.  If 
possible, water for washing should be stored separately from drinking-water.  During an 
epidemic, soap should be provided to those without it.  If soap is not available, ash or earth can 
be used to scrub the hands.  Do not dry washed hands with dirty cloths.  Air-dry wet hands. 
 
 
 
 
 
 
Message: 
 
Message: 
ARE YOU PROTECTED FROM DYSENTERY (bloody diarrhoea)? 
Washing your hands protects yourself and others from disease.   
 
Always wash: 
C after defecation   
C after cleaning a child who has defecated 
C after disposing of a child’s stool 
C before and after eating 
C before preparing or handling food. 
 
ARE YOU READY FOR HAND-WASHING? 
Do you have: 
C Clean water  
C Soap (or if you do not have soap, use ash or earth to  
scrub your hands) 
• Clean cloth for drying. 
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Safe handling of food 
 
Encourage the following food safety practices:  
    
C Do not eat raw food, except undamaged fruits and vegetables that are peeled and eaten 
immediately. 
C Cook food until it is hot throughout 
C Eat food while it is still hot, or reheat it thoroughly before eating 
C Wash and thoroughly dry all cooking and serving utensils after use 
C Keep cooked food and clean utensils separate from uncooked foods and potentially
 contaminated utensils 
C Wash hands thoroughly with soap before preparing food 
C Protect food from flies by means of fly screens. 
 
 
 
 
 
 
Message: 
DO YOU PREPARE FOOD SAFELY? 
 
Cooking kills germs 
C Thoroughly cook all meats, fish and vegetables 
C Eat cooked meats, fish and vegetables while they are hot. 
 
Washing protects from disease  
C Wash your hands before preparing or serving food 
C Wash your dishes and utensils with soap and water 
C Wash your cutting board especially well with soap. 
 
Peeling protects from disease 
C Only eat fruits that have been freshly peeled (such as bananas and oranges) 
 
KEEP IT CLEAN:  COOK IT, PEEL IT, OR LEAVE IT. 
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Safe disposal of human waste 
 
High priority should be given to ensuring the safe disposal of human waste at all time, and 
especially during epidemics of diarrhea.  Sanitary systems appropriate for local conditions 
should be constructed with the cooperation of the community.  
  
Community messages should emphasize 
 
C Everyone should use latrines properly, including children 
C Transfer children’s excreta with a scoop or shovel to the latrine or bury in a hole. 
C Avoid defecating on the ground, or in or near the water supply. 
 
When large groups of people congregate, as for fairs, funerals, or religious festivals, ensure the 
safe disposal of human waste.  If there is no latrine, designate areas for defecation and provide a 
shovel to bury the excreta. 
 
 
 
 
 
Message: 
 
 
 
 
 
 
 
 
 
 
 
 
ARE YOU PROTECTED FROM DYSENTERY (bloody diarrhoea)? 
DO YOU USE A TOILET OR LATRINE? 
 
Germs that cause dysentery live in feces.  Even a person who is healthy might have 
dysentery germs. 
 
C Always use a toilet or latrine.  It you don’t have one – build one! 
C Keep the toilet or latrine clean 
C Wash your hands with soap (or ash) and clean water after using the toilet or latrine. 
 
KEEP IT CLEAN:  USE A TOILET OR LATRINE 
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Clean drinking water and storage 
 
C Community drinking water supply and storage 
 
1. Piped water.  To maintain safety, properly chlorinate piped water.  To prevent 
entry of contaminated groundwater into pipes, repair leaking joints and maintain 
constant pressure in the system.   
 
2. Exposed water source (a river, pond, or open well).  If these sources are used for 
drinking water, fence around them to protect from contamination by people and 
animals.  Dig drainage ditches to prevent storm water and other surface water 
from flowing into the drinking water source.  Do not allow defecation within 10 
meters of the water source, and should be downhill, or downstream, from it.  
 
3. Closed wells.  Equip with a well-head drainage apron, and with a pulley, 
windlass, or pump.   
 
4. Trucked in.  If locally available water is likely to be contaminated, drinking water 
should be supplied by tankers or transported in drums, if it is adequately 
chlorinated and a regular supply can be ensured.  The trucking of water, however, 
is expensive and difficult to sustain; it is usually considered a short-term measure 
until a local supply can be established.  
   
C Home drinking water storage and treatment 
 
When the safety of the drinking water is uncertain, it should be chlorinated in the home 
or boiled.  
 
To prevent contamination of drinking water, families should store drinking water using 
one of the following types of containers: 
 
1. Covered containers that are cleaned daily and kept away from children and 
animals.  Water should be removed from the containers using a long-handled 
dipper, kept specially for this purpose. 
 
2. Narrow-mouthed containers with an opening too small to allow the insertion of a 
hand.  Water should be removed by pouring from the opening or by a spigot. 
 
Water used for bathing, washing and other purposes other than drinking need not be 
treated and should be stored separately from drinking water. 
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Safe disposal of bodies 
 
The body fluids of persons who die due to diarrhoea or a viral hemorrhagic fever are still 
infectious.  Use extreme caution when preparing the bodies of suspected cholera or viral 
hemorrhagic fever patients. 
 
· Hold funerals of persons quickly and close to the place of death.   
· Discourage washing of dead bodies 
· Discourage distribution of food during funerals 
 
 
     
 
 
 
 
 
 
 
 
Reducing exposure to mosquitoes 
 
 
 
 
 
 
 
 
 
Personal Protection: 
 
 C Use insect repellents 
  
 C Use bednets, impregnated with insecticide 
  
 C Tuck the lower edge of the bednet under the bedding 
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Section 6 
Provide feedback 
 
 
 
 
This section describes how to: 
 
· Write an outbreak response report 
· Develop information sheets summarizing data and its 
interpretation 
· Develop and distribute a public health bulletin 
· Develop district newsletters, fact sheets and reports 
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6.0 Provide feedback 
 
Often, health facilities or districts reliably report surveillance data to the 
next level as required.  If the facility does not receive information back 
about how the data were used or what the data meant, health staff may 
think that their reporting is not important.  As a result, future reporting 
may not be as reliable because health staff will not know if the 
information they sent to other levels was useful or necessary.  They will 
have a good understanding of the health situation at their own level, but 
they will not know or understand the situation at a district or national 
level. 
 
When the district or national managers receive data, they should respond 
to the health facilities that reported it.   The purpose of the feedback is to 
reinforce health staff efforts to participate in the surveillance system.  
Another purpose is to raise awareness about certain diseases and any 
achievements of disease control and prevention projects in the area. 
 
Feedback may be written, such as a monthly newsletter, or it may be given 
orally, for example, during a monthly staff meeting. 
  
This section focuses on district leve l feedback.  But the information can 
also be applied in health facility and national levels. 
 
6.1 Write an outbreak response report  
 
After an outbreak response has taken place, district staff who led the 
investigation need to prepare a report.  An example of a recommended 
report is in the Annex to this section.  Use a copy of the report as feedback 
to the health levels that reported the cases in the first place.  
 
6.2 Develop information summary sheets  
 
An information summary sheet is a report that presents data and its 
interpretation in a table or other graphic format.  For example: 
 
· At a staff meeting, or during a supervisory visit, give a verbal 
report or comment about the data that were reported by the health 
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facility during a given period of time.  Display the data in a simple 
table.  Sit with the health staff and show them the data.  Discuss 
the likely conclusions that can be drawn from the data they have 
seen.  Consider conclusions not only for the health facility, but for 
the district as a whole. 
 
· Prepare a single sheet with a simple table that shows how the data 
reported for this period are different from the data reported for 
some other period or target population.  For example, show the 
number of cases of diarrhoea with dehydration in children less than 
5 years of age from the same period last year.   Compare them with 
a corresponding period this year, after a water vessel project was 
implemented in a high risk area, for example. 
 
· Use the summary sheets to support requests made to higher levels 
for additional funds, supplies and resources. 
 
6.3 Develop and distribute a public health bulletin  
 
In many countries or international regions, the national level or region 
publishes a national public health bulletin on a regular basis.  These 
bulletins have a wider audience than just the health staff in a particular 
district or health facility.  The bulletins are usually brief (2 to 8 pages). 
 
The bulletins contain at least: 
 
· a summary table showing the number of reported cases and deaths 
to date for each priority disease 
· a commentary or message on a given disease or topic.  
 
If a national public health bulletin is sent to the district office, display it 
where others can see it.  Make copies to distribute to health facility staff.  
Take a copy of the bulletin with you on your next supervisory visit to 
show health staff how data they report contributes to public health. 
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6.4 Develop a district newsletter  
 
The purpose of a public health bulletin is to present facts in a limited 
format and time frame.  The newsletter cannot describe detailed lessons 
learned dur ing an outbreak, or specific examples of a malaria campaign.  
On the other hand, the newsletter can be used to inform and motivate 
health workers. 
 
The target audience for a newsletter could be health staff in the district or 
region.   The newsletter can be 2 to 4 pages long and produced simply 
with a computer-entered or typewritten text.   
 
Examples of articles summary of article that could occur in a newsletter 
are: 
 
· Summary of national or district data for a given priority disease 
· Report of progress towards a specific public health target 
· Report of a specific achievement towards public health by an 
individual heath worker or a group of health workers. 
· Description of special events or activities (for example, a change in 
market day). 
 
6.5 Develop fact sheets  
 
Fact sheets are brief summaries of 1 to 2 pages.  They are prepared by 
health staff for the general public.  They usually deal with a single topic or 
message.  For example, the district would like to give the community 
information about a shigella outbreak.  The fact sheet states the steps for 
hand washing and clean food preparation in addition to a table with the 
number of cases and deaths.  These are sheets that could be hung on a 
bulletin board or distributed to community groups that are planning health 
education campaigns. 
 
Other methods for providing feedback include: 
 
· Talking to staff or reaching them electronically (E-mail, for 
example) 
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· Guidelines and technical manuals   
· Briefing reports 
· Health education materials 
· Oral reports. 
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Annexes to Section 6 
 
· ANNEX 28 Sample district outbreak report framework 
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ANNEX 28   District Outbreak Report 
 
 
__________________________________________________________________________________________________________________________________ 
Title/Description (include disease/condition investigated) 
 
          __________________________________________________       ________________________________________________________________________________________ 
Period      Place (Villages, Neighborhoods, District, Province) 
 
Executive summary: _____________________________________________________________ 
____________________________________________________ 
 
Introduction: 
Background: 
 
 
Reasons for investigation 
(public health significance, 
threshold met, etc.) 
 
Investigation and 
outbreak 
preparedness: 
 
Methods: 
Dates of investigation: 
 
Site(s) of investigation (health care 
facilities, villages, other): 
 
 
Case finding (indicate what was done 
regarding case finding, e.g., register 
review, contact investigation, alerting 
other health facilities, other) 
 
 
Lab specimens collected: 
 
 Describe response and 
intervention (include dates): 
 
 
Results: 
Date and location of first known (index) case:    Date and health facility of first case   
       seen by the health care system 
 
Results of additional case finding: 
 
 
Lab analysis and results: 
 
With text, describe key features of results 
of time, place, and person analysis 
For detailed results by time (epi curve), 
place (map), and person characteristics 
(table) and line lists, see attached. 
 
 
Results of response and evidence 
of impact. 
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Self-evaluation of the timeliness and quality of outbreak detection, investigation, and response 
Outbreak detection: 
- Interval between onset of index case (or occurrence of an usual cluster at the    _________________     ________________     _______________ 
community level) [date 1] to arrival of first outbreak case at the health facility  Date 1  Date 2       Interval 
[date 2] (Target: <3 days):  
 
- Interval between initial outbreak case seen at the health facility (or date of         _________________     ________________     _______________ 
outbreak threshold crossing at the health facility) [date 1] and reporting to the   Date 1  Date 2       Interval 
district health team [date 2] (Target: within 24 hours): 
 
- Cumulative interval between onset of index case (or occurrence of an usual       _________________     ________________     _______________ 
cluster at the community or health facility) [date 1] to notification to the district Date 1  Date 2       Interval 
[date 2] (Target: <7 days): 
 
Outbreak investigation: 
 
 
- Case forms/line listed completed?   ____Yes  _____No      - Laboratory specimens taken (if required)?  ____Yes ____No 
 
- Interval between notification of district [date 1] and district field investiga-        _________________     ________________     _______________  
tion conducted [date 2] (Target: within 48 hours)    Date 1  Date 2       Interval 
 
- Interval between sending specimens to the lab [date 1] and receipt of results by  _________________     ________________     _______________ 
the district [date 2] (Target: 3-7 days, depending on type of test)   Date 1  Date 2       Interval 
 
Outbreak response: 
 
- Interval between notification of outbreak to district [date 1] and concrete        _________________     ________________     _______________ 
response by the district [date 2] (Target: within 48 hours of notification)  Date 1  Date 2       Interval 
 
 
 
 
Evaluation and Feedback: 
- Interval between end of the outbreak [date 1] and finalization of outbreak report  ________________     ________________     _______________ 
with case forms/line list sent to national level [date 2] (Target: 2 weeks)  Date 1  Date 2       Interval 
 
- Outbreak management committee met? ____Yes ____No  
 
- Feedback given to health facilities and community? ____Yes ____No       _________________________________________________________ 
Method of feedback used 
Other aspects, evaluation: 
 
Interpretations, discussion, and conclusions: 
 
 
 
 
 
 
Recommended public health actions: Comment on following levels: community, health facility, district, partners, provincial, and national 
 
 
 
 
 
District Epidemic Committee Chairperson: ______________________________________ ____________________________________ 
Name      Signature 
          District Medical Officer: ______________________________________ ____________________________________ 
     Name      Signature 
Date reported completed: _________________________________________ 
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Section 7 
Evaluate and improve surveillance and response 
 
 
 
 
· Monitor the quality of surveillance activities at the district 
level 
· Report timeliness and completeness to other levels 
· Identify targets and indicators 
· Supervise surveillance and response activities 
· Take action to improve surveillance in next year’s plan. 
 
 
  168 
 
  169 
 
7.0 Evaluate and improve surveillance and response 
 
Section 3 of these guidelines describes how each month, the health staff 
responsible for surveillance at the health facility and at the district level 
review and analyze the data reported during the month.  They make 
conclusions each month about the:  
 
· Timeliness and completeness of reporting, and  
· How well routine prevention and control activities are taking place 
so that when problems are detected, districts respond with 
appropriate action. 
 
The same information can also be used to monitor and evaluate the quality 
of: 
 
· The reporting of immediately-reportable diseases, outbreak 
investigations and outbreak responses. 
· Reporting of summary data on a routine basis. 
 
Note: Evaluating outbreak investigations and response are described in 
Section 5.5. 
 
When improvements have been made to the disease surveillance system in 
your district, and the new activities have become routine, evaluate the 
system every year.  During the evaluation, determine whether: 
 
· The surveillance objectives are being met 
· Surveillance data are used for action 
· The improved surveillance has had an impact on health events in 
the district. 
  
The information in this section will describe how to routinely monitor and 
annually evaluate the performance of the surveillance system and specific 
disease control and prevention programmes. 
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7.1 Monitor the quality of the surveillance system  
 
An important indicator of a quality reporting system is to measure its 
timeliness and completeness.  When reports are sent and received on time, 
the possibility of a prompt and effective response is greater.  
Completeness of reporting describes whether all the reporting units have 
reported as expected.   If reports are late, or are not submitted, the 
aggregated information for the district (or other administrative area) will 
not be accurate.  Outbreaks can go undetected, and other opportunities to 
respond to identified problems will be missed. 
 
7.1.1 Monitor and evaluate detection of immediately 
reportable diseases 
 
Monitor and evaluate the interval between the onset of the first known 
case and when the first case was seen in the health facility.  This delay in 
the use of health services is one of the factors in the evolution of the 
illness, and, therefore, its prognosis. 
 
Other intervals to monitor for detection of immediately reportable diseases 
include monitoring reporting from the community to the health facility 
(within 48 hours of onset of illness), from the health facility to the district 
(within 24 hours) and from the time the threshold is reached to a concrete 
response. 
  
7.1.2 Monitor timeliness and completeness of monthly 
reporting   
 
Routinely monitor the receipt of reports to evaluate the timeliness of 
reporting and the completeness of the information.  Use a monitoring tool 
such as a record of reports received to monitor timeliness and 
completeness of reporting in your district. A sample form for recording 
timeliness of reporting is in Annex 30 at the end of this section.   
 
If you routinely record and review the dates on which reports are received, 
the effectiveness of the system can be assessed easily each month during 
the analysis of routine and case-based data.  For example, use the record 
of reports received to: 
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· Measure how many reporting units submitted reports for a given 
month 
· Identify which reporting units have reported 
· Measure how many reports were submitted on time. 
 
7.1.3 Identify problems and take action  
 
If the monitoring information shows that a health facility or other 
reporting unit has not provided a report, or if the report is not on time, 
contact the surveillance focal point at the facility.  Work with the 
designated staff to identify what has caused the problem and develop 
solutions together.  For example, find out if health staff have a reliable 
supply of forms for reporting the required information. Another example 
is if a new staff person has started at the facility and does not know the 
procedure for reporting.  Or, health staff are not motivated to send the 
reports because they do not think it is important and do not have resources 
to take action.   
 
Make plans with the reporting unit to find solutions for improving the 
situation.  Explain that when information is complete, the district can 
assist health staff more efficiently with planning responses and carrying 
them out.  For example, if lack of supplies is a problem, the district can 
use the reporting information to advocate with higher levels in the system. 
 
7.1.4 Report timeliness and completeness to other levels 
 
When routine reports of the number of cases are sent to the provincial, 
regional or national level, also send the data for timeliness and 
completeness.  This will help the other levels understand the situation 
more clearly and evaluate the quality of the data that is being sent.  For 
example, if the report to the central level states that two cases of measles 
were detected during the month, it should also include information about 
the number of health facilities that reported. It will make a difference to 
the other levels when they evaluate the information if the 2 cases occurred 
with only 20% rather than 100% of the units reporting. 
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7.1.5 Identify targets and indicators  
 
Measuring indicators is a method for measuring the extent of achievement 
for a particular program or activity.  The achievement is compared to 
overall recommended standard quality practices.  It can also measure 
progress towards implementing an overall program target.  For example, a 
district may have as its goal the achievement of 100% completeness of 
reporting by a certain period.  An indicator can be developed to measure 
the proportion or percentage of facilities that are reporting.  This 
proportion is then compared with the desired goal or target, and can be 
used to evaluate progress and, therefore, the quality of the service or 
activity. 
 
List possible indicators to measure in the district.  These may be indicators 
that relate to national goals and indicators, or to specific plans for 
improving integrated surveillance and response activities in a district.  
Select the indicators that are most relevant to the district’s plan for 
improving surveillance this year, and that will provide information that the 
district can use.  Sample district level indicators are on the next page.  
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District-level indicators for monitoring quality of surveillance and response at the health facility 
 
Domain or function of 
surveillance Indicator: Regularly monitor the number of health facilities that: 
Identify and record suspected 
cases  
C Have a clinical register 
C Correctly record information in the register 
Confirm suspected cases C Have access to a functioning laboratory that can reliably 
process specimens (sputum, stool, blood, serum, cerebral 
spinal fluid, for example)  for confirmation of priority diseases. 
C Safely collect and properly package specimens for transport 
to higher level laboratory 
C Submit specimens of priority diseases for confirmation in a 
timely way  
Review and analyze data C Keep up-to-date trend lines for each selected priority diseases 
C Have detected a new epidemic 
C Have an action threshold for each priority disease 
Report data C Report case-based information for immediately reportable 
diseases 
C Have a reliable supply of reporting forms 
C Accurately record case register data on summary report forms 
C Submitted reports on time to the district during last 3 months 
C Submitted required number of reports during last 3 months  
Respond to outbreak 
thresholds and analysis results 
C Used local information to conduct a community disease 
prevention and control activity during the last 12 months. 
C Implemented prevention and control measures based on local 
data for at least one epidemic-prone disease 
Provide feedback C Received a bulletin or report from district or other level about 
data health facility reported to other levels during the year 
C Met with community members to discuss investigation results 
during last 6 months. 
Maintain readiness for 
epidemic response 
C Use standard case management protocols for priority 
diseases 
C Use a minimum level of standard precautions with all febrile 
patients regardless of infection status 
C Maintain an emergency stock of urgent drugs and treatment 
supplies for responding to epidemic-prone diseases seen 
previously in the area.  
Supervision C Used a supervision checklist for surveillance during 
supervisory visit at least once in last 6 months  
Training C Conducted training for health staff on one or more of following 
topics in last 12 months: using case definitions, handling 
specimens safely, collecting and reporting data, analyzing 
and interpreting trends, using thresholds for action, 
supervisory skills 
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Resources C Have reliable transportation methods, with fuel source as 
needed (bicycles, motorcycle, vehicle, fuel) 
C Have access to reliable communication methods (telephone, 
facsimile, radiophone, electronic mail, others) 
C Have supplies for carrying out outbreak investigations 
C Have funds for implementing response actions  
 
7.1.6 Select data for measuring the indicators 
 
After you have selected relevant indicators, specify the numerator and the 
denominator.  For example, a district has as its objective to have all health 
facilities keep trend lines in an analysis workbook for the selected priority 
diseases.  The analysis workbooks are monitored during supervisory visits.   
 
Indicator:  The proportion of health facilities in the district that 
keep trend lines for priority diseases. 
 
Numerator:  The number of health facilities that keep trend lines 
for priority diseases. 
 
Denominator:  The number of health facilities in the district. 
 
7.2 Conduct supervision  
 
Supervision is a process of helping health staff to improve their work 
performance.  Supervision is not an inspection.  Rather, good supervision 
aims to sustain good quality services rather than finding things that are 
wrong.   
 
In a good system, supervisors and health professionals work together to 
review progress, identify problems, decide what has caused the problem 
and develop feasible solutions.  
 
7.2.1 Improve job descriptions to include surveillance tasks 
relevant to each category of health staff  
 
Job descriptions are the basis for conducting supervision and assessing 
performance.  Review the job descriptions of health staff who have a role 
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in the surveillance and response system.  Make sure that the job 
description states: 
· The surveillance tasks the specific category of health staff should 
perform 
· To whom the health staff person reports 
· Other health staff that are supervised by the specific category or 
person. 
 
7.2.2 Prepare a supervision plan  
 
Include surveillance and response targets in the overall plan for 
supervision in your district.  For example: 
 
· Decide how often to monitor health staff performance .  Fore 
example, a district may decide to conduct a supervisory visit at 
least 2 times a year for each health facility.  In some countries, 
depending on resources, supervisory visits take place more often 
(monthly, for example). 
 
· Ask health facility supervisors to make a schedule of the 
supervision they will conduct over the next year in their own 
facilities and to any community sites that report to the facility. 
 
· Make sure that transport is available for supervision and for 
surveillance activities that require transportation.  For example, 
coordinate travel or logistics for surve illance supervisory visits 
with visits made by other programs or activities. 
 
· Include other reporting sites in supervision of district surveillance 
activities such as clinics, medical centers and community reporting 
sites in the overall plan.  Include private health centers if feasible. 
 
· Identify and obtain necessary resources for supervision. 
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7.2.3 Conduct supervisory visits  
 
Begin regularly scheduled supervision in the district to ensure that: 
 
· Health workers know how to identify and use standard case 
definitions to record suspected cases of priority diseases seen in 
their health facility. 
 
· Priority diseases are recorded in the case register according to the 
case definition. 
 
· Some data is analyzed in the health facility to identify thresholds to 
take action both for routinely reported priority diseases (disease of 
public health importance) and case-based diseases (epidemic prone 
diseases, and diseases targeted for eradication or elimination). 
 
· Reported cases of diseases for which a single case is a suspected 
outbreak are investigated promptly. 
 
· Response takes place when outbreaks are confirmed, or when 
problems are identified in routine reporting. 
 
· Response actions are monitored and action is taken by the health 
facility to improve surveillance actions and readiness for outbreak 
response. 
 
Make sure during the visit to: 
 
1. Provide feedback to health staff during each visit.  Let the health 
staff know what is working well.  Also give feedback on how the 
data reported previously was used to detect outbreaks and take 
action to reduce illness, mortality and disability in the district.  If 
improvements are needed, discuss solutions with the staff. 
 
2. Provide on-the-job training as needed if a problem is identified.  
For example, during a review of the analysis workbook, the 
supervisor noted that case fatality rates were not calculated 
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correctly.  The supervisor met with the health staff who do the 
calculation and reviewed the steps for calculating the rate with the 
staff. 
 
3. Follow up on any request for assistance such as for emergency 
response equipment or supplies. 
 
4. If a solution to a pre-existing problem was identified in a previous 
visit, check to see how well the solution has been implemented.  
Find out if problems are still occurring and modify the solution if 
necessary. 
      
7.2.4 Use a supervisory checklist  
 
Each health facility has unique problems and priorities that require 
specific problem solving and corrections.  To maintain the positive 
motivation of the health facility staff for making the improvements, 
consider developing a graduated checklist to guide the supervisory visit.  
The items listed in a graduated checklist are selected based on what has 
been achieved so far at the health facility.  For example, when the facility 
has achieved one objective (using standard case definitions consistently, 
for example), work with health facility staff to include the next indicator 
or item for monitoring performance (using thresholds for action, for 
example).  Revise the supervisory checklist accordingly.  Use it during 
future visits to help health staff monitor their activities and progress 
towards an improved system. 
 
During the visit, use a checklist to monitor how well health staff are 
carrying out the recommended surveillance functions. For example, a 
district surveillance officer visiting a health facility for a supervisory visit 
should verify the following: 
 
Identify and  Check in the clinic register to see if the 
Register cases  diagnoses correspond to the recommended case 
definition. 
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Check the register to see if all the columns in the 
registry are filled out correctly. 
 
Confirm cases Compare the laboratory records for priority diseases 
with the number of cases seen in the clinic for the 
same period of time. For example, compare the 
number of positive malaria slides with the reported 
number of hospitalized malaria cases. 
 
Reporting  Ask to see copies of the most recent reports or for 
the most recent reporting period.  Compare the 
number of cases of priority diseases that were 
reported with the number recorded in the register. 
 
Check the date on which the case report was sent 
against the date recommended for sending the 
report. 
 
Check the reports to make sure they are complete 
and accurate. 
 
Review and  Verify that trend lines are prepared and 
analyze data  kept up-to-date for priority diseases 
Ask to see the “Health Facility Analysis Book”, if 
these are in use in your district.  Look to see if the 
trend lines for selected diseases are up-to-date. 
 
Preparedness  Look at the stocks of emergency drugs, supplies and 
protective clothing to be sure there is an adequate 
supply. 
 
Note: A sample supervisory checklist is in Annex 29 at the end of this 
section.  The questions to be answered during the supervisory visit can be 
adapted or modified to meet the specific concerns and extent of progress 
towards an integrated surveillance system within the health facility. 
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7.2.5 Write a report of the supervisory visit  
 
Provide in the report achievements that were recognized during the visit.  
Also state the actions that were planned with the health staff and any 
requests for additional resources, funds or special problems. 
 
7.3 Use supervisory visits to improve surveillance 
activities in the district 
 
Visits of surveillance supervisors and regional or provincial disease 
control programmes are good opportunities to discuss and improve disease 
control in your district.  For example, if a national malaria control person 
visits the district, you can discuss why the inpatient malaria deaths have 
not been declining.  You can ask about additional ideas or resources that 
the malaria control programme can provide. 
 
7.4 Annually evaluate quality of surveillance and 
response 
 
7.4.1 Determine indicators and program targets to evaluate  
 
Depending on the development status of surveillance in a district, select 
indicators for evaluation that will provide information that relates to the 
district’s priorities and objectives for the year. Selected indicators are 
likely to be the following: 
 
· Indicators for measuring quality of surveillance in general.  For 
example, to evaluate timeliness and completeness of reporting, 
select as an indicator the percentage of health facilities that 
reported routine information on time. 
 
· Indicators for measuring quality of surveillance for specific 
diseases (for example, to monitor response to surveillance data 
about meningitis, select as an indicator the percentage of health 
facilities where meningitis outbreaks were detected -- that is, the 
rate was more than 15 suspected cases per 100 000 population -- 
and which were laboratory confirmed.) 
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7.4.2 Compile and organize monitoring and other results  
 
Gather data from several sources.  For example: 
 
· Review the objectives for the year listed in the district’s annual 
plan for improving surveillance and response. 
· Gather the monthly summaries of cases and deaths reported to the 
district, spot maps, and other analysis results performed by the 
district.   
· Collect as well any results from special surveys or studies that 
were done in the district over the last year.   
· Include case investigation forms and reports of outbreak response 
activities that took place in the district.   
· Gather summary information from the community and also from 
health staff. 
 
7.4.3 Analyze results  
 
As you evaluate the summary data for the year, decide: 
 
· Were the reports complete, on time and accurate? 
· What were significant changes in disease trends during the year?   
· If an increase occurred, was the problem identified?  
· If additional cases are still occurring, why are they occurring?  
Where are they occurring?   
· Were appropriate and timely actions taken in response to the 
surveillance data?   
· Were supervisory visits conducted as planned and follow up tasks 
carried out as planned? 
· Did the community feel that response activities were successful? 
· Were any actions taken to address health staff requests or 
suggestions about services or surveillance? 
 
7.4.4 Identify problems and their causes  
 
If problems occurred, and the district did not meet an expected target, or 
reach a desired level of performance with any indicator, look to see what 
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caused the difference between what was planned and what actually 
occurred.  If a problem is identified, talk with the district team and health 
facility staff to find out the possible causes of the problem.   
 
7.4.5 Prioritize plans for improvements to surveillance and 
response in next year’s plan  
 
Include in the district plan for the next year successful activities that 
should continue.  Also include feasible solutions selected as a result of 
analysis of this year’s annual evaluation.  
 
Plan to implement the solution.  For example: 
 
1. State the new activity and its objectives 
2. Specify the personnel who will carry out the activity. 
3. Estimate the cost of the activity 
4. Develop a timetable for the activity.  Define the sequence of 
activities in logical order. 
5. Specify the logistics for the new activity (equipment, personnel, 
transportation, resource allocation) 
 
7.4.6 Provide feedback to health facilities about the 
evaluation  
 
Provide a report and give feedback to health facilities and others in the 
district about the results of the evaluation activity.  Mention in the 
feedback report: 
 
· What the objectives were for the year 
· What was actually achieved 
· What were likely reasons for any differences between what was 
planned and what was achieved 
· Recommended solutions and prioritized activities for improving 
surveillance and response in the district. 
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Annexes to Section 7  
 
· ANNEX 29 Sample form for recording timeliness and completeness of monthly 
reporting from the health facility to the district level 
 
· ANNEX 30 Sample indicators for monitoring by the provincial or national level of 
district- level surveillance activities 
 
· ANNEX 31 Sample supervisory checklist for surveillance and response activities at the 
health facility level 
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ANNEX 29  Sample form for recording timeliness and 
completeness of monthly reporting from the health 
facility to the district. 
Nota bene: legend  
 T = arrived on time 
 L = arrived late 
 W = report not received 
 
Country ___________________  District _________________ Year ________ 
 
Name of health 
Facility 
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
 
 
            
 
 
            
 
 
            
 
 
            
 
 
            
 
 
            
 
 
            
 
 
            
Total number of 
reports expected (N) 
            
Total reports sent 
on time (T) 
            
Total reports sent 
late (L) 
            
Total number of 
reports not received 
(W)  
            
Timeliness of the 
reports =  
100 * T / N 
            
Completeness of 
reporting =  
100 * (N-W)  / N 
            
 
Please note that timeliness and completeness are expressed as percents (%). When the surveillance system 
is good, the rates for timeliness and completeness should approach 100%. This table allows for 
monitoring the progress of these two indicators in the district so that action can be taken to improve 
timeliness for each health facility in the district. 
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ANNEX 30  Indicators for monitoring the quality of district level 
surveillance activities 
            
 
To evaluate the quality of surveillance functions listed in column 1 below, regularly monitor and 
observe the progress for the following indicators listed in column 2.  When comparing several 
health facilities at the same level of the health system, use proportions or rates. 
 
For this 
surveillance 
function: Regularly monitor the number of districts that : 
Maintain readiness 
for epidemic 
response  
C Have a plan for outbreak response 
C Have access to emergency stocks of drugs and supplies at all times 
during the last 12 months 
C Have access to funds for outbreak response 
C Have a team trained to conduct an outbreak investigation 
Identify suspected 
cases 
C Have a surveillance coordinating focal point at the district level 
C Review case registers and logs  
Investigate and 
confirm reported 
outbreaks 
C Investigated at least one reported outbreak during the last 12 months   
C Have laboratory capacity within the district that can confirm suspected 
cases of priority diseases 
C Confirm priority diseases in a timely way 
C Are able to demonstrate safe handling, packaging, storing, and 
transport of specimens to higher level laboratory  
Report data  C Have a reliable supply of recommended forms at all times over the last 
6 months 
C Submitted all required reports to the next highest level on time during 
the last 6 months  
Analyze data  C Describe outbreak data by time, place and person 
C Perform trend analysis by health facility 
C Have an action threshold for each priority disease and appropriate  
denominators and a defined response action 
C Compare quarterly data 
Response  C Responded within 48 hours of reaching the threshold for action. 
C Meet with community about a health problem at least once every 6 
months 
C Achieved acceptable case fatality rates during the most recent 
outbreak (for example, no more than 10% for meningitis, no more than 
1% for cholera) 
C Have management committees that evaluated their preparedness and 
response activities during the last 12 months  
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Provide feedback C Prepare and disseminate a written report of surveillance information at 
least quarterly during the last year 
C Received a written report or bulletin containing information district 
reported from a higher level during the last year 
C Provide feedback to the community 
Supervision C Number of health facilities that received a supervisory visit from the 
district surveillance focal point during the last 6 months  
Training C Number of health personnel in the district that received training for a 
surveillance function or topic such as investigation during the last 12 
months. 
Resources and 
personnel 
Number of districts with: 
C transportation or logistical supports (vehicles with fuel, motor cycles) 
C supplies for carrying out data management (computers, statistical 
program package) 
C communication methods (reliable telephone service, facsimile, 
radiophone, electronic mail) 
C information and education materials (VCR and monitor, portable 
generator, screen, projector (slides or film) 
C human resources (trained epidemiologist, laboratory technologists, 
data managers  
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ANNEX 31 Checklist for supervising surveillance and response activities at the health facility 
Health Facility:_______________________________________Date of Supervisory Visit:________________________________________ 
 
ACTIVITY SUPERVISORY QUESTION ANSWER 
COMMENT 
(What Caused Problem) 
Identify Suspected 
Cases  
1. How often do you collect information from the community 
about reports of suspected cases or deaths due to a priority 
disease or condition? 
G__________ 
 
 
 
Register cases 1. Are diagnoses of cases of priority diseases recorded in the 
clinic register according to the standard case definition? 
GYes  GNo  
Report 1. Do health staff use a standard case definition to report the 
suspected cases and outbreaks? 
 
2. Do you record information about immediately notifiable 
diseases on a case form or line list? 
GYes  GNo 
 
 
GYes  GNo 
 
 
Analyze and 
Interpret 
1. Do you plot the numbers of cases and deaths for each priority 
disease on a graph?  (Ask to see the health facility’s analysis 
book.  Look to see if the trend lines are up-to date.) 
 
2. Do you plot the distribution of cases on a map? 
 
GYes  GNo 
 
 
 
 
GYes  GNo 
 
Investigate and 
Confirm Reported 
Cases and 
Outbreaks 
 
1. If an epidemic-prone disease was suspected, was it reported 
immediately to the district office? 
 
2. For the cases of priority diseases needing laboratory tests 
seen since the last supervisory visit, how many had 
laboratory results? 
 
3. Are appropriate supplies available or set aside for collecting 
laboratory specimens during an urgent situation and show me 
the supply? 
GYes  GNo 
 
 
Number of results 
obtained:__________ 
Number of expected cases 
seen:_____________ 
 
 
GYes  GNo 
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ACTIVITY SUPERVISORY QUESTION ANSWER 
COMMENT 
(What Caused Problem) 
Respond 1. Are appropriate supplies available for responding to a 
confirmed case or outbreak (for example, immunization 
supplies and vaccine,  ORS, antibiotics, and so on)?  
 
1. Please show me the supplies for carrying out a recommended 
response. 
 
3. Who is the outbreak coordinator for this facility? 
 
 
4. How often do you provide information and training in outbreak 
response to the staff of this facility? 
GYes  GNo 
 
 
 
GYes  GNo 
 
Name:___________ 
Designation:__________ 
 
 
Training is done ____________ 
 
Provide Feedback 1. How often do you report information to the community? 
 
2. Do you receive the latest bulletin from the (central, 
subnational) level? 
Report it __________ 
 
 
 
 
Evaluate and 
Improve the 
System 
1. Were the last 3 routine monthly reports sent to the district 
office? 
 
2. Were the last 3 routine monthly reports sent on time? 
GYes  GNo 
 
 
GYes  GNo 
 
Epidemic 
Preparedness 
1. What precautions do health staff (including laboratory staff) 
take routinely with all patients regardless of the patients’ 
infection status? 
 
2. How do you estimate the number of supplies to set aside for 
use during an emergency situation? 
Minimum level of standard 
precautions:  ___________ 
 
 
How supplies are estimated: 
________________________ 
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Section 8 
Summary guidelines for 
specific priority diseases and conditions 
 
 
 
 
· Take action to respond to alert and action 
thresholds for specific diseases 
· Identify surveillance goals and objectives for 
each priority disease 
· Identify data to analyze and interpret for each 
priority disease 
· Prepare to use the district analysis workbook. 
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The pages in this section provide summary guidelines for each of the priority diseases targeted for 
integrated disease surveillance by WHO/AFRO.  Look at the table below to see what information is 
available in the summary guidelines.  Detailed guidelines for each disease or condition are available from 
WHO/AFRO or your national program manager or disease control officer. 
 
Name of priority disease for integrated disease surveillance 
Background In this section, you will find general information about: 
 
§ The disease, the agent that causes the disease or infection, geographic range affected, 
and other epidemiologic information.  
§ Transmission routes such as person-to-person, unprotected contact with infectious body 
fluids or contaminated materials, vector-borne, and so on. 
§ Why the disease is a priority disease for surveillance.  For example, the disease is 
responsible for a high number of deaths, disability and illness, especially in African 
countries. 
§ General risk factors and specific risk factors in African countries. 
§ Any additional background information that might serve the district surveillance team. 
Surveillance goal This section states the purpose for surveillance of this disease.  
 
Generally, the purpose for surveillance of these priority diseases is for early detection and 
response to the leading causes of death, illness and disability.  
Recommended case 
definition 
Suspected case: A definition is provided for suspecting a case or outbreak of this disease.   
 
Confirmed case: A definition is provided for classifying a case as confirmed through laboratory 
diagnostic testing. 
Respond to alert 
threshold for epidemic-
prone diseases 
 
 
or 
 
Respond to a suspected 
outbreak for other 
diseases of public health 
importance  
For epidemic-prone diseases, and for disease targeted for elimination or eradication, a single case 
is a suspected outbreak and requires immediate reporting.  Prompt responses should follow such 
as reporting the case, treating the case, collecting specimens for confirming the case, and 
investigating the case to determine if it is an outbreak, and, if so, determine  the risk factors 
associated with the case. 
 
Some diseases have specified thresholds for alerting the health facility or district to a problem. 
 
For other priority diseases of public health importance, an outbreak is suspected when there is any 
unusual increase in the number of cases when compared with previous time periods.  This should 
prompt a response such as reporting the increase and investigating what might have caused the 
unusual increase.  If laboratory confirmation is indicated, specimens should be collected for 
laboratory confirmation. 
Respond to action 
threshold for epidemic-
prone diseases 
 
or  
 
Respond to a suspected 
outbreak for other 
diseases of public health 
importance  
For epidemic-prone diseases, and for disease targeted for elimination or eradication, a confirmed 
case should trigger a response action such as conducting an emergency immunization activity, 
enhancing access to safe drinking water, community education campaigns, and improving case 
management. 
 
 
For other priority diseases of public health importance, a confirmed outbreak should prompt an 
appropriate response such as improving coverage for specified immunizations, strengthening case 
management for IMCI diseases, providing information, education and communication about 
preventing and controlling the disease, and so on. 
Analyze and interpret 
data 
This section contains generic information about the data to collect, analyze and interpret.  The data 
may be from outbreak response or for more long-term analysis.  The key points to consider for 
interpreting the data and specific elements for analysis are stated (time, place, person).   
 
Additional guidelines about analyzing and interpreting data for specific diseases are in the District 
Analysis Book, which may accompany these guidelines.  
Reference  Appropriate references for further information are available from WHO.  The most relevant to the 
district level is stated for each disease. 
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Cholera 
Background § Acute illness with profuse watery diarrhoea caused by Vibrio cholerae 
serogroups O1 or O139.  The disease is transmitted mainly through 
eating or drinking contaminated food or water; that is, cholera is spread 
through the fecal-oral route. 
§ Cholera causes over 100 000 deaths per year.  It may produce rapidly 
progressive epidemics or worldwide pandemics.  In endemic areas, 
sporadic cases (less than 5% of all non-outbreak-related diarrhoea 
cases) and small outbreaks may occur. 
§ Incubation period is from a few hours to 5 days, usually in the range 
from 2 to 3 days. 
§ There has been a resurgence of cholera in Africa since the mid-1980s, 
where over 80% of the world’s cases occurred in 1999, with the 
majority of cases occurring from January through April.   
§ Cholera may cause severe dehydration in only a few hours.  The case 
fatality rate (CFR) may exceed 50% in untreated patients with severe 
dehydration.  If patients present at the health facility and correct 
treatment is received, the CFR is usually less than 1%.  At least 90% of 
the cases are mild, and they remain undiagnosed. 
§ Risk factors: eating or drinking of contaminated foods such as 
uncooked seafood or shellfish from estuarine waters, lack of 
continuous access to safe water and food supplies, attending large 
gatherings of people including ceremonies such as weddings or 
funerals, contact with persons who died of cholera. 
§ Other enteric diarrhoea may cause watery diarrhoea, especially in 
children less than 5 years of age.  Please see Diarrhoea with 
dehydration summary guidelines. 
Surveillance goal § Detect and respond promptly and appropriately to cases and outbreaks 
of watery diarrhoea promptly.  To confirm an outbreak, collect stool 
specimens transported in Cary-Blair medium. 
§ Immediate case-based reporting of cases and deaths when an 
outbreak is suspected. 
Recommended case 
definition 
Suspected case: 
In a patient age 5 years or more, severe dehydration or death from acute 
watery diarrhoea. 
 
If there is a cholera epidemic, a suspected case is any person age 5 years or 
more with acute watery diarrhoea, with or without vomiting. 
 
Confirmed case: 
A suspected case in which Vibrio cholerae O1 or O139 has been isolated in the 
stool. 
Respond to alert 
threshold for 
epidemic-prone 
diseases 
 
If a single case is suspected: 
§ Report case-based information immediately. 
§ Manage and treat the case according to national guidelines. 
§ Enhance strict handwashing and isolation procedures. 
§ Conduct case-based investigation to identify similar cases not previous 
reported and confirm the outbreak. 
§ Obtain stool specimen from 5 patients within 5 days of onset of acute 
watery diarrhoea, and before antibiotic treatment is started.  See 
laboratory guidelines for information on how to prepare, store and ship 
the specimens. 
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Respond to action 
threshold for  
epidemic-prone 
diseases 
If a suspected case is confirmed: 
§ Establish treatment center in locality where cases occur.  Treat cases 
onsite rather than asking patients to go to standing treatment centers 
elsewhere. 
§ Strengthen management and treatment of cases. 
§ Mobilize community early to enable rapid case detection and treatment.  
Survey the availability of clean drinking water. 
§ Work with community leaders to limit the number of funerals or other 
large gatherings for ceremonies or other reasons, especially during an 
epidemic. 
§ Reduce sporadic and outbreak-related cases through continuous 
access to safe water.  Promote safe preparation of food (especially 
seafood, fruits, and vegetables).  Promote safe disposal of human 
waste. 
Analyze and 
interpret data  
Time: Graph weekly cases and deaths and construct an epidemic 
curve during outbreaks.  Report case-based information 
immediately and summary information monthly for routine 
surveillance. 
 
Place: Plot the location of case households.  
 
Person: Count weekly total cases and deaths for sporadic cases and 
during outbreaks.  Analyze age distribution, distribution 
according to sources of drinking water, assess risk factors to 
improve control of sporadic cases and outbreaks.   
Reference  Management of the patient with cholera, World Health Organization, 1992.  
WHO/CDD/SER/91.15 Rev1 (1992) 
 
Epidemic diarrhoeal disease preparedness and response--Training and 
practice.  Facilitator and participant manuals.  World Health Organization, 1997.  
WHO/EMC/DIS/97.3 and WHO/EMC/DIS/97.4 
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Diarrhoea with blood (dysentery) 
Background § Shigella dysenteriae is the most common cause of enteric infections 
and is transmitted from person-to-person through fecal-oral spread. 
§ Large scale outbreaks may be caused by Shigella dysentariae type 1 
(SD1) With up to 30% of populations infected.  The case fatality rate 
may approach 20% among young children and elderly persons with 
severe dehydration. 
§ The incubation period is from 1 to 4 days. 
§ Clinical illness is characterized by acute fever and bloody diarrhoea, 
and can also present with systemic symptoms and signs as well as 
dehydration especially in young children. 
§ Risk factor: overcrowded areas with unsafe water and poor sanitation 
(for example, refugee and famine populations). 
§ SD1 is frequently resistant to multiple antibiotics including 
trimethoprim-sulfamethoxazole. 
§ Enterohaemorrhagic and enteroinvasive E. coli and other bacteria or 
parasites such as Entamoeba histolytica may also cause bloody 
diarrhoea. 
Surveillance goal § Detect and respond to dysentery outbreaks promptly. 
§ Improve percentage of laboratory-confirmed cases and evaluate 
proportion verified as type 1 (SD1). 
§ Determine antibiotic sensitivity pattern of the agents isolated 
(especially SD1) both for routine surveillance and during outbreaks. 
Recommended case 
definition 
Suspected case:  
A person with diarrhoea with visible blood in stool. 
 
Confirmed case:  
Suspected case with stool culture positive for Shigella dysentariae 1. 
Respond to alert 
threshold for 
epidemic-prone 
diseases 
 
 
If you observe that the number of cases or deaths is increasing over a 
period of time: 
§ Report the suspected case to the next level of the health system. 
§ Treat the suspected cases with oral rehydration and antibiotics based 
on recent susceptibility results, if available. 
§ Obtain stool or rectal swab specimen for confirming the outbreak. 
§ Investigate the case to determine risk factors contributing to 
transmission. 
Respond to action 
threshold for 
epidemic-prone 
diseases 
If a suspected case is confirmed: 
§ Search for additional cases in locality of confirmed case. 
§ Strengthen case management and treatment. 
§ Mobilize community to enable rapid case detection and treatment. 
§ Identify high risk populations using person, place, time data. 
§ Reduce sporadic and outbreak-related cases by promoting 
handwashing with soap or ash and water after defecating and before 
handling food, strengthening access to safe water supply and storage, 
and use of latrines and safe disposal of human waste. 
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Analyze and 
interpret data  
Time: Graph monthly trends in cases and deaths.  Construct an 
epidemic curve for outbreak cases. 
 
Place: Plot location of case households. 
 
Person: Count cases and deaths each month.  During an outbreak, 
count outbreak-related cases by week.  Routinely analyze age 
distribution.  Assess risk factors to improve control and 
prevention of sporadic diseases and outbreaks. 
Reference  Guidelines for the control of epidemics due to Shigella dysenteriae type 1.   
WHO/CDR/95.4 
 
Safe Water Systems for the Developing World:  A Handbook for Implementing 
Household-based Water Treatment and Safe Storage Projects.   Department of 
Health & Human Services.   Centers for Disease Control and Prevention. 
Atlanta.  2000 
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Diarrhoea with dehydration in children less than 5 years of age 
Background § Diarrhoea with dehydration in children less than 5 years of age is due 
to infections of the gastrointestinal tract caused by viruses (especially 
Rotavirus), bacteria (E. Coli, Salmonellae, shigellae, Campylobacter, 
Yersinia, and others), and parasites (Giardia, Entamoeba, 
cryptosporidia, cyclospora).  These disease are transmitted through 
eating contaminated food or water, or through fecal-oral spread. 
§ Diarrhoea diseases represent the second leading cause of death 
among children less than 5 years of age in many African countries, with 
more than 3 million deaths per year. 
§ Different epidemiological patterns (for example, seasonality) are 
observed for different pathogens. 
§ The WHO and UNICEF advocate that each district team use the 
Integrated Management of Childhood Illnesses (IMCI) strategy to 
reduce morbidity and mortality of childhood diarrhoea. 
Surveillance goal § Detect diarrhoea outbreaks promptly. Laboratory confirmation can 
confirm specific pathogenic agent outbreak, but laboratory confirmation 
is not necessary for routine surveillance of diarrhoea with dehydration. 
§ Monitor antimicrobial resistance during outbreaks of bacterial origin. 
Recommended case 
definition 
Suspected case: 
Passage of 3 or more loose or watery stools in the past 24 hours with or 
without dehydration and: 
 
Some dehydration -- two or more of the following signs: restlessness, 
irritability; sunken eyes; thirsty; skin pinch goes back slowly, or 
Severe dehydration -- two or more of the following signs: lethargy or 
unconsciousness; sunken eyes; not able to drink or drinking poorly; 
skin pinch goes back very slowly. 
 
Confirmed case: 
Suspected case confirmed with stool culture for a known enteric pathogen.  
Note:  Laboratory confirmation of specific agent causing outbreak is not 
routinely recommended for surveillance purposes. 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance  
If you observe that the number of cases or deaths is increasing over a 
period of time: 
§ Report the problem to the next level. 
§ Investigate the cause for the increased number of cases or deaths and 
identify the problem. 
§ Make sure that cases are managed according to IMCI guidelines. 
§ Encourage home-based therapy with oral rehydration. 
Respond to a 
confirmed outbreak 
for other diseases of 
public health 
importance  
If the number of cases or deaths increase to two times the number 
usually seen in a similar period in the past: 
§ Assess health worker practice of IMCI guidelines for managing cases 
and improve performance for classifying diarrhoea with dehydration in 
children less than 5 years of age. 
§ Teach mothers about home treatment with oral rehydration. 
§ Conduct community education about boiling and chlorinating water, 
and safe water storage and preparation of foods. 
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Analyze and 
interpret data  
Time: Graph cases and deaths to compare with same period in 
previous years.  Prepare graphs for outpatient diarrhoea with 
some dehydration and for diarrhoea with severe dehydration.  
Construct an epidemic curve when outbreaks are detected. 
 
Place: Plot location of case households. 
 
Person: Report monthly totals due to diarrhoea with some dehydration 
and also for diarrhoea with severe dehydration from outpatient 
services.  Also report monthly inpatient total cases and deaths 
due to diarrhoea with severe dehydration. 
Reference  Management of childhood illness: Clinical skills training course for first level 
health facilities.  World Health Organization.  WHO/CDR/95.14 
 
Integrated Management of Childhood Illness: A WHO/UNICEF Initiative Bulletin 
of the World Health Organization.  Vol. 75, 1997, Supplement 1, 1997.  ISBN 
92 4 068750 5 
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Dracunculiasis 
Background § Dracunculiasis is commonly known as Guinea worm.  It is caused by a 
large nematode, a disabling parasite that emerge through the skin of 
the infected person. 
§ This is an old disease, known since antiquity, leaving many patients 
with unfortunate socio-economic consequences.  It is transmitted 
through  ingestion of a crustacean (cyclops) eaten by an immature form 
of the nematode (larvae).  The cyclops lives found in stagnant water 
sources (lakes, swamps and rivers) in rural areas in African countries.  
The female nematode discharges from the host’s skin when there is 
contact with water.  The incubation period is for a period of 9 to 12 
months.  There is no treatment or vaccine against the illness. 
§ Successful disease control strategies conducted by an international 
coalition and their partners has pushed Dracunculiasis towards 
eradication.  In the first quarter of 2000, 27 000 cases of Guinea worm 
were reported to the WHO compared to 892 000 that were reported for 
all of 1989, showing a reduction of 87%. 
§ The illness is endemic in 13 countries in Africa: Benin, Burkina Faso, 
Centrafrique, Cote d’Ivoire, Ghana, Ethiopia, Mali, Mauritania, Niger, 
Nigeria, Sudan, Togo and Uganda. 
Surveillance goal § Active detection and investigation of each case at the community level.  
Monthly reporting of cases to the next level. 
§ In zones where Guinea worm has been eradicated, maintain active 
searches for additional cases. 
§ Report all imported cases to countries or areas of origin. 
§ Integrate into surveillance to confirm absence of transmission. 
Recommended case 
definition 
Suspected case:  
A person presenting or having presented in the last 12 months with a skin 
lesion and emergence of Guinea worm. 
 
Confirmed case: No confirmation required. 
Respond to alert 
threshold for  
disease targeted for 
eradication 
 
If a single case is suspected: 
§ Report the case according to national program guidelines for 
eradication of Dracunculiasis. 
§ Treat case with metronidazole to decrease disability associated with 
painful leg lesions. 
§ Conduct case investigation to confirm risk factors. 
§ Improve access to safe water according to national guidelines. 
Analyze and 
interpret data  
Time: Graph cases quarterly. 
 
Place: Plot distribution of households and work sites for cases from 
which cases have been reported. 
 
Person:  Count quarterly cases, and analyze age distribution.  Report 
monthly to next levels. 
Reference  Dracunculiasis or guinea-worm, Geneva, World Health Organization, 
WHO/CDS/CEE/DRA/99.2, 1999 
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Leprosy 
Background § Leprosy is a chronic mycobacterial disease of the skin, the peripheral 
nerves and upper airway mucous membranes.  The disease is 
transmitted mainly through airborne spread from nasal secretions of 
patients infected by Hansen’s bacillus and also through inoculation into 
broken skin.  Leprosy is endemic in several tropical areas around the 
world, including Africa. 
§ Patients are classified into two groups, depending on presence of skin 
and nerve signs: 
--          Multibacillary patients (MB) with more than 5 skins patches and 
several nerve enlargements. 
--          Paucibacillary patients (PB) with one to five skin patches and a 
single nerve enlargement. 
§ Leprosy control has improved greatly through use of WHO 
recommended multidrug therapy (MDT).  Multiple drug therapy 
combining two or three drugs (rifampicin, clofaximine and dapsone) is 
very effective in curing leprosy.   At the end of 1999, leprosy point 
prevalence in African countries was 1.6 cases per 10 000 population 
with about 70 000 registered cases. 
§ Incubation period is 6 months to 20 years or more.  Infection is 
probably frequent but clinical disease is rare, even among the most 
close contacts of patients.  Multibacillary patients are most contagious, 
but infectiousness is reduced rapidly as soon as multiple drug therapy 
begins.  Leprosy can be complicated by neuritis and leprosy reactions, 
resulting in impairment and disabilities of hands, feet, and eyes. 
§ Leprosy has historically been associated with social isolation and 
psychosocial consequences.  This social stigma still persists in some 
countries in Africa. 
§ Some skin diseases such as tinea versicolor, mycosis, vitiligo, 
Scleroderma, psoriasis, systemic lupus erythematosus and Von 
Recklinghausen disease may be mistaken for leprosy. 
Surveillance goal § Observe national trends towards the leprosy elimination target, defined 
as a reduction in prevalence to less than 1 case per 10 000 population. 
§ Monitor resistance of Hansen’s bacillus to drugs used for multi-drug 
therapy (MTD) on an ongoing basis. 
§ As leprosy nears elimination, supplement routine surveillance with 
community-based surveillance. 
Recommended case 
definition 
Suspected case: 
A person showing one of three cardinal signs of leprosy: hypopigmented or 
reddish skin lesion, loss or decrease of sensations in skin patch, enlargement 
or peripheral nerve. 
 
Confirmed case: A person showing at least two cardinal signs of leprosy and 
who has not completed a full course of treatment with MCD. 
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Respond to alert 
threshold for 
diseases targeted 
for elimination 
If a single case is suspected: 
§ Report the suspected case to the appropriate level of the health 
system. 
§ Investigate case for risk factors. 
§ Begin appropriate case management: 
-- MB patients must be treated for 12 months with a three-drug 
regimen (12 MB blister packs to be taken in a period of 18 
months). 
-- PB patients must be treated for 6 months with a two drugs MDT 
regimen ( 6 PB blister packs to be taken in a period of 9 months) 
Respond to action 
threshold for 
diseases targeted 
for elimination 
If a suspected case is confirmed: 
§ Examine patients for skin and nerve signs at each contact patient has 
with a health worker to diagnose and care for leprosy reactions and 
impairments. 
§ Examine risk factors for treatment interruption (for example, inadequate 
supplies of MDT in the health center, poor accessability of patients’ 
villages, and so on).  Give sufficient blister packs for a full course of 
treatment to patients unable to attend a health center monthly. 
§ Identify any fast increase or decrease of new case s during a period.  
Assess adequacy of surveillance in areas where under- or ever-
reporting is suspected.  Monitor distribution of MDT drugs. 
 
Analyze and 
interpret data  
Time: Graph cases by date diagnosed and treatment begun. 
 
Place: Plot cases by location of households and disease classification 
(MB or PB) 
 
Person: Count newly detected cases monthly by the type of leprosy 
(MB or PB).  Analyze age and disability distribution and 
treatment outcomes (cases cured, defaulted, relapsed). 
Reference  A guide to eliminating leprosy as a public health problem, Second Edition 1997.  
Action Programme for the Elimination of Leprosy, World Health Organization.  
WHO/CTD/LEP/94.2 
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Malaria 
Background § Malaria is a highly prevalent tropical illness with fever following the bite 
of infective female Anopheles mosquitoes which transmit a parasite, 
Plasmodium falciparum, p. ovale, P. vivax, or P. malariae.  Serious 
malarial infections are usually due to P. falciparum which may result in 
severe anaemia and cerebral involvement. 
§ Malaria is one of the leading causes of illness and death in many 
African countries.  There are 900 000 deaths per year in Africa mainly 
in children less than 5 years of age and pregnant women.  
§ Incubation period from the time of being bitten to onset of symptoms is 
7 to 30 days.  The incubation period may be longer, especially with 
non- P. falciparum species. 
§ Transmission of malaria is highly seasonal in some areas in African 
countries. 
§ P. falciparum is often resistant to chloroquine and is becoming resistant 
to sulfadoxine-pyrimethamine, and other drugs. 
Surveillance goal § Detect malaria epidemics promptly, especially in areas with seasonal 
epidemic transmission or with a large population at risk. 
§ Improve percentage of malaria cases confirmed microscopically. 
§ Monitor anti-malarial resistance of sporadic cases and outbreak-related 
cases.  Use sentinel populations in selected sites for monitoring anti-
microbial resistance. 
Recommended case 
definition 
Uncomplicated malaria: 
Any person with fever or fever with headache, back pain, chills, sweats, 
myalgia, nausea, and vomiting diagnosed clinically as malaria. 
 
Confirmed uncomplicated malaria : 
Any person with fever or fever with headache, back pain, chills, sweats, 
myalgia, nausea and vomiting and with laboratory confirmation of diagnosis by 
malaria blood film or other diagnostic test for malaria parasites. 
 
Severe malaria  
Any person hospitalized with a primary diagnosis of malaria and confirmed by a 
positive blood smear or other diagnostic test for malaria. 
 
Malaria with severe anaemia  
Any child 2 months up to 5 years with malaria and, if an outpatient, with severe 
palmar pallor, or if an inpatient, with a laboratory test confirming severe 
anaemia.   (Note: Young infants less than 2 months are usually classified as 
serious bacterial infection and are referred for further evaluation.) 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance  
If there is an unusual increase in the number of new malaria cases or 
deaths as compared to the same period in previous non-epidemic years:  
§ Report suspected epidemic to the next level 
§ Treat with appropriate anti-malarial drugs according to national 
programme recommendations 
§ Investigate the cause for the increase in new cases 
§ Make sure new cases in children age 2 months up to 5 years are 
managed according to IMCI guidelines. 
§ Conduct community education for prompt detection of cases and 
access to health facilities.  
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Respond to a 
confirmed outbreak 
for other diseases of 
public health 
importance 
 
If the number of new cases exceeds the upper limit of cases seen in a 
previous non-epidemic period in previous years: 
§ Evaluate and improve, as needed, prevention strategies, such as use 
of permithirin-impregnated bed nets, especially for young children, 
pregnant women, and other high risk populations. 
Analyze and 
interpret data  
Time: Graph the number of cases by month.  Construct an epidemic 
curve during epidemics. 
 
Place: Plot location of households for new cases and deaths. 
 
Person: Count the number of new malaria cases and deaths by month 
and analyze age groups and time of onset. 
Reference  Malaria epidemics: Detection and control, forecasting and prevention.  Geneva.  
World Health Organization. WHO/MAL/98.1084 
 
Note: Setting an epidemic threshold: 
 
The national Malaria Control Programme can assist districts and health centers with determining 
appropriate thresholds for detecting possible epidemics.   In the absence of a threshold set by the 
national programme, the following method can be used to determine the threshold level for a malaria 
epidemic.  The threshold is determined using the median and the 3rd Quartile of a period of time (for 
example, 5-year data from a health facility or district by month): 
 
1. Look at the number of malaria cases at a specific health facility or district by month for the past 5 
years. 
 
2. Determine the median for each month (for example, each January for the last 5 years).  Rank the 
monthly data for each month for the five years in ascending order.  Identify the number in the 
middle of each month’s series (for example, the series of data for January) for the five years.  
This is the median.  Repeat this process for each month in the five years. 
 
3. Determine the 3rd Quartile for the monthly series by identifying the 4th highest number from the 
bottom in each data series (since data is ranked in ascending order).  This is the 3rd Quartile 
representing the upper limit of the expected normal number of malaria cases. 
 
4. Plot the 3rd Quartile for each data series by months for the five year period and join the points 
with a line.  The line represents the upper limit of the expected number of cases. 
 
5. Plot the median for each data series by month for the five year period and join the points with a 
line.  This line represents the lowest limit of expected number of cases. 
 
6. The area between the two lines (the median and the 3rd Quartile) represents the “normal 
channel”.  If the number of currently observed cases of malaria falls between the two lines, the 
number of new cases for that month is assumed to be “normal”.  If the number is above the 3rd 
Quartile (upper limit), this is an indication of a possible malaria epidemic. 
 
 
Source: WHO/AFRO Regional Malaria Programme
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Measles 
Background § Measles is a febrile rash illness due to paramyxovirus (Morbillivirus) 
transmitted human-to-human via airborne droplet spread.  It is the 
fourth leading cause of death in children less than 5 years of age in 
many African countries. 
§ The incubation period is 7 to 18 days from exposure to onset of fever. 
§ Among children with vitamin A deficiency and malnutrition, measles 
may result in severe illness due to the virus itself and associated 
bacterial infections, especially pneumonia; only the minority of cases 
are severe. 
§ Measles is among the most transmissible of human infections.  Large 
outbreaks occur every few years in areas with low vaccine coverage 
and where there is an accumulation of persons who have never been 
infected or vaccinated.  The true incidence of measles far exceeds 
reported cases. 
§ Risk factors include low vaccine coverage (<85 to 90%) which allows 
accumulation of susceptible persons at high risk for measles.  
Outbreaks can be explosive in areas of high population density. 
§ Other viral illnesses such as rubella may cause or contribute to similar 
outbreaks. 
Surveillance goal § Detect outbreaks of fever with rash illness promptly: 
 
In elimination with a measles elimination target: immediate case-based 
reporting of suspected cases and deat hs of fever with rash illness; 
confirm all suspected measles cases with laboratory test (usually 
serum IgM). 
 
In countries with accelerated measles control programs: Summary 
reporting of cases and deaths for routine surveillance and outbreaks; 
confirm the first five cases of suspected measles in a health facility per 
week with laboratory test (usually serum IgM) 
Recommended case 
definition 
Suspected case: 
Any person with fever and maculopapular (non-vesicular) generalized rash and 
cough, coryza or conjunctivitis (red eyes) or any person in whom a clinician 
suspects measles. 
 
Confirmed case:  
A suspected cases with laboratory confirmation (positive IgM antibody) or 
epidemiological link to confirmed cases in an outbreak. 
Respond to alert 
threshold for 
epidemic-prone 
diseases 
If an outbreak is suspected: 
§ Report suspected case to the next level. 
§ Collect blood sample for confirming the outbreak. 
§ Treat cases with oral rehydration, vitamin A, and antibiotics for 
prevention of bacterial superinfection.  Use airborne isolation 
precautions where feasible. 
§ Investigate the case or outbreak to identify causes for outbreak. 
Respond to action 
threshold for 
epidemic-prone 
diseases 
If an outbreak is confirmed: 
§ Improve routine vaccine coverage through the EPI, and lead 
supplemental vaccination activities in areas of low vaccine coverage. 
§ Mobilize the community early to enable rapid case detection and 
treatment. 
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Analyze and 
interpret data  
Time: Graph weekly cases and deaths.  Construct epidemic curve for 
outbreak cases. 
 
Place: Plot location of case households. 
 
Person: Count total cases and analyze by age group and immunization 
status. 
Reference  Using surveillance data and outbreak investigations to strengthen measles 
immunization programmes, Geneva, World Health Organization.  
WHO/EPI/GEN/96.02 
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Meningitis 
Background § Acute infection of the central nervous system usually caused by 
Nausari meningitis, Haemophilus influenzae, or Streptococcus 
pneumoniae, encapsulated bacteria transmitted human-to-human via 
airborne droplet spread. 
§ In meningitis outbreak countries, large outbreaks due to N. meningitis 
(incidence great than 1 case per 1000 population) may occur 
November through May.  Outside the meningitis belt, smaller outbreaks 
may occur year-round. 
§ Incubation period is 2 to 10 days. 
§ Attack rates are highest among children aged less than 15 years.  
Case fatality rates are usually 10 to 20% among treated patients, and 
>70% among untreated cases. 
§ Antimicrobial resistance to chloramphenicol has not yet been detected 
in Africa.  Resistance to sulfonamides is widespread. 
§ Viral or tuberculous meningitis and HIV-related opportunistic infections 
are among the conditions which may mimic this disease.  Meningitis 
due to Haemophilus influenzae occurs principally in children less than 
5 years of age. 
Surveillance goal § Promptly detect meningitis outbreaks and confirm etiology of first 5 to 
10 cases.   Perform lumbar puncture and Gram stain of cerebral spinal 
fluid (CSF) on all cases of suspected meningitis where feasible to 
confirm etiology of meningitis for improved surveillance. 
§ Perform periodic serogrouping to determine if cause of outbreak is 
vaccine-preventable. 
§ Perform periodic susceptibility testing for penicillin and 
chloramphenicol. 
Recommended case 
definition 
Suspected case:  
Any person with sudden onset of fever (>38.5?C rectal or 38.0?C axillary) and 
one of the following signs: neck stiffness, altered consciousness or other 
meningeal sign. 
 
Confirmed case: 
A suspected case confirmed by isolation of N. meningitis from CSF or blood. 
Respond to alert 
threshold for  
epidemic-prone 
diseases 
 
If alert threshold is reached: 
§ Population greater than 30 000, 5 cases per 100 000 inhabitants per 
week. 
§ Population less than 30 000, 2 cases in 1 week or an increase in the 
number compared to the same time in previous years. 
 
Respond to alert threshold: 
Inform next level of health system and investigate the cases 
Confirm the cases. 
Treat and manage cases appropriately with oily chloramphenicol. 
Intensify surveillance for additional cases in the area. 
Prepare to conduct a mass vaccination campaign. 
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Respond to action 
threshold for 
epidemic-prone 
diseases 
 
 
If action threshold is reached: 
§ Population greater than 30 000: In one week, 15 cases per 100 000 
inhabitants per week confirms epidemic in all situation.  If no epidemic 
during last 3 years and vaccine coverage against meningococcal 
meningitis is <80%, action threshold is 10 cases per 100 000 
inhabitants per week. 
§ Population less than 30 000: 5 cases in 1 week or doubling of the 
number of cases over a 3-week period. 
 
Respond to action threshold: 
§ Begin mass vaccination campaign 
§ Distribute treatment supplies to health centers 
§ Treat according to epidemic protocol 
§ Inform the public 
§ Define the age group at highest risk (usually persons age 1 through 30 
years of age) and complete a mass vaccination campaign within 10 
days of outbreak detection. 
§ Mobilize community to permit early case detection and treatment, and 
improve vaccine coverage during mass vaccination campaigns for 
outbreak control. 
Analyze and 
interpret data  
Time: In meningitis belt countries during epidemic season, graph 
weekly cases and deaths.  Otherwise, graph monthly trends in 
cases and deaths.  Construct an epidemic curve for outbreak 
cases. 
 
Place: In epidemics (not in endemic situations), plot location of case 
households.  Estimate distance to the nearest health facility. 
 
Person: Count total sporadic and outbreak cases.  Analyze age 
distribution. 
 
Target case fatality rate: <10% 
Reference  Weekly Epidemiological Record N 38, September 2000 
(http://www.who.int/wer/pdf/2000/wer7538.pdf) 
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Neonatal tetanus 
Background § A neuromuscular toxin-mediated illness caused by the anaerobic 
spore-forming soil bacterium Clostridium tetani.  The disease is 
transmitted when spores enter open wounds (injections, cutting the 
umbilical cord) or breaks in the skin. 
§ While tetanus may occur in adults, infection primarily affects newborns.  
Neonatal tetanus has decreased dramatically in countries with 
improved maternal tetanus immunization rates.  As a result, tetanus is 
targeted for elimination in many African countries. 
§ Incubation period is 3 to 21 days, with an average of approximately 6 
days. 
§ Risk factors: Unclean cord care practices during delivery for neonates.  
Lack of antibody protection in incompletely immunized mothers. 
Surveillance goal § Detect cases of neonatal tetanus immediately to confirm the case and 
prevent additional cases by immunizing at least pregnant women in 
area around the confirmed case. 
§ Identify high risk areas and target tetanus toxoid campaigns to women 
of childbearing age. 
Recommended case 
definition 
Suspected case:  
Any newborn with a normal ability to suck and cry during the first two days of 
life, and who, between the 3rd and 28th day of age, cannot suck normally, and 
becomes stiff or has convulsions or both. 
 
Confirmed case: 
No laboratory confirmation recommended. 
Respond to alert 
threshold for 
diseases targeted 
for elimination 
If a single case is suspected: 
§ Report case-based information immediately to the next level. 
§ Conduct an investigation to determine the risk for transmission 
§ Treat and manage the case according to national recommendations, 
usually with supportive care and, if feasible, in intensive care. No 
routine isolation precautions are needed. 
Respond to alert 
threshold for 
diseases targeted 
for elimination 
If a case is confirmed through investigation: 
§ Immunize the mother with at least 2 doses of tetanus toxoid and other 
pregnant women in the same locality as the case. 
§ Conduct a supplemental immunization activity for women of 
childbearing age in the locality. 
§ Improve routine vaccine coverage through EPI and maternal 
immunization programme activities. 
§ Educate birth attendants and women of childbearing age on the need 
for clean cord cutting and care.  Increase the number of trained birth 
attendants. 
Analyze and 
interpret data  
Time: Graph cases and deaths monthly.  Target should reflect 
elimination target for each district. 
 
Place: Plot location of case households and location of birth 
attendants. 
 
Person: Count monthly cases and deaths.  Analyze each case of NNT 
by cord care practices. 
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Reference  Field manual for neonatal tetanus elimination.  Geneva, World Health 
Organization. WHO/V&B/99.14 
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New AIDS Cases 
Background § AIDS is an infection of human lymphocytes (types of white blood cells) 
and other organs.  It is caused by a retrovirus, human 
immunodeficiency virus (HIV).  The virus is transmitted from human to 
human by sexual intercourse, needle injections, transfusions, 
transplacental or trans-vaginal routes, breast milk or other direct 
contact with infected human bodily fluids. 
§ Acquired immunodeficiency syndrome (AIDS) results in late-stage HIV 
infection and immunosuppression, with reduced numbers and function 
to T-lymphocytes.  Primary HIV-related organ involvement and a 
variety of opportunistic infections result in death unless the growth of 
the virus is stopped by drugs that can kill the virus (antiretroviral 
therapy).  When HIV infection progresses to illness, the symptoms are 
usually due to the failure of the immune system to resist other 
infectious diseases called opportunistic infections (OI).  These include 
tuberculosis, bacterial pneumonia or sepsis, oro-pharyngeal 
candidiasis, chronic diarrhoea, chronic skin infections, recurrent herpes 
zoster, and others. 
§ Twenty-four million Africans, close to one in ten adults between the 
ages of 15 and 49 years of age, are living with HIV/AIDS.  The impact 
of the epidemic is already measurable in greatly increased adult and 
child morbidity and mortality.  HIV/AIDS is now the leading cause of 
adult mortality in the African region. 
§ Incubation period is approximately 1 to 3 months from the time of 
infection to the time that antibodies can be detected in a laboratory 
process.  The time from HIV infection to the onset of AIDS is generally 
7 to 9 years. 
§ Risk factors: populations at high risk of acquiring HIV are commercial 
sex workers with or without other sexually transmitted infections (STIs).  
Some STIs may increase HIV transmission.  Others at risk include 
intravenous drug users (IDU), recipients of unscreened blood products 
and neonates born to HIV-infected mothers. 
§ Tuberculosis, visceral leishmaniasis, trypanosomiasis, and other 
subacute or chronic bacterial, parasitic, and viral infections may cause 
similar syndromes. 
Surveillance goal § Monitor the impact of HIV/AIDS interventions in trends of incidence and 
prevalence of HIV infections, AIDS and STIs through sentinel sites, 
surveys and special studies (according to guidelines for second 
generation surveillance of HIV/AIDS). 
§ Estimate the burden of HIV/AIDS in the district using available 
information from HIV sentinel populations so that each new AIDS case 
is counted. 
§ Monitor local STI epidemiology as possible cofactor for HIV 
transmission.  
§ Monitor local opportunistic infection epidemiology, including TB 
§ Improve percentage of suspected HIV/AIDS cases confirmed via 
serology. 
§ Improve HIV/AIDS screening. 
Recommended case 
definition 
Who/AFRO recommends that countries use either Bangui or Abidjan HIV/AIDS 
case definitions.  A positive ELISA for confirming HIV and a rapid test for 
confirming the positive results are sufficient for an epidemiologic case definition 
for HIV. 
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Public health 
actions 
?  Monitor local STI and opportunistic infections, including TB,  as 
possible cofactor for HIV. 
?  Improve percentage of suspected HIV/AIDS cases confirmed via 
serology. 
?  Monitor use of condoms by commercial sex workers. 
?  Provide voluntary counseling and testing services at district and sub-
district levels. 
?  Treatment of individual cases with antiretroviral therapy is not yet 
widely available in most African countries.  Rapid diagnosis and 
treatment of AIDS-related OI may prolong life expectancy but this has 
not been widely evaluated in developing countries. 
?  Promote condom use, especially among high-risk individuals. 
?  Treat STIs, especially syphilis, chancroid diseases, and other 
ulcerative processes. 
?  Mobilize non-paid blood donors and promote appropriate use of blood. 
?  Promote good infection control practices within health facilities in the 
district.  
?  Educate patients and their sexual partners to refrain from donating 
blood, tissues, semen or breast milk. 
Analyze and 
interpret data  
Time: Count new AIDS cases and report monthly.  Analyze by 
number of cases confirmed with serology.  At the end of the 
year, calculate the total number of cases and include trends for 
HIV serosurveillance, STI surveillance and results of any 
special studies (socio-behavioural studies, drug sensitivity to 
antimicrobial agents, and so on). 
 
Reference  Guidelines for Sexually Transmitted Infections Surveillance.  Geneva.  UNAIDS 
and World Health Organizaiton.  WHO/CDS/CSR/EDC/99.3.  UNAIDS/99.33E 
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Onchocerciasis 
Background § Filarial infection of the skin and eye caused by Onchocerca volvulus  
transmitted by the bite of female Simulium black flies. 
§ Nearly all of the worlds’ estimated 18 million infected persons (of whom 
more than 250 000 are blind) live within 26 African countries.  
Onchocerciasis is the second leading infectious cause of blindness 
worldwide.  It causes debilitating skin problems, leading to significant 
decreases in productivity in areas where it is endemic.  Entire villages have 
relocated away from the fertile lands near rivers where black flies breed. 
§ Incubation period is years to decades since repeated infection is necessary 
for disease manifestations.  Clinical illness is unusual in children even in 
endemic areas. 
§ Other filaria (for example, Loa loa and Mansonella) and other chronic skin 
and eye disease can produce similar clinical findings. 
Surveillance goal § Early detection with goal of reducing the recurrence of transmission of the 
parasite in areas where it has been eradicated (zones covered by the 
Onchocerciasis Programme). 
§ Conduct periodic surveillance in sentinel villages: screen using 
diethylcarbamzaine (DEC); in case of a positive reaction to DEC, confirm 
with a microscopic examination of a skin biopsy from each suspected case. 
Recommended case 
definition 
Suspected case: In an endemic area, any person with fibrous nodules in 
subcutaneous tissues. 
 
Confirmed case: A suspected case that is laboratory confirmed by presence of 
one or more of the following: microfilariae in skin snips, adult worms in excised 
nodules, or typical ocular manifestations (such as slit-lamp observations of 
microfilariae in the cornea, the anterior chamber, or the vitreous body). 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance  
If a suspected case is detected: 
§ Report the case according to national guidelines 
§ Collect specimen for confirming the case 
§ Investigate the case to determine the cause of the case 
§ Treat the case according to national guidelines. 
Respond to a 
confirmed outbreak 
for other diseases of 
public health 
importance  
If a case is confirmed: 
§ Conduct a migration investigation to identify the origins of infection and 
initiate control activities. 
§ Carry out vector control activities according to OCP guidelines. 
§ Conduct periodic mass treatment with ivermectin in areas with endemic 
onchocerciasis during the last 10 years. 
§ Conduct active case finding via population-based surveys and skin snips. 
Analyze and interpret 
data 
Time: Graph cases quarterly. 
 
Place: Plot distribution of patients’ household and workplaces 
 
Person:            Count quarterly cases and analyze age distribution. 
Reference  WHO Recommended Surveillance Standards. Second edition.  
WHO/CDS/CSR/ISR/99.2 
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Plague 
Background § Zoonotic systemic bacterial infection caused by Yersinia pestis (plague 
bacillus) usually transmitted to humans by rodents and their fleas. 
§ Main disease forms: bubonic, pneumonic, and septicemic; large-scale 
epidemics may occur in urban or rural settings. 
§ Incubation period is 1 to 7 days. 
§ Case fatality rate (CFR) may exceed 50-60% in untreated bubonic 
plague and approaches 100% in untreated pneumonic or septicemic 
plague, but is usually <1% with appropriate treatment. 
§ Risk factor: rural residence.  Exposure to infected populations of wild or 
domesticated rodents and their fleas. 
Surveillance goal § Detect outbreaks of plague promptly.  Verify etiology of all suspected 
non-outbreak-related cases and the first 5 to 10 outbreak-related 
cases. 
Recommended case 
definition 
Suspected case: 
Any person with sudden onset of fever, chills, headache, severe malaise, 
prostration and very painful swelling of lymph nodes, or cough with blood 
stained sputum, chest pain, and difficulty in breathing. 
 
Confirmed case: 
Suspected case confirmed by isolation of Yersinia pestis from blood or 
aspiration of buboes, or epidemiologic link to confirmed cases or outbreak. 
Respond to alert 
threshold for 
epidemic-prone 
diseases 
If a single case is suspected: 
§ Report case-based information to the next level. 
§ Collect specimen for confirming the case. 
§ Investigate the case. 
§ Treat the patient with streptomycin, gentamicin or chloramphenicol, 
and administer chemoprophylaxis of close contacts with tetracycline for 
seven days from time of last exposure. 
Respond to action 
threshold for 
epidemic-prone 
diseases 
 
If the suspected case is confirmed: 
§ Isolate patients and contacts of pneumonic plague with precautions 
against airborne spread (wear masks, for example) until at least after 
48 hours of appropriate antibiotic therapy. 
§ Mobilize community to enable rapid case detection and treatment, and 
to recognize mass rodent die-off as a sign of possible impending 
epidemic. 
§ Identify high risk population groups through person, place, and time 
analysis. 
§ Reduce sporadic and outbreak-related cases via improved control or 
rodent populations (remove trash, food sources, and rat harborages) 
and protect against fleas with insect repellent on skin and clothing and 
environmental flea control (especially in homes and seaports and 
airports). 
  215 
 
Analyze and 
interpret data  
Time: Graph monthly trends in cases and deaths.  Construct 
epidemic curve for outbreak cases. 
 
Place: Plot the location of case households. 
 
Person: Immediate case-based reporting of cases and deaths for 
routine surveillance.  Count weekly cases and deaths for 
outbreaks.  Analyze age distribution and assess risk factors to 
improve control of sporadic disease and outbreaks. 
Reference Plague Manual: Epidemiology, Distribution, Surveillance and Control/ Manuel    
de la Peste: Epidémiologie, Répartition, Surveillance et Lutte.  
WHO/CDS/CSR/EDC/99.2 
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Pneumonia 
Background § Infection of the lower airways caused by bacteria or viruses transmitted 
person-to-person via aerosolized respiratory droplet spread.  The main 
bacterial causes of pneumonia among children are Streptococcus 
pneumoniae (the pneumococcus) and Haemophilus influenzae type b 
(Hib). 
§ Acute respiratory infections (ARIs) and pneumonia represent the 
number one cause of mortality among children less than 5 years of 
age. 
§ Incubation period is usually less than 7 days, depending on the 
etiology.   
§ WHO and UNICEF recommend use of Integrated Management of 
Childhood Illness (IMCI) strategy to reduce morbidity and mortality 
attributable to childhood pneumonia.  Early antimicrobial therapy has 
been shown to reduce mortality. 
§ Resistance of the pneumococcus and Hib to beta-lactams (for 
example, ampicillin), sulfonamides (for example, tremethoprim-
sulfamethoxazole) and other antimicrobials is increasing. 
§ Viruses such as respiratory syncytial virus (RSV) may also cause ARI 
and pneumonia. 
Surveillance goal § Early identification of pneumonia cases and epidemics using clinical 
definitions. 
§ Monitor antimicrobial resistance routinely and during outbreaks. 
§ Reducing the proportion of severe pneumonia cases compared to non-
severe pneumonia cases to monitor quality of interventions. 
Recommended case 
definition 
Clinical case definition (IMCI) for pneumonia: 
A child presenting with cough or difficult breathing and: 
-- 50 or more breaths per minute for infant age 2 months 
up to 1 year 
-- 40 or more breaths per minute for young child 1 year 
up to 5 years. 
(Note: A young infant age 0 up to 2 months with cough and fast 
breathing is classified in IMCI as “serious bacterial infection” and is 
referred for further evaluation.) 
 
Clinical case definition (IMCI) for severe pneumonia: 
A child presenting with cough or difficult breathing and any general danger 
sign, or chest indrawing or stridor in a calm child.  General danger signs for 
children 2 months to 5 years are: unable to drink or breast feed, vomits 
everything, convulsions, lethargy, or unconsciousness. 
 
Confirmed case: 
Radiographic or laboratory confirmation of pneumonia will not be feasible in 
most districts. 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance  
If you observe that the number of cases or deaths is increasing over a 
period of time: 
§ Report the problem to the next level. 
§ Investigate the cause for the increase and identify the problem. 
§ Make sure that cases are managed according to IMCI guidelines. 
§ Treat cases appropriately with recommended antimicrobial drugs 
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Respond to a 
confirmed outbreak 
of other disease of 
public health 
importance  
If the number of case or deaths increases to two times the number 
usually seen during a similar period in the past: 
§ Assess health worker practices of IMCI guidelines for assessing, 
classifying and treating children with pneumonia and severe 
pneumonia. 
§ Identify high risk populations through analysis of person, place and 
time. 
§ Conduct community education about when to seek care for pneumonia. 
Analyze and 
interpret data  
Time: Conduct month-to-month analysis for unexpected or unusual 
increases.  Graph cases and deaths by month.  Construct 
epidemic curve for outbreak cases.  Plot month-to-month data 
and compare to previous periods. 
 
Place: Plot location of case households. 
 
Person: Count monthly pneumonia and severe pneumonia cases.   
Count pneumonia deaths.  Analyze age distribution. 
Reference Integrated Management of Childhood Illnesses.  World Health Organization.  
WHO/CDR/95.14.1 
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Poliomyelitis (Acute flaccid paralysis) 
Background § Poliovirus (genus Enterovirus) serotypes 1, 2, and 3 are transmitted 
from person-to-person via fecal-oral spread. 
§ Incubation period is 7 to 14 days for paralytic cases and the range is 
approximately 3 to 35 days.  The virus may be shed for several years 
by immunocompromised persons. 
§ Infection is usually asymptomatic, but may cause a febrile syndrome 
with or without meningitis.  In less than 5% of infections paralysis 
results, often of a single leg. 
§ Polio infection occurs almost exclusively among children.  Infection 
may occur with any of 3 serotypes of Poliovirus.  Immunity is serotype-
specific and lifelong. 
§ Paralytic polio, though not fatal, has devastating social and economic 
consequences among affected individuals. 
§ The Polio Eradication Program has nearly halted ongoing wild-type 
polio transmission worldwide through use of oral poliovirus (OPV) 
vaccine.  Globally, poliovirus type 2 appears to have been eliminated.  
Serotypes 1 and 3 poliovirus still circulate in several African countries, 
and surveillance is not yet adequate to assure eradication in many 
countries.  
§ Areas with low vaccine coverage may allow ongoing wild-type 
transmission. 
§ Other neurologic illnesses may cause AFP, for example, Guillain-Barré 
syndrome and transverse myelitis. 
Surveillance goal § Immediate case-based reporting of all poliomyelitis cases.  Weekly 
summary reporting of cases for routine surveillance and outbreaks. 
§ Detect cases of acute flaccid paralysis (AFP) and obtain laboratory 
confirmation of the etiology of all suspected AFP cases.  Obtain tow or 
more stool specimens with 14 days of the onset of paralysis for viral 
isolation. 
§ Surveillance for AFP is used to capture all true cases of paralytic 
poliomyelitis.  Target for surveillance performance to provide 
certification of polio eradications is 1 case of AFP per year per 100 000 
population aged less than 15 years. 
Recommended case 
definition 
Suspected case: 
Any child under 15 years of age with acute flaccid paralysis or any person with 
paralytic illness at any age in whom the clinician suspects poliomyelitis. 
 
Confirmed case: A suspected case with virus isolation in stool. 
Respond to alert 
threshold for  
diseases targeted 
for eradication 
If a single case is suspected: 
§ Report the suspected case immediately according to the national polio 
eradication programme guidelines. 
§ Conduct a case-based investigation.  Include a vaccination history for 
the patient. 
§ Collect two stool specimens.  Collect the first one when the case is 
investigated.  Collect the second one from the same patient 24 to 48 
hours later.  See laboratory guidelines for information on how to 
prepare, store and ship the specimen. 
§ Obtain virologic data from reference laboratory to confirm wild-type 
poliomyelitis or VAPP. 
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Respond to action 
threshold for  
diseases targeted 
for eradication 
If a case is confirmed: 
§ If wild polio virus is isolated from stool specimen, refer to national polio 
eradication programme guidelines for recommended response actions.  
The national level will decide which actions to take and may include: 
-- Specify reasons for non-vaccination of each unvaccinated case 
and address the identified deficiencies. 
-- Immediately conduct “mopping-up” vaccination campaign 
around the vicinity of the case. 
-- Conduct surveys to identify areas of low OPV coverage during 
routine EPI activities, and improve routine vaccine coverage of 
OPV and other EPI antigens. 
-- Lead supplemental vaccination campaigns during National 
Immunization Days (NIDs) or Sub-National Immunization Days 
(SNIDs).  Focus supplemental vaccination activities in areas of 
low vaccine coverage during EPI.  Consider use of house-to-
house vaccination teams in selected areas. 
Analyze and 
interpret data  
Time: Graph monthly cases (which should be zero to very few cases 
per area per year), or weekly cases during an outbreak.  
Evaluate the percent of suspected cases reported within 48 
hours and the percentage with adequate laboratory evaluation. 
 
Place: Plot location of case households.  Investigate the 
circumstances of poliovirus transmission in each case 
thoroughly.  Examine the possibility of other potential areas of 
transmission. 
 
Person: Count monthly routine and outbreak -related cases.  Analyze 
age distribution.  Assess risk factors for low vaccine coverage. 
Reference  Field Guide for Supplementary Activities Aimed at Achieving Polio Eradication.  
World Health Organization. 
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Sexually transmitted infections 
(Urethral discharge.  Male and female genital ulcer) 
Background § Infections of the human genito-urinary and reproductive systems 
transmitted via human sexual contact (sexually transmitted disease, 
STIs).  The most common causes of male urethral discharge are a) the 
gonococcus Nausari gonorrheaea and b) Chlamydia trachomatis.  The 
most common causes of male and female genital ulcer are c) syphilis 
(Treponema pallidum), d) herpes simplex virus (HSV1 or 2) and e) 
chancroid (Haemophilus ducreyi). 
§ STIs are endemic in most countries of the world, including countries in 
Africa.  Multiple simultaneous STIs are common (for example, 
gonorrhea plus Chlamydia).  STIs may be most highly prevalent in 
areas where HIV occurs and may facilitate HIV transmission.  STIs 
may be primary or from repeated attacks of urethral discharge. 
§ STIs are a leading cause of abortion and stillbirth, prematurity, and 
congenital infections.  They may lead to pelvic inflammatory disease 
(PID), a major cause of decreased fertility. 
§ Incubation periods for gonorrhea are 2 to 7 days; Chlamydia 7 to 14 
days (or longer);  syphilis, 10 days to 12 weeks (usually around 3 
weeks), and chancroid, 3 to 14 days. 
§ STIs may be more commonly diagnosed in men, in whom clinical 
evidence of infection may be more readily apparent. 
Surveillance goal § Early detection and treatment of STI reduces transmission rates.  
Active efforts to diagnose latent syphilis may prevent significant 
disability. 
§ Improve early and effective treatment of STIs using simple algorithms 
based on syndromic diagnosis for index cases and partners. 
§ Carry out laboratory-based anti-microbial sensitivity monitoring and 
modify treatment guidelines accordingly at the national level. 
§ Compare surveillance data for both STIs and HIV/AIDS since STIs may 
reflect co-presence of HIV. 
Recommended case 
definition 
Suspected case: 
§ Genital ulcer syndrome (non-vesicular): Any male with an ulcer on the 
penis, scrotum, or rectum, with or without inguinal adenopathy, or any 
female with ulcer on labia, vagina, or rectum, with or without inguinal 
adenopathy. 
§ Urethral discharge syndrome: Any male with urethral discharge with or 
without dysuria. 
 
Confirmed case: 
§ Genital ulcer syndrome (non-vesicular): Any suspected case confirmed 
by a laboratory method. 
§ Urethral discharge syndrome: A suspected case confirmed by a 
laboratory method (for example Gram stain showing intracellular Gram-
negative diplococci). 
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Public health action § Conduct active case finding for specific target groups. 
§ Conduct primary prevention activities such as promotion of safer 
sexual behaviours and provision of condoms. 
§ Assess use of algorithms for detection and treatment of STIs. And 
improve health worker practice with algorithms. 
§ Include STI prevention and care services in maternal and child health, 
and family planning services. 
§ Target acceptable and effective STI prevention and care services to 
populations identified as vulnerable to STI transmission. 
§ Promote early STI health seeking behaviour. 
Analyze and 
interpret data  
Time: Graph cases each quarter. 
 
Place: No recommendation for analysis of place. 
 
Person: Count quarterly cases and analyze age distribution. 
Reference Guidelines for Sexually Transmitted Infections Surveillance.  Geneva.  UNAIDS 
and World Health Organizaiton.  WHO/CDS/CSR/EDC/99.3.  UNAIDS/99.33E  
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Trypanosomiasis 
Background § Trypanosomiasis is an infection of blood, lymphatics and central 
nervous system.  In Africa it is caused by the protozoan Trypanosoma 
burcei rhodesiense and T. b. gambiense, which are transmitted by the 
bit of infected Glossina (tsetse) flies. 
§ Trypanosomiasis is endemic in over 30 African countries in West, 
Central and East Africa.  It is highly epidemic in the Democratic 
Republic of Congo, Angola, and other areas of civil conflict, where 80% 
of some village populations may be infected.  Cattle are the major 
reservoir of Trypanosoma brucei rhodesiense, and humans are the 
major reservoir for T. b. gambiense. 
§ Incubation period is usually days to weeks with T. b. rhodesiense, and 
months to years with T. b. gambiense infections.  Without treatment, 
both forms are usually fatal. 
§ Trypanosomiasis control strategies include human and cattle 
population surveys to treat infected persons and diminish cattle 
reservoirs, and tsetse fly habitat control (for example, removal of 
bushes and tall grasses near villages, and use of residual insecticides). 
§ Tuberculosis, malaria, bacterial meningitis, HIV/AIDS, and other central 
nervous system or systemic infections can produce similar clinical 
findings. 
Surveillance goal § Increase percentage of cases confirmed by laboratory methods. 
§ Use population-based surveys and serologic screening for active case 
finding in endemic areas. 
§ Conduct human and cattle screening in trypanosomiasis-free areas. 
Recommended case 
definition 
Suspected case:  
Early stage: a painful chancre originating as a papule and then 
evolving into a nodule at the primary fly bite site.  There may be fever, 
intense headache, insomnia, painless lymphadenopathy, anaemia, 
local oedema and rash. 
Late stage: cachexia, somnolence, and central nervous system signs. 
Confirmed case: 
A suspected case confirmed by card agglutination trypanosomal test 
(CATT) or by isolation of trypanosomes in blood lymph nodes or 
cerebrospinal fluid. 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance 
If you observe that the number of cases or deaths is increasing over a 
period of time: 
§ Report the problem according to national guidelines. 
§ Treat any individual suspected and confirmed cases with appropriate 
therapy in closely monitored setting. 
§ Collect specimen for laboratory confirmation. 
§ Investigate cause of increasing number of cases to identify problems 
with prevention activities. 
Respond to a 
confirmed outbreak 
for other diseases of 
public health 
importance  
If the number of cases or deaths increases to two times the number 
usually seen in a similar period in the past: 
§ Assess prevention activities in the area around the cases and take 
action to improve them as indicated. 
§ Conduct active case finding activities if it is an endemic area. 
§ Conduct vector control activities specified by national guidelines. 
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Analyze and 
interpret data  
Time: Graph quarterly cases. 
 
Place: Plot the distribution of case households.   
 
Person: Count monthly cases, and analyze age distribution. 
Reference 
 
Control and Surveillance of African Trypanosomiasis. Report of a WHO Expert 
Committee, Geneva,World Health Organization, 1998  (WHO Technical Report 
Series, No. 881). 
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Tuberculosis 
Background § Infection of the lungs and other organs usually caused by 
Mycobacterium tuberculosis transmitted person-to-person by droplet 
infection through coughing, sneezing or spitting.  Clinically, the 
pulmonary form of the disease is more common than the extra-
pulmonary form.  The cardinal symptoms of pulmonary TB are chronic 
cough, weight loss, fever, loss of appetite and night sweats. 
§ Tuberculosis (TB) is a leading cause of infectious illness and death 
worldwide with over 8 million new cases and 3 million deaths per year.  
In African countries, approximately 1.6 million of the new cases and 
over 600 000 cases occur each year.  It is also estimated that between 
30 and 50% of all new TB cases detected are infected with HIV and 
40% of all AIDS deaths are due to TB.  Those who are at highest risk 
of dying from TB include people with HIV/AIDS, malnutrition and other 
immuno-compromising conditions, the very young, and the very old. 
§ The global HIV pandemic has been a major cause of increasing TB 
cases, especially in African countries. 
§ Incubation period is approximately 1 to 3 months. 
§ WHO recommends the Directly Observed Therapy, Short-course 
(DOTS) strategy to maximize compliance and treatment efficacy and to 
reduce development of drug-resistant strains.  The DOTS strategy has 
been implemented by at least 40 of 46 Member States in the African 
region.  Varying degrees of success have been achieved in controlling 
TB where resources and motivation for diagnosis, treatment, and 
patient follow up are adequate. 
§ Clinically, bacterial pneumonia, malaria, trypanosomiasis, HIV/AIDS 
and a variety of other bacterial, parasitic, and viral infections may 
cause similar syndromes of fever, cough, fatigue, and weight loss, or 
may themselves precipitate active TB in an already infected individual.  
Abdominal or other extrapulmonary sites of infection may occur after 
ingestion of unpasteurized cows/ milk (M. bovis). 
Surveillance goal § Early detection of persons with infectious lung disease to improve 
chances of clinical improvement and reduce transmission of TB. 
§ Improve percentage of TB cases confirmed by microscopy 
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Recommended case 
definition 
Suspected case: 
Any person with a cough of 3 weeks or more. 
 
Confirmed case: 
Smear-positive pulmonary TB: a) a suspected patient with at least 2 
sputum specimens positive for acid-fast bacilli (AFB), or b) one sputum 
specimen positive for AFB by microscopy and radiographic 
abnormalities consistent with active PTB as determined by the treating 
medical officer, or c) one positive sputum smear by microscopy and 
one sputum specimen positive on culture for AFB. 
 
Smear negative PTB: a patient who fulfills all the following criteria: a) 
two sets taken at least 2 weeks apart of at least two sputum specimens 
negative for AFB on microscopy, radiographic abnormalities consistent 
with PTB and a lack of clinical response despite one week of a broad 
spectrum antibiotic, a decision by a physician to treat with a full course 
of anti-TB chemotherapy, or b) a patient who fulfills all the following 
criteria: severely ill, at least two sputum specimens negative for AFB by 
microscopy, radiographic abnormalities consistent with extensive 
pulmonary TB (interstitial and miliary), a decision by a physician to treat 
with a full course of anti-TB chemotherapy, or c) a patient whose initial 
sputum smears were negative, who had sputum sent for culture 
initially, and whose subsequent sputum culture result is positive. 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance  
If you observe that the number of cases or deaths is increasing over a 
period of time: 
§ Report problem to the next level, or according to national guidelines. 
§ Treat individual cases with direct observation (DOTS) including a 
treatment supporter. 
§ Where feasible, isolate persons using respiratory infection control 
practices, especially if multi-drug resistant TB is suspected. 
§ Investigate cause of increase, including performance of DOTS 
programme in your area. 
Respond to a 
suspected outbreak 
for other diseases of 
public health 
importance  
If the number of cases or deaths increases to two times the number 
usually seen in a similar period in the past: 
§ Assess health worker performance with detection and treatment of 
smear-positive PTB and improve practices as needed. 
§ Assess DOTS program and take action to make identified 
improvements. 
§ Conduct drug susceptibility tests to establish patterns of resistance. 
Analyze and 
interpret data  
Time: Graph cases and deaths monthly. 
 
Place : Plot distribution of case households and workplaces. 
 
Person: Count monthly cases and deaths.  Analyze age and sex 
distribution quarterly. 
Reference Treatment of Tuberculosis: Guidelines for National Programmes.  
WHO/TB/97.230 
Policy Statement of Prevention Therapy Against TB in People Living with HIV, 
WHO/TB/98.255 
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Viral hemorrhagic fevers 
Background § This is a hemorrhagic disease syndrome caused by the following 
viruses:  Ebola-Marburg (filoviruses), Lassa fever, Rift Valley fever 
(RVF), Congo-Crimean hemorrhagic fever (CCHF), and dengue 
hemorrhagic fever (DHF).  No DHF has been reported in Africa.   
§ The disease is transmitted from person-to-person (Ebola, Marburg, 
Lassa, CCHF), or via mosquitos (RVF, dengue), ticks (CCHF), rodents 
(Lassa), or contact with infected animals (RVF, CCHF).  Ebola and 
Marburg may be transmitted via sexual contact. 
§ Some viral hemorrhagic fevers (VHF) have explosive outbreak 
potential: international reporting to WHO is required within 24 hours. 
§ Incubation period is variable, from 3 to 21 day depending on etiology. 
§ The minority of cases have hemorrhagic symptoms, but among those 
with these symptoms, the case fatality rate is high (15% to 90%). 
§ Risk factors: In the health care setting, outbreaks may be amplified 
when standard barrier precautions are not taken, or in ceremonies 
involving touching ill or deceased infected persons or their secretions.  
Sporadic cases may arise from sexual contact or via sylvatic exposures 
(for example, occupation), or possibly following direct contact with 
infected animals. 
§ Other hemorrhagic conditions that may mimic VHF include yellow 
fever, dengue, anthrax, leptospirosis, rickettsial infections, relapsing 
fever, and other infectious agents and toxic exposures. 
Surveillance goal § Detect hemorrhagic fever cases and outbreaks promptly and seek 
laboratory verification of the etiology of all cases of suspected VHF. 
§ In outbreak settings, the disease spectrum of VHF agents may include 
non-hemorrhagic febrile syndromes, and laboratory testing should be 
considered among persons with milder symptoms suggestive of viral 
illness. 
Recommended case 
definition 
Suspected case: 
Illness with onset of fever and no response to usual causes of fever in 
the area, and at least one of the following signs: bloody diarrhoea, 
bleeding from gums, bleeding into skin (purpura), bleeding into eyes 
and urine. 
 
Confirmed case: 
A suspected case with laboratory confirmation (positive IgM antibody or 
viral isolation), or epidemiologic link to confirmed cases or outbreak. 
Respond to alert 
threshold for 
epidemic-prone 
diseases 
 
If a single case is suspected: 
§ Report case-based information immediately to the appropriate levels. 
§ Begin VHF isolation precautions immediately and enhance standard 
precautions throughout the health care setting.  Use protective clothing, 
disinfection of surfaces and spills, safe disposal of materials used for 
patient care and safe disposal of patient waste. 
§ Treat and manage the patient with supportive care. 
§ Collect specimen safely to confirm the case. 
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Respond to action 
threshold for 
epidemic-prone 
diseases 
 
 
If a single case is confirmed: 
§ Maintain strict VHF infection control practices throughout the duration 
of the outbreak. 
§ Mobilize the community for early detection and care. 
§ Conduct community education about the confirmed case, how the 
disease is transmitted, and how to use infection control in the home 
care setting.   
§ Conduct active searches for additional cases that may not come to the 
health care setting (older women or small children, for example) and 
provide information about prevention in the home and when to seek 
care. 
§ Request additional help from national levels as needed. 
§ Establish isolated ward to handle additional cases that may come to 
the health center. 
Analyze and 
interpret data 
Time: Graph cases and deaths monthly.  Construct an epidemic 
curve during the outbreak. 
 
Place: Plot location of case households and work sites using precise 
mapping. 
 
Person: Immediate case-based reporting of cases and deaths.  During 
the outbreak, count and report cases and deaths.  Analyze age 
and sex distribution.  Assess risk factors immediately and 
consider request for  assistance to improve outbreak control. 
Reference  Infection control for VHF in the African health care setting, WHO, 1998.  
WHO/EMC 
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Yellow fever 
Background § Viral hemorrhagic disease caused by a flavivirus transmitted human-to-
human via Aedes mosquitos (urban epidemics) or via forest mosquito 
species and forest primate reservoirs (jungle cycle). 
§ Large scale outbreaks every 3 to 10 years in villages or cities.  
Sporadic cases can occur regularly in endemic areas.  Resurgence of 
disease in Africa since mid-1980s.  True incidence far exceeds 
reported cases. 
§ Incubation period 3 to 6 days after the bite from an infected mosquito. 
§ While only the minority of cases are severe, case fatality rate may be 
25% to 50% among patients with syndrome of hemorrhage, jaundice, 
and renal disease. 
§ Risk factor: sporadic cases often linked to occupation or village location 
near woods or where monkeys are numerous.  Also non-vaccinated 
persons. 
§ International reporting to WHO required within 24 hours. 
§ VHF and other infections causing hemorrhage may mimic yellow fever. 
Surveillance goal § Detect hemorrhagic fever cases and outbreaks promptly, and seek 
laboratory verification of the etiology of all cases of suspected yellow 
fever. (Other viral hemorrhagic fevers, dengue, anthrax, leptospirosis, 
rickettsial diseases, malaria, and other infectious agents and toxic 
exposures may cause similar epidemics.) 
Recommended case 
definition 
Suspected case:   
A person with acute onset of fever followed by jaundice within two 
weeks of onset of first symptoms.  Hemorrhagic manifestations and 
renal failure may occur. 
Confirmed case: 
A suspected case with laboratory confirmation (positive IgM antibody or 
viral isolation) or epidemiologic link to confirmed cases or outbreaks. 
Respond to alert 
threshold for  
epidemic-prone 
diseases 
 
If a single case is suspected: 
§ Report case-based information immediately to the next level. 
§ Treat and manage the patient with supportive care administered under 
a bednet (ORS, paracetamol for dehydration, fever) and strict isolation 
procedures. 
§ Collect specimen for laboratory confirmation. 
§ Investigate the case to determine how transmission occurred. 
§ Plan for an immunization activity. 
Action threshold for 
responding to 
epidemic-prone 
diseases 
 
If a single case is confirmed: 
§ Mobilize community early to enable rapid case detection and treatment. 
§ Conduct a mass campaign in appropriate age group in the area (ages 
6 months and older) and in areas with low vaccine coverage. 
§ Identify high risk population groups and take steps to reduce exposure 
to mosquitos. 
§ Improve routine and mass vaccination campaigns to include yellow 
fever in high risk areas. 
  229 
 
Analyze and 
interpret data  
Time: Graph cases and deaths monthly.  During an outbreak, graph 
cases and deaths weekly.  Construct an epidemic curve during 
outbreaks. 
 
Place: Plot location of case households and occupation with precise 
mapping. 
 
Person: Report immediate case-based information for cases and 
deaths.  Report summary totals monthly.  During outbreak, 
count cases and deaths weekly.  Analyze by age.  Assess risk 
factors to improve prevention of sporadic outbreaks. 
Reference  District guidelines for yellow fever surveillance.  WHO 1998 
 
